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Abstract 
 
Pichia pastoris is a commonly used recombinant protein expression host, predominantly due to ease 
of genetic manipulation and its capacity for high cell densities in cheap culture media. While 
considerable yields can be achieved in this way, the specific productivity is relatively low. 
Consequently, the full impact of this host on industrial biotechnology has not yet been realised. 
 
This research aimed to develop a strategy to optimise production of single chain antibody fragments 
(scFvs), an industrially relevant protein, using an integrated modelling and experimental approach. 
Initially, a dynamic model was constructed from literature sources to reproduce the scFv production 
pathway in P. pastoris. It incorporated aspects of transcription, translation, folding and misfolding in 
the endoplasmic reticulum (ER). Moreover, the unfolded protein response (UPR) and ER-associated 
degradation (ERAD) were added as these two stress pathways are crucial to productivity. Simulations 
qualitatively reproduced phenomena including secretion saturation and the negative influence of 
high gene copy numbers on yield.  
 
The model was used to target evaluation of the experimental system: P. pastoris strains expressing 
the scFvs BC1 and MFE23. RT Q-PCR and LC-MS/MS results revealed some surprising correlations 
between certain factors, such as the concentration of Kar2 and PDI, and yield. Moreover, it showed 
that there was more than one route to high productivity. Finally, it suggested that there may be an 
internal regulation of Kar2 that would be crucial to strategies aiming to increase yield through 
overexpression of that chaperone. 
 
Together, the results revealed a more complex picture of productivity than previously understood. In 
order to develop a strategy for optimal scFv production in P. pastoris, a greater understanding of the 
underlying biology and biochemistry is required. This research has suggested targets for future work 
which should generate insight into the network of factors responsible. 
  
 - 4 - 
Declaration of originality 
 
I certify that the work presented in this thesis is my own; all other material has been acknowledged 
accordingly. 
 
Kate Elizabeth Royle 
Sunday, 06 April 2014 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 - 5 - 
Acknowledgements 
 
I would like to thank my supervisors David Leak and Cleo Kontoravdi, for giving me the opportunity 
to do this research and for their support and guidance throughout. I would also like to thank Karen 
Polizzi for encouraging me from the nine month report to the final draft. The trials and tribulations 
of developing the LC-MS/MS protocol would never have rendered anything useful without the 
advice and patience of Mark Bennett. To Ioscani Jimenez del Val, who managed the impossible task 
of teaching a biologist the importance of an index reduction, I am thankful. Lastly, I am grateful to 
the BBSRC for funding the project, and the SGM and IChemE for sponsoring my attendance at 
conferences which shaped this research. 
 
My thanks to Jeremy Bartosiak-Jentys for troubleshooting, a sofa in Bath, and for collaborating with 
Nicola Crowhurst in jug-and-a-pint antics. I am appreciative to the members of the Leak and 
Kontoravdi lab groups, my Uni and home friends – all of whom helped celebrate the science victories 
and commiserate the repeated failures.  
 
Finally, my heartfelt thanks to my family who have supported me throughout and always had red 
wine at the ready. This thesis is dedicated to number nine.  
 
 
 
 
 
 
 
 
 
“Always laugh when you can. It is cheap medicine” 
Lord Byron (1788 - 1824)  
 - 6 - 
Contents 
 
Copyright declaration ............................................................................................................................. 2 
Abstract ................................................................................................................................................... 3 
Declaration of originality ........................................................................................................................ 4 
Acknowledgements ................................................................................................................................. 5 
Contents .................................................................................................................................................. 6 
List of figures ......................................................................................................................................... 13 
List of tables .......................................................................................................................................... 16 
List of abbreviations and nomenclature ............................................................................................... 17 
1. Introduction .................................................................................................................................. 22 
1.1 Recombinant gene expression and the biopharmaceutical industry ................................... 22 
1.2 Expression hosts .................................................................................................................... 23 
1.2.1 Bacteria ......................................................................................................................... 24 
1.2.2 Yeast species and filamentous fungi ............................................................................. 25 
1.2.3 Plant cells ...................................................................................................................... 26 
1.2.4 Insect cells ..................................................................................................................... 27 
1.2.5 Mammalian cells ........................................................................................................... 27 
1.2.6 Summarising the key features of expression hosts ...................................................... 28 
1.2.7 Distribution of expression systems in the biopharmaceutical industry ....................... 29 
1.3 Pichia pastoris and the problem of low specific productivity ............................................... 30 
1.3.1 Protein production pathway of P. pastoris ................................................................... 30 
1.3.2 Endoplasmic reticulum-associated degradation ........................................................... 33 
1.3.3 Unfolded protein response ........................................................................................... 35 
 - 7 - 
1.3.4 Protein glycosylation and transport through the Golgi network .................................. 37 
1.4 Increasing specific productivity of heterologous protein production in P. pastoris ............. 37 
1.4.1 Transcription ................................................................................................................. 38 
1.4.2 Translation .................................................................................................................... 38 
1.4.3 Folding and glycosylation .............................................................................................. 39 
1.4.4 Secretion and the extracellular environment ............................................................... 40 
1.4.5 Simultaneously targeting multiple parts of the protein production pathway .............. 41 
1.5 Modelling as a guide to increasing protein production in P. pastoris .................................. 41 
1.5.1 Mathematical modelling in biology .............................................................................. 41 
1.5.2 Dynamic modelling ....................................................................................................... 42 
1.5.3 Stages in model development ...................................................................................... 42 
1.5.4 Previous models ............................................................................................................ 44 
1.5.5 Strategy for modelling protein production in P. pastoris ............................................. 47 
1.6 Single-chain antibody fragments: an industrially relevant and informative protein platform 
to explore cellular capacity ............................................................................................................... 47 
1.6.1 BC1 ................................................................................................................................ 49 
1.6.2 MFE23 ........................................................................................................................... 49 
1.7 Aims and objectives .............................................................................................................. 49 
2. Materials and methods ................................................................................................................. 51 
2.1 Strains and plasmids ............................................................................................................. 51 
2.1.1 Antibiotics ..................................................................................................................... 52 
2.1.2 Glycerol stocks .............................................................................................................. 52 
2.1.3 Sterilisation ................................................................................................................... 52 
2.2 Media .................................................................................................................................... 53 
2.2.1 Bacterial media ............................................................................................................. 53 
2.2.2 Yeast media ................................................................................................................... 53 
2.2.3 Measurement of cell density ........................................................................................ 54 
2.3 Molecular biology methods .................................................................................................. 54 
 - 8 - 
2.3.1 Agarose gel electrophoresis .......................................................................................... 54 
2.3.2 Plasmid DNA extraction ................................................................................................ 55 
2.3.3 Yeast genomic DNA extraction ..................................................................................... 55 
2.3.4 Yeast RNA storage, extraction and quality analysis ...................................................... 56 
2.3.5 Restriction digests ......................................................................................................... 56 
2.3.6 Ligations ........................................................................................................................ 56 
2.3.7 DNA purification ............................................................................................................ 56 
2.3.8 DNA quantification ........................................................................................................ 57 
2.3.9 DNA sequencing ............................................................................................................ 57 
2.3.10 End-point polymerase chain reaction (PCR) and primer details ................................... 57 
2.3.11 Reverse-transcriptase quantitative PCR (RT Q-PCR) analysis and primer details ......... 59 
2.3.12 Preparation and heat shock transformation of TSS competent E. coli cells ................. 62 
2.3.13 Preparation and transformation of electrocompetent P. pastoris GS115 cells ............ 63 
2.3.14 Southern blot analysis ................................................................................................... 63 
2.4 Protein methods ................................................................................................................... 64 
2.4.1 SDS-PAGE protein gels .................................................................................................. 64 
2.4.2 Native-PAGE protein gels .............................................................................................. 65 
2.4.3 Protein quantification ................................................................................................... 66 
2.4.4 Dialysis .......................................................................................................................... 66 
2.5 Dot-blot detection of expression level of transformants ..................................................... 66 
2.6 Analysis of scFv glycosylation ............................................................................................... 67 
2.7 Culture conditions ................................................................................................................. 68 
2.8 Generation of isotopically labelled peptides for LC-MS/MS ................................................. 68 
2.8.1 Whole protein standards .............................................................................................. 68 
2.9 SpikeTides™ TQL peptides .................................................................................................... 70 
2.10 LC-MS/MS quantification of Kar2 and PDI ............................................................................ 71 
2.11 Statistical analysis ................................................................................................................. 73 
3. Modelling scFv production ............................................................................................................ 75 
 - 9 - 
3.1 Introduction .......................................................................................................................... 75 
3.2 Model definition ................................................................................................................... 78 
3.2.1 Transcription ................................................................................................................. 78 
3.2.2 Translation .................................................................................................................... 80 
3.2.3 Protein folding............................................................................................................... 82 
3.2.4 Protein misfolding ......................................................................................................... 86 
3.2.5 Adding chaperones to the system ................................................................................ 88 
3.2.6 Removing misfolded protein from the system through ERAD ...................................... 96 
3.2.7 Up-regulation of UPR targets ...................................................................................... 100 
3.2.8 Initial conditions .......................................................................................................... 105 
3.2.9 Emergent properties ................................................................................................... 105 
3.3 Discussion ............................................................................................................................ 115 
3.3.1 Model analysis ............................................................................................................ 115 
3.3.2 Model assumptions ..................................................................................................... 116 
3.3.3 Comparisons to previous models and novelty ............................................................ 119 
3.3.4 Single chain-antibody fragments are difficult to produce .......................................... 120 
3.3.5 Directing experimental analysis .................................................................................. 121 
4. Generating an experimental system ........................................................................................... 122 
4.1 Introduction ........................................................................................................................ 122 
4.1.1 Heterogeneity in specific productivity in P. pastoris .................................................. 122 
4.1.2 Generating an experimental system to produce applicable data ............................... 123 
4.2 Results ................................................................................................................................. 124 
4.2.1 Construct descriptions ................................................................................................ 124 
4.2.2 Cloning the single-chain antibody fragments into E. coli JM109 ................................ 125 
4.2.3 Transforming P. pastoris GS115 with pPICZαA[BC1/MFE23] ...................................... 125 
4.2.4 Dot blot analysis of secretion to select high and low secretors of each scFv ............. 125 
4.2.5 Southern blot analysis to ascertain gene copy number ............................................. 127 
4.2.6 Evaluating the secreted scFvs for N-linked glycosylation ........................................... 128 
 - 10 - 
4.2.7 Developing a growth protocol to meet requirements ................................................ 130 
4.3 Discussion ............................................................................................................................ 135 
5. Development of an LC-MS/MS method to quantify Kar2 and PDI ............................................. 137 
5.1 Introduction ........................................................................................................................ 137 
5.1.1 Liquid chromatography-mass spectrometry ............................................................... 137 
5.2 Results ................................................................................................................................. 139 
5.2.1 Transforming pET28a[KAR2] and pET28a[PDI] into E. coli BL21 (DE3) ΔArgA ΔLysA . 139 
5.2.2 Optimising expression from auxotrophic strains ........................................................ 139 
5.2.3 Small scale purification ............................................................................................... 141 
5.2.4 Expression with labels and large scale purification .................................................... 142 
5.2.5 Absolute quantification with isotopically labelled synthetic peptides ....................... 145 
5.3 Discussion ............................................................................................................................ 151 
6. Targeted experimental characterisation of strains ..................................................................... 153 
6.1 Introduction ........................................................................................................................ 153 
6.2 Results ................................................................................................................................. 154 
6.2.1 Culture profile of P. pastoris wild-type and scFv strains ............................................. 154 
6.2.2 Absolute quantification of SCFV transcripts before and after induction .................... 156 
6.2.3 UPR characterisation before and after induction ....................................................... 158 
6.2.4 Quantification of Kar2 and PDI before and after induction ........................................ 161 
6.2.5 ERAD characterisation before and after induction ..................................................... 164 
6.3 Discussion ............................................................................................................................ 167 
6.3.1 Transcription from the AOX1 promoter was not an idealised switch ........................ 167 
6.3.2 HAC1 up-regulation indicates stress, but KAR2 and PDI alone does not .................... 169 
6.3.3 Kar2 and PDI protein levels ......................................................................................... 170 
6.3.4 A role for transcriptional down-regulation in stress amelioration? ........................... 171 
6.3.5 Correlations with yield: more than one route to productivity ................................... 172 
6.3.6 High yield strains correlate with low native Kar2 and PDI concentration .................. 174 
6.3.7 Ramifications for the model........................................................................................ 175 
 - 11 - 
7. Overexpressing Kar2 and PDI in the high secreting strains ........................................................ 177 
7.1 Introduction ........................................................................................................................ 177 
7.2 Results ................................................................................................................................. 178 
7.2.1 Construct description .................................................................................................. 178 
7.2.2 Cloning KAR2 and PDI into pIB2 .................................................................................. 179 
7.2.3 Transforming high secreting strains with pIB2-PDI-IRES-KAR2 ................................... 180 
7.2.4 Characterisation of overexpression strains ................................................................ 180 
7.2.5 Absolute quantification of KAR2 and PDI in pIB2[PIK] transformants ........................ 182 
7.2.6 LC-MS/MS quantification of Kar2 and PDI in pIB2[PIK] transformants ...................... 184 
7.2.7 Relative quantification of HAC1 expression in pIB2[PIK] transformants .................... 186 
7.3 Discussion ............................................................................................................................ 187 
7.3.1 pIB2[PIK] transformants are not stable ...................................................................... 187 
7.3.2 Exogenous constructs not subject to the same internal regulation ........................... 188 
7.3.3 Chaperone up-regulation is a double-edged sword ................................................... 189 
8. Discussion .................................................................................................................................... 190 
8.1 Summary of results ............................................................................................................. 190 
8.2 Main conclusions ................................................................................................................ 191 
8.2.1 Modelling the protein production pathway of P. pastoris for industrial production . 191 
8.3 Recommendations for future work .................................................................................... 194 
8.3.1 Expansion of the model with the aim of engineering productivity ............................ 195 
8.3.2 The P. pastoris molecular toolbox and a synthetic approach to host optimisation ... 196 
8.4 Summary ............................................................................................................................. 197 
9. Reference list .............................................................................................................................. 198 
10. Appendix I: Single cell model of scFv production ....................................................................... 216 
10.1 Equations ............................................................................................................................ 216 
10.2 Parameters .......................................................................................................................... 219 
10.3 Initial conditions .................................................................................................................. 220 
11. Appendix II: In silico prediction of N-linked glycosylation sites .................................................. 221 
 - 12 - 
12. Appendix III: DNA sequences ...................................................................................................... 222 
12.1 BC1 sequence of pPICZαA[BC1] .......................................................................................... 222 
12.2 MFE23 sequence of pPICZαA[MFE23] ................................................................................ 223 
12.3 PIK sequence of pIB2[PIK] ................................................................................................... 224 
12.4 P. pastoris and S. cerevisiae Kar2 alignment ....................................................................... 226 
13. Appendix IV: RT Q-PCR standard curve reproducibility .............................................................. 227 
14. Appendix V: Statistical results ..................................................................................................... 228 
  
 - 13 - 
List of figures 
 
Figure 1 – Technology trends in worldwide sales of prescription and over-the-counter drugs ........... 23 
Figure 2 – Host organisms used for the manufacture of new biological entities ................................. 29 
Figure 3 – Specific productivity is the outcome of the whole protein production pathway ................ 31 
Figure 4 – Aspects of the ERAD mechanism based on [A] Hrd1 and [B] Doa10 ................................... 34 
Figure 5 – The unfolded protein response under [A] normal and [B] stressed conditions .................. 35 
Figure 6 – Heat map of the codon usage bias within and between three model organisms ............... 39 
Figure 7 – Schematic of an intact monoclonal antibody and two prevalent derivatives ..................... 48 
Figure 8 – Reference for estimation of DNA size .................................................................................. 55 
Figure 9 – Schematic of the scFv production model ............................................................................. 77 
Figure 10 – SCFV mRNA profile in the nucleus and cytoplasm ............................................................. 80 
Figure 11 – Translation and the linear accumulation of unfolded protein during induction. .............. 82 
Figure 12 – Comparison of modified (MM_E) [1] and standard Michaelis-Menten (MM) kinetics ....... 84 
Figure 13 – The slow phase of variable domain association................................................................. 85 
Figure 14 – Schematic of the protein folding energy landscape .......................................................... 86 
Figure 15 – Incorporating protein misfolding into the system ............................................................. 87 
Figure 16 – Splitting PDI dependent folding into association and catalysis steps. ............................... 90 
Figure 17 – Amending the Kar2 equilibrium expression to account for threshold activation .............. 94 
Figure 18 – The addition of Kar2 to the system. ................................................................................... 95 
Figure 19 – The addition of the ERAD pathway .................................................................................... 99 
Figure 20 – HAC1U splicing and the UPR response.............................................................................. 104 
Figure 21 – Secretion saturation ......................................................................................................... 106 
Figure 22 – Conversion of PDI kinetics from mass action to equilibrium ........................................... 110 
Figure 23 – Secretion saturation and the negative influence of high copy number on yield ............. 110 
Figure 24 – Proteins difficult to fold induce more stress .................................................................... 112 
Figure 25 – Artificially increasing the number of Kar2 molecules ...................................................... 113 
Figure 26 – Artificially increasing the number of PDI molecules ........................................................ 114 
Figure 27 – Artificially increasing the number of both Kar2 and PDI molecules ................................ 115 
 - 14 - 
Figure 28 – pPICZαA expression construct with the SCFV gene ......................................................... 124 
Figure 29 – Dot blot analysis of GS115[BC1] and GS115[MFE23] transformant expression .............. 126 
Figure 30 – Southern blot to analyse SCFV copy number in high and low secreting strains .............. 128 
Figure 31 – ScFv secretion from GS115[BC1]H and GS115[MFE23]H ................................................. 129 
Figure 32 – PNGase F digestion of BC1 and MFE23 ............................................................................ 130 
Figure 33 – Culture profiles of P. pastoris GS115 and the scFv strains grown on BMGY ................... 131 
Figure 34 – Change in ACT1 expression before and after scFv induction ........................................... 132 
Figure 35 – Culture profile of P. pastoris GS115[BC1]H ...................................................................... 134 
Figure 36 – Expression of two internal controls, ACT1 and SGA1, before and after scFv induction .. 134 
Figure 37 – Overview of absolute quantification with MRM and LC-MS/MS ..................................... 138 
Figure 38 – Optimisation of expression conditions for [A] Kar2 and [B] PDI ...................................... 140 
Figure 39 – Kar2 and PDI expression in the soluble and insoluble fractions ...................................... 141 
Figure 40 – Kar2 and PDI purification ................................................................................................. 141 
Figure 41 – Analysis of FPLC purification of [A] Kar2 and [B] PDI ....................................................... 142 
Figure 42 – Non-denaturing analysis of [A] Kar2 and [B] PDI elution fractions .................................. 143 
Figure 43 – Chemical denaturants and heat do not dissociate, but can degrade, complexes ........... 144 
Figure 44 – Analysis of PDI electroelution from polyacrylamide gels................................................. 145 
Figure 45 – The effect of digest time on quantitation of daughter ions ............................................ 146 
Figure 46 – Dose response analysis of internal standards .................................................................. 147 
Figure 47 – Selecting an appropriate concentration of internal standard ......................................... 148 
Figure 48 – Analysis of peptide loss during C18 purification .............................................................. 149 
Figure 49 – Culture profiles of P. pastoris GS115 and the scFv strains ............................................... 155 
Figure 50 – BC1 and MFE23 standards for absolute quantification of SCFV transcripts .................... 155 
Figure 51 – SCFV transcription profile, before and after induction .................................................... 157 
Figure 52 – Relative quantification of UPR transcripts in scFv strains at zero hours ......................... 158 
Figure 53 – Relative quantification of UPR transcripts in GS115 ........................................................ 159 
Figure 54 – Relative quantification of UPR transcripts in scFv strains ................................................ 160 
Figure 55 – Kar2 and PDI concentration in the scFv strains at zero hours ......................................... 162 
Figure 56 – Comparisons of Kar2 and PDI concentration between the scFv strains .......................... 163 
Figure 57 – Relative quantification of ERAD transcripts in GS115 ...................................................... 165 
Figure 58 – Relative quantification of ERAD transcripts in scFv strains at zero hours ....................... 165 
Figure 59 – Relative quantification of ERAD transcripts in high and low secreting scFv strains ........ 166 
Figure 60 – pIB2[PIK] expression construct ........................................................................................ 179 
Figure 61 – Culture profile of the high secreting parental strains and PIK transformants ................. 181 
 - 15 - 
Figure 62 – Standards for absolute quantification of KAR2 and PDI .................................................. 181 
Figure 63 – Absolute quantification of [A] KAR2 and [B] PDI in parental and pIB2[PIK] strains ......... 183 
Figure 64 – Kar2 and PDI profile in the parental and pIB2[PIK] transformants .................................. 185 
Figure 65 – Relative quantification of HAC1 transcripts in scFv strains with PIK construct ............... 187 
  
 - 16 - 
List of tables 
 
Table 1 – The advantages, disadvantages and current applications of expression systems ................ 28 
Table 2 – Strains and plasmids used in this study ................................................................................. 51 
Table 3 – Primers for end-point PCR ..................................................................................................... 58 
Table 4 – Primers for RT Q-PCR ............................................................................................................. 61 
Table 5 – Composition of 10%, 12% and stacking gels used in SDS-PAGE ............................................ 64 
Table 6 – Composition of 10%, 12% and stacking gels used in Native-PAGE ....................................... 65 
Table 7 – Analytical gradient profile for liquid chromatography .......................................................... 73 
Table 8 – MRM transitions and instrument parameters for quantification of Kar2 and PDI ............... 74 
Table 9 – Heat map of Kar2 and PDI concentration detected by each of the transitions .................. 150 
Table 10 – Heat map of signal-to-noise ratio of each of the transitions ............................................ 151 
Table 11 – Heat map of RNA and MS targets with yield ..................................................................... 173 
Table 12 – Parameters values employed in model simulations ......................................................... 219 
Table 13 – Initial conditions for each state variable of the model ..................................................... 220 
  
 - 17 - 
List of abbreviations and nomenclature 
 
ACT1 β-Actin 
ANOVA Analysis of variance 
pAOX1 Alcohol oxidase 1 promoter 
BMGY Buffered glycerol-complex medium 
BMMY Buffered methanol-complex medium; induces pAOX1 
Ct Cycle threshold, RT Q-PCR 
Cdc48 ATPase involved in ubiquitin-mediated protein degradation 
CE Collision energy 
CEA Carcinoembryonic antigen  
CH Heavy-chain constant domain of a monoclonal antibody 
CHO Chinese Hamster Ovary 
CL Light-chain constant domain of a monoclonal antibody 
COPII Coat protein complex II  
cps Counts per second 
CQA Critical quality attribute 
CXP Collision cell exit potential  
Doa10 A ubiquitin protein ligase (E3) 
DTT Dithiothreitol 
DP De-clustering potential 
E1 Ubiquitin-activating enzyme 
E2 Ubiquitin-conjugating enzyme 
E3 Ubiquitin protein ligase 
ELISA Enzyme-linked immunosorbent assay  
ER Endoplasmic reticulum 
ERAD ER associated degradation 
Ero1 ER oxidoreductin 1 
Fab Antigen-binding fragment  
 - 18 - 
FAD Flavin adenine dinucleotide  
FAssociation Flux of folded protein, from the folding intermediate 
FAssociation_Kar2 Flux of folded protein, from the folding intermediate bound to Kar2 
FDA United States Food and Drug Administration   
FE3_Deg Flux of E3 to degradation 
FE3_Influx Flux of E3 into the system 
FERAD Flux of misfolded protein, bound to Kar2, to degradation by ERAD 
FFPIntra_Misfolding Flux of misfolded protein from unfolded protein bound to Kar2 
FHAC1S_Deg Flux of HAC1S to degradation 
FKar2_Deg Flux of Kar2 to degradation 
FKar2_Influx Flux of Kar2 into the system 
FPDI_Deg Flux of PDI to degradation 
FPDI_Influx Flux of PDI into the system 
FPIntra Folding intermediate 
FPIntra|Kar2 Folding intermediate bound to Kar2 
FPLC Fast protein liquid chromatography 
FSplicing Flux of HAC1S from HAC1U mRNA 
FTranslation Flux of unfolded protein from translation 
FUP|Kar2|PDI_Association Flux of unfolded protein, bound to Kar2, binding PDI 
FUP|PDI_Association Flux of unfolded protein binding PDI 
FUP_Folding Flux of folding intermediate from unfolded protein 
FUP|Kar2_Folding Flux of folding intermediate from unfolded protein, bound to Kar2 
FUP_Misfolding Flux of misfolded protein from unfolded protein 
pGAP Glyceraldehyde-3-phosphate dehydrogenase promoter 
GRAS Generally Recognised as Safe 
HAC1S Spliced HAC1 mRNA 
HAC1U Unspliced HAC1 mRNA 
Hrd1 E3, ubiquitin protein ligase 
Hrd3 ERAD-associated E3 ubiquitin-protein ligase component 
Ire1 Inositol-requiring protein 1 
Ire1|Kar2 Ire1 bound to Kar2 
Ire1A Activated Ire1, with unfolded protein bound 
Ire1O Oligomeric structure formed from Ire1 monomers 
IRES Internal ribosome entry site 
 - 19 - 
Kar2 Hsp70 chaperone 
KAR2 Kar2 transcript 
Kar2Threshold Threshold concentration of Kar2 at which full UPR is induced 
kAssoc Rate of folded protein from the folding intermediate  
kcatE3 Catalytic constant of E3 
kcatPDI Catalytic constant of PDI 
KcFPIntra|Kar2 Equilibrium constant for the folding intermediate bound to Kar2 
KcIre1|Kar2 Equilibrium constant for Ire1 bound to Kar2 
KcIre1_Active Equilibrium constant for Ire1 bound to unfolded protein 
KcMP|Kar2 Equilibrium constant for misfolded protein bound to Kar2 
KcMP|PDI Equilibrium constant for misfolded protein bound to PDI 
KcUP|Kar2 Equilibrium constant for unfolded protein bound to Kar2 
KcUP|Kar2|PDI Equilibrium constant for unfolded protein, bound to Kar2, bound to PDI 
KcUP|PDI Equilibrium constant for unfolded protein bound to PDI 
kE3_Basal Rate of basal, or non-UPR, influx of E3 to the system 
kE3_Deg Rate of E3 degradation 
kExp Rate of nuclear mRNA export 
kHAC1_Deg Rate of HAC1S degradation 
kKar2_Basal Rate of basal, or non-UPR, influx of Kar2 to the system 
kKar2_Deg Rate of Kar2 degradation 
kmDeg Rate of cytoplasmic mRNA degradation 
kmE3 Michaelis constant of E3 
kmE3_UPR Michaelis constant for E3 up-regulation by the UPR 
kmFold Rate of protein misfolding 
kmKar2_UPR Michaelis constant for Kar2 up-regulation by the UPR 
kmPDI Michaelis constant of PDI 
kmPDI_UPR Michaelis constant for PDI up-regulation by the UPR 
kPDI_Association Rate of PDI binding to substrate 
kPDI_Basal Rate of basal, or non-UPR, influx of PDI to the system 
kPDI_Deg Rate of PDI degradation 
kSplice Rate of HAC1U splicing by Ire1A 
kTrans Rate of translation 
kTscript Rate of transcriptionealis 
LC-MS Liquid chromatography mass spectrometry 
 - 20 - 
mAb Monoclonal antibody 
MFPIntra Matrix of the folding intermediate 
MIre1 Matrix of Ire1 
MKar2 Matrix of Kar2 
MM Standard Michaelis-Menten kinetics 
MM_E Modified Michaelis-Menten kinetics, as per Erguler et al. [1]  
MMP Matrix of misfolded protein 
MP Misfolded protein 
MP|Kar2 Misfolded protein bound to Kar2 
MP|PDI Misfolded protein bound to PDI 
MPD Degraded misfolded protein 
MPDI Matrix of PDI 
MUP Matrix of unfolded protein 
Mxr1 Methanol expression regulator 1 protein  
ODE Ordinary differential equation 
PDI Protein disulphide isomerase 
PDI PDI transcript 
PNGaseF Peptide-N-Glycosidase F 
PTM Post-translational modification 
RNAseq RNA sequencing 
RT Q-PCR Reverse transcriptase quantitative polymerase chain reaction 
scFv Single-chain antibody fragment 
SCFV SCFV nucleic acid 
SCFVC Cytoplasmic SCFV mRNA 
SCFVD Degraded SCFV mRNA 
SCFVG SCFV gene integrated into P. pastoris host chromosome 
SCFVN Nuclear SCFV mRNA 
SDS Sodium dodecyl sulphate 
SGA1 Sporulation-specific glycoamylase 
SILAC Stable isotope labelling by amino acids in cell culture  
SRP Signal recognition particle 
TGN Trans-Golgi network  
Tm Melting temperature of oligonucleotides 
Ubc7 Ubiquitin-conjugating enzyme 7 
 - 21 - 
UP Unfolded protein  
UP|Kar2 Unfolded protein bound to Kar2 
UP|Kar2|PDI Unfolded protein, bound to Kar2 and PDI 
UP|PDI Unfolded protein bound to PDI 
UPR Unfolded protein response 
UPRE Unfolded protein response element 
VH Heavy-chain variable domain of a mAb 
VL Light-chain variable domain of a mAb 
vmaxE3_UPR Catalytic constant for E3 up-regulation by the UPR 
vmaxKar2_UPR Catalytic constant for Kar2 up-regulation by the UPR 
vmaxPDI_UPR Catalytic constant for PDI up-regulation by the UPR 
 - 22 - 
1. Introduction 
 
1.1 Recombinant gene expression and the biopharmaceutical industry 
 
Recombinant gene expression has revolutionised agricultural, fuel, food and waste industries by 
allowing the transfer of genes encoding valuable proteins into expression hosts. These can overcome 
problems associated with the native host organism, such as low yields, cultivation difficulties in 
large-scale industrial processes and safety issues. The technology has also had a major impact on the 
pharmaceutical industry and healthcare. For instance, following the discovery of insulin in 1922 
crude extracts of livestock pancreases were used to treat diabetes, often resulting in allergic 
reactions [2]. Purification and preparation of the protein drug developed over the years, but concerns 
remained regarding the inherent immunogenicity and unsustainability: critically, worldwide 
shortages were predicted by the end of the 20th century. The advent of recombinant DNA 
technology in the 1970s, however, allowed the transfer of the gene encoding human insulin into a 
production host. As a result, Humulin™ was produced in Escherichia coli and in 1982 it was the first 
therapeutic recombinant protein to gain FDA approval [3].   
 
The example of insulin, as well as highlighting superior yield and safety characteristics, demonstrates 
a further advantage of recombinant gene expression: it allows sequence modifications and the 
engineering of synthetic drugs. Frequently, adjustments improve the stability in storage, 
functionality (both of the protein itself and through the generation of fusion molecules), 
immunogenicity and pharmacokinetics such as the absorption, distribution, metabolism and 
excretion processes [4-6]. The amino acid sequence of insulin has been modified to alter the 
pharmacokinetic properties such that many new analogues have fast or slow acting profiles; the 
former for a large influx following a meal and the latter for the basal metabolic level [7]. Strikingly, 
the half-life of fully synthetic human insulin and porcine insulin is 5.5 minutes [8]; the half-life of the 
latest long acting analogue to be approved by the FDA, Degludec (Novo Nordisk, Denmark), is 25.4 
hours [9]. 
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Considering the potential of this technology, it is unsurprising that its biopharmaceutical applications 
are both lucrative and increasing in number (Figure 1). In 2011, 16 of the top 50 selling drugs 
worldwide were derived from recombinant technology[10] with sales of $53.4 billion in the US [11].  
 
 
 
Figure 1 – Technology trends in worldwide sales of prescription and over-the-counter drugs 
Biotechnology products are having an increasing stake in all prescription and over-the-counter sales, with 
growth projected to continue. [INSET] As these products have a high commercial value, the trend is much 
more potent in the top 100 grossing drugs. Data from EvaluatePharma, 2012 
[10]
. 
 
1.2 Expression hosts 
 
There are a great many expression hosts available, ranging across the tree of life: from bacteria, 
yeasts and filamentous fungi through insect cells and mammalian cells, extending to whole 
transgenic plants and animals [12]. All expression hosts must be genetically amenable, to allow the 
heterologous gene to be incorporated. Chromosomal integration is preferred as the resulting genetic 
modifications are mitotically stable and maintenance of a selection pressure, typical of heterologous 
genes carried on plasmid vectors, is not required. Ideally, the underlying biochemistry and 
metabolism of the organism is well understood, the genome sequence is freely available and a 
wealth of strains and vectors has been generated for expression purposes. Additionally, a 
biopharmaceutical expression host that is cheap to grow to high cell density and systematically 
produces high yields of easily purified, quality recombinant protein is preferable. As function is 
dependent on structure, the latter attribute is crucial; the products must be fully folded with all the 
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necessary post-translational modifications (PTMs). Commonly, amino acids can be covalently 
modified through phosphorylation, acetylation, methylation, glycosylation, sulphation, 
ubiquitination and disulphide bond formation all of which are crucial for the correct activity, 
localisation, half-life and interactions [13]. Finally, expression hosts divergent from the intended 
recipients are advantageous as they do not share potentially dangerous oncogenic and viral agents 
so eliminating transfer risk [14]. Likewise hosts that have achieved the generally recognised as safe 
(GRAS) status from the US Food and Drug Administration (FDA) are valuable. 
 
Despite the diversity of expression hosts available, no one system can embody all the desired 
attributes for recombinant protein production. Each has benefits and limitations, so host selection is 
inevitably a compromise. Although the expression hosts have very divergent evolutionary 
backgrounds, within each type only a few species are in frequent use. Efforts have been targeted at 
optimising existing hosts rather than exploring new ones, as it is more efficient to use those already 
considered safe by regulatory authorities [15]. 
 
1.2.1 Bacteria 
 
Bacterial hosts benefit from being relatively easy to genetically manipulate; additionally, the 
combination of a fast growth rate with rapid protein expression potentially generates high 
recombinant product specific productivity [12]. The most popular bacterial production host, in 
industry as in academia, is E. coli [16]. As the mainstay of molecular biology, E. coli is the best 
characterised and has a comprehensively developed toolbox of strains and vector systems for 
recombinant protein production. As expression strategies are becoming more complex the control 
bestowed by the many highly characterised promoters, vectors and strains is increasingly attractive. 
  
While E. coli has been a dominant expression system, it has generally been used for small, simple 
proteins – it struggles to produce high yields of larger proteins with numerous disulphide bonds [12]. 
Additionally, it lacks the capacity for glycosylation which the majority of eukaryotic proteins contain 
[17]. However, strains have been engineered to overcome some of these limitations. For instance, the 
cytoplasmic reductive pathways of the strain SMG96 have been removed such that it promotes 
disulphide bond formation; the SHuffle® strain is now commercially available through New England 
Biolabs [18].  Similarly, an E. coli strain has been engineered to glycosylate a eukaryotic protein 
through integrating a combination of Campylobacter jejuni and yeast glycosylation enzymes [19]. It is, 
however, limited to surface glycosylation of exposed sites as this occurs following protein folding. 
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Finally, proteins are commonly expressed intracellularly necessitating a complex downstream 
purification protocol to separate the soluble recombinant product from the crowded intracellular 
milieu. As such products are intended for medicinal use, the regulations on purity are strict – 
prudently so – and overheads of thorough downstream processing can account for 80% of the total 
production cost [20]. To provide a means of product separation, recombinant protein can be directed 
towards relatively pure, insoluble aggregates (or inclusion bodies) [21,22] however this strategy 
requires ex vivo solubilisation and refolding, which is much harder for the larger, complex protein 
structures. Gram-positive bacteria such as Streptomyces and Bacillus species have evolved superior 
secretory pathways and are therefore used for expression strategies with this purpose [16,23]. 
 
1.2.2 Yeast species and filamentous fungi 
 
Yeast hosts combine the advantages of bacterial expression, such as fast growth and rapid protein 
production, with slightly more complex disulphide and glycosylation capacities [24]. Additionally, 
directed chromosomal integration is relatively easy using a dominant homologous recombination 
system [25]. The two most frequently used species are Pichia pastoris and Saccharomyces cerevisiae 
[12].  
 
In contrast to S. cerevisiae, P. pastoris is an obligatory respiratory species and can grow to very high 
cell densities, frequently reaching hundreds of grams per litre [24]. As product concentration is 
roughly proportional to the cell concentration, high cell densities can result in high yields [26]. Further 
features include the availability of a commercial package with well-characterised expression vectors 
from Invitrogen™. Also, as P. pastoris secretes a very low level of native proteins (around 20 are 
detectable in growth on glucose media [27]) directing the product to the secretory pathway allows 
easy purification. Such advantages have allowed P. pastoris to become an increasingly common 
expression host, and the first biopharmaceutical produced in this organism was approved in 2009 
(Kalbitor®, Dyax Corp.).  
 
Despite this, S. cerevisiae remains the dominant yeast expression host. P. pastoris has a long 
industrial history and although there are an increasing number of expression studies, little work has 
been conducted regarding the underlying genetics and physiology of the species [28]. In contrast, S. 
cerevisiae is a model organism and has been studied academically concurrently with industrial use 
for decades. Consequently, the molecular toolbox for this species is much more extensive than that 
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of P. pastoris, as is knowledge of the molecular biology and biochemistry underpinning heterologous 
protein production in this organism.  
 
The major disadvantage with yeast expression hosts is immunogenic glycosylation: although both P. 
pastoris and S. cerevisiae can perform some oligosaccharide additions, the profiles do not precisely 
match that of native human proteins [24]. Having said that, P. pastoris produces glycoproteins which 
are considerably less hypermannosylated than S. cerevisiae. This has allowed the genetic engineering 
of a strain mimicking the human glycosylation profile [29] which has been commercially marketed as 
GlycoFi with several industrial research studies [30-33]. 
 
Filamentous fungi are also commonly used in biotechnology; they share many of the advantages and 
disadvantages of yeast species. Those that are most commonly used are Aspergillus niger, 
Aspergillus oryzae and Trichoderma reesei [34]. Although biopharmaceutical proteins have been 
expressed, these hosts are predominantly employed for production of industrial enzymes such as 
those which degrade polysaccharides, including cellulases, amylases, pectinases, lipases and 
xylanases [35,36].  
 
1.2.3 Plant cells 
 
Although yeast expression platforms can overcome some of the issues associated with expressing 
complex proteins in bacteria, the glycosylation pathways remain clearly divergent from full 
mammalian pathways. This has left avenues open for less productive expression systems that can 
nonetheless produce better mimics of the native protein, such as plant cells. 
 
Although plant cells can be cultured in isolation, the yields are generally not sufficient to be 
commercially viable [37]. Instead whole plants or sections thereof have commonly been employed for 
the production of therapeutics. Indeed, if the proteins are solely expressed in the seeds of a plant, 
the downstream processing and storage capacities are greatly improved [37]. Moreover, the 
production costs are very low, at around 2-10% of microbial systems [38].  
 
The major limiting factor in using plants as expression hosts is the low level of protein expression,  
preventing its industrial uptake [37]. A further concern is the anxiety surrounding the potential for 
transmission to food crops and the potential for mistaking recombinant crops as food [39]. 
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1.2.4 Insect cells 
 
Like plants, insect cells have better developed glycosylation and PTM capacities than yeast; they do 
not, however, benefit from such cheap production. The most common format is the baculovirus-
infected insect cell platform; specifically the multicapsid nucleopolyhedrovirus Autographa 
californica is used to infect a lepidopteron insect cell line [40,41]. The two most common cell lines are 
Sf9, derived from Spodoptera frugiperda, and High Five™, derived from Trichoplusia ni. Although 
used frequently in academia for the production of small amounts of protein, this form of expression 
system is not frequently employed in industry as the cells do not survive the infection; consequently 
the production of large quantities requires repeated preparation of new genetically modified cells 
[42]. 
 
1.2.5 Mammalian cells 
 
All the previous hosts have one common limitation: their capacity for PTMs is not identical to that of 
native, human cells and consequently they cannot produce elaborately processed proteins. 
Consequently mammalian cells are still the host of choice for many products in the 
biopharmaceutical industry [43]. The dominant hosts in mammalian cell culture are Chinese Hamster 
Ovary (CHO) cells; they were amongst the first to be used for this purpose due to the availability of 
an auxotrophic mutant which provided a selection marker for the stable introduction of 
heterologous genes [44].  
 
The capacity of mammalian cells to produce native PTMs and their long industrial history justifies 
their popularity as a production host. They are, however, limited in several regards. Firstly, targeted 
genetic manipulation and the generation of a wide variety of molecular tools has been hampered by 
the lack of a public genome; a draft sequence was only published in 2011 [45]. Secondly, compared to 
model microbes the underlying cellular and molecular biochemistry is less well understood, 
particularly systems-wide, predominantly because the pathways are so complex [15]. Finally, the 
stable transfection and isolation of a clonal cell line can take between six and twelve months, 
incurring high development costs [46].  
 
As an alternative to the culture of individual cells, transgenic animals have been generated for the 
expression of therapeutics. Although much rarer, two hosts are currently being studied or are in use: 
livestock milk and chicken egg whites [42]. Uniquely, purification may not be necessary as the 
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therapeutic could be consumed directly. Safety, on the other hand, is a double-edged sword: while 
animals have been grown for human use for centuries and are generally considered to be safe [37], 
they share many potential pathogens with humans. Moreover, production would clearly raise moral 
issues [42]. Finally, the cost and labour incurred in generating transgenic animals currently precludes 
their use [42].  
 
1.2.6 Summarising the key features of expression hosts 
 
Table 1 – The advantages, disadvantages and current applications of expression systems  
 
Expression system Advantages Disadvantages 
Bacteria Simple culture conditions; 
Easy genetic manipulation; 
Fast growth rate; 
Rapid protein expression; 
Comprehensive toolbox of strains and 
vector systems. 
Inefficient disulphide bond generation; 
No capacity for glycosylation; 
Intracellular expression necessitates 
complex downstream purification or ex 
vivo solubilisation and refolding from 
inclusion bodies. 
Yeast species & 
filamentous fungi 
Simple culture conditions; 
Directed chromosomal integration; 
Fast growth rate; 
Very high cell densities; 
Rapid protein expression; 
Better disulphide bond generation; 
Some capacity for glycosylation; 
Product secretion allows easy purification; 
Comprehensive toolbox of strains and 
vector systems†. 
Large, complex proteins have lower 
productivities; 
Immunogenic glycosylation. 
Isolated plant cells 
& whole plants 
Very low production costs; 
Efficient disulphide bond generation; 
Less immunogenic glycosylation; 
Target protein to plant section (E.g. seed) 
aiding downstream processing.  
Isolated plant cells produce low yields; 
Anxiety surrounding the potential for 
transmission to food crops. 
Insect cells Moderate growth rate; 
Efficient disulphide bond generation; 
Less immunogenic glycosylation. 
Expensive growth media; 
Large product yield requires repeated 
preparation of new genetically modified 
cells. 
Mammalian cells Efficient disulphide bond generation; 
Closest capacity for human glycosylation;  
Product secretion allows easy purification.  
Expensive growth media; 
Fewer developed tools for targeted 
genetic manipulation; 
Stable transfectants are slow and costly. 
† Applies only to Saccharomyces cerevisiae 
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1.2.7 Distribution of expression systems in the biopharmaceutical industry 
 
Clearly, different expression systems offer different advantages and selection is a compromise. Every 
protein product has critical quality attributes (CQAs), or specific characteristics which determine its 
efficacy. These specify the host requirements; for instance, the glycosylation of monoclonal 
antibodies (mAbs) is crucial to their efficacy therefore commercial products are exclusively 
manufactured in mammalian cells. If a product can be produced in a number of systems, the choice 
becomes a trade-off between many factors including process costs and yield.  
 
Figure 2 – Host organisms used for the manufacture of new biological entities  
Over half of the new biological entities approved between 2006 and 2010 were generated by mammalian 
expression systems, the most frequent of which was the Chinese Hamster Ovary cell. The second most 
dominant system, Escherichia coli, produced just under a third of new entities. The third most popular system 
used was yeast, most commonly Saccharomyces cerevisiae. ‘Other’ includes transgenic animals (one product), 
direct synthesis (one product) and baculovirus-insect cell–based system (two products). Data from Walsh, 
2010 [47]. 
 
Over 200 vaccines, blood and biologic products are currently licensed by the FDA and these range 
widely in size, structural complexity and PTMs. Consequently, all expression systems are used in the 
biopharmaceutical industry; the extent to which they are employed, however, depends on the 
dominance of the particular product type. The host organisms used to produce new biological 
entities, approved between 2006 and 2010, show a prevalence of mammalian cell hosts – 
Mammalian cells
55%
Escherichia coli
29%
Other
7%
Saccharomyces 
cerevisiae
7%
Pichia pastoris
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particularly CHO cells (Figure 2). This can be attributed to mAbs, the most successful class of 
biologics, of which there are currently 34 FDA approved products with US sales of $15.5 billion in 
2010 [11].  
 
1.3 Pichia pastoris and the problem of low specific productivity 
 
Although mammalian systems currently dominate biopharmaceutical production, the high labour 
and production costs incurred inflate the product price. The FDA has recently approved the use of a 
combination treatment plan against HER2-positive, late-stage breast cancer, consisting of two mAbs 
and a chemotherapy drug, estimated to cost more than $200,000 per patient per year [11]. The use of 
microbial production platforms would reduce the development and production costs: considerably 
less time would be required to generate a stable cell line and the high density cultures could yield 
high quantities of protein. The latter point is particularly important: antibody therapies require large 
doses and target diseases such as cancer and diabetes involve high numbers of patients; 
consequently total production demand will be on the order of tons per year [48]. Previously, the use 
of microbial platforms has been hindered by the incapacity for native human glycosylation profiles, 
but as strains of P. pastoris have been engineered to improve this, the species is fast becoming a 
realistic alternative. 
 
Despite the advantages, the specific productivity of P. pastoris is relatively low. In other words, 
although high yields can be derived from high density cultures, the protein production rate of each 
cell is actually quite low. In order for the biopharmaceutical industry to consider the costs of 
changing production hosts, the new platform has to be very attractive. Increasing the specific 
productivity from Pichia, allowing the species to achieve its full potential, would aid this. 
 
1.3.1 Protein production pathway of P. pastoris 
 
Specific productivity is the reflection of many different processes which constitute the protein 
production pathway, beginning with transcription of the heterologous gene in the nucleus (Figure 3). 
The mRNA is exported to the cytoplasm, where it forms a complex with the translational machinery 
at the membrane of the endoplasmic reticulum (ER). The nascent protein is co-translationally 
translocated and folds within the ER. Fully folded protein is transported to the Golgi apparatus 
through COPII vesicles, and exported through clathrin-coated vesicles. The latter fuse with the cell 
membrane and the protein is secreted.  
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Figure 3 – Specific productivity is the outcome of the whole protein production pathway 
The heterologous gene is transcribed in the nucleus and the mRNA is exported to the cytoplasm. There it is 
bound by the translation machinery and the nascent protein is co-translationally translocated into the ER. 
There it has the chance to fold, with the aid of the chaperone Kar2 and the foldase/isomerase PDI. Folded 
protein is transported to the Golgi apparatus through COPII vesicles, and exported through clathrin-coated 
vesicles. The latter fuse with the cell membrane and the protein is secreted. 
 
The majority of heterologous proteins produced in P. pastoris are expressed by the AOX1 promoter, 
based on the control and strength of the induction mechanism. AOX1 encodes the first enzyme in 
the methanol utilisation pathway; as such, it is strongly induced when methanol is present in the 
medium [49]. Using this promoter allows the separation of host growth and recombinant protein 
production phases. Once induced the transcription level of the native Aox1 protein is increased more 
than 1000-fold and it can constitute more than 30% of the cellular protein content [50]. Despite the 
tight regulation and high productivity the AOX1 promoter offers, induction by methanol is not ideal 
for industrial processes. It is flammable, raising process safety concerns; metabolism produces a 
great deal of heat, making control of culture temperature more difficult; and consumes large 
quantities of oxygen such that ensuring adequate availability in a large culture is also difficult [27]. 
Finally, the toxicity of methanol induces cell lysis, reducing the biomass yield and releasing proteases 
which can degrade the protein product [27]. Considering recent advances using the constitutive GAP 
promoter, the habitual employment of AOX1 may need to be reconsidered [51].  
 
Regardless of the promoter choice, transcription requires the assembly of a polymerase complex and 
the three stages of initiation, elongation and termination. Concurrently, new mRNA molecules are 
- INTRODUCTION - 
- 32 - 
extensively tailored with 5’ capping, splicing and 3’ end-processing [52]. Finally, mature mRNA 
molecules are exported to the cytoplasm through the nuclear pore complex. 
 
Once in the cytoplasm, a ribosome assembles on the mRNA and translation initiates. The majority of 
expression strategies in P. pastoris direct recombinant proteins to the secretory pathway, which 
requires co-translational translocation into the ER.  Targeting is typically achieved by fusing the N-
terminal signal sequence from the α-Factor of S. cerevisiae to the N-terminus of the recombinant 
protein. The sequence is highly hydrophobic, such that when it emerges from the ribosome it is 
recognised by a signal recognition particle (SRP). The complex binds the SRP receptor on the ER 
membrane, and together they direct the nascent polypeptide into the ER concurrent with translation 
[53,54]. The channel through which the nascent polypeptide enters the ER is formed by Sec61 [55].  
 
Once in the ER, the proteins fold into their native three dimensional structures. This can occur 
spontaneously [56], as the primary amino acid sequence dictates the energy landscape. Folding 
progresses through interactions which increase the thermodynamic stability of the nascent 
structure. This spontaneous process is, however, exceptionally slow and incompatible with the time 
scale of secretion in vivo [57]. Moreover, the crowded milieu of the ER increases the likelihood of non-
native interactions and promotes side reactions such as aggregation or the formation of incorrect 
disulphide bonds. As the unique three-dimensional structure of proteins is crucial to their biological 
function, ensuring accurate and efficient folding is necessary [58]. Therefore, cells utilise an oxidising 
environment, for the formation of disulphide bonds, and a complement of chaperones and oxidases 
to assist the folding of proteins in the ER [59]. 
 
The dominant chaperone of the ER is Kar2, the yeast homologue of the immunoglobulin heavy chain 
binding protein (BiP). A member of the Hsp70 chaperone family, this 70 kDa protein is highly 
conserved. Under normal conditions, it is constitutively expressed to between 5 and 10% of ER 
lumenal protein; under stress, however, it is rapidly and intensively induced [60-62]. Kar2 sequesters 
polypeptides emerging into the ER through a C-terminal binding domain, stabilising the immature 
protein and preventing it from aggregating [63]. Concomitantly ATP binds the N-terminus of Kar2 and 
subsequent hydrolysis initiates protein release [64,65]. This cycle of binding and release allows the 
nascent protein time to fold properly and bury its hydrophobic residues before aggregation occurs 
[63].  
 
The main contributor in covalent bond formation is protein disulphide isomerase, a 55 kDa member 
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of the PDI family of proteins. This abundant protein comprises around 0.8% of total cellular protein 
in yeast, and was first isolated by Anfinsen and co-workers more than 40 years ago [57,66,67]. It acts 
predominantly as an oxidase and isomerase; as the former, it can catalyse the formation of 
disulphide bonds between cysteine residues, and as the latter it also shuffles incorrect pairings [67]. 
However, PDI has additionally been shown to bind peptides irrespective of the presence of cysteines 
[68]. This suggests it has other functions; indeed it has been shown to act as a chaperone in several 
studies [69-71].  
 
As PDI forms disulphide bonds by accepting reducing equivalents, to remain functional it has to be 
continually re-oxidised by the thiol oxidase Ero1p [72,73]. Ero1p contains two disulphide bonds and the 
flavin adenine dinucleotide (FAD) cofactor. Reduced PDI is directly reoxidised by the first external 
cysteine pair which is in turn reoxidised by the second, internal cysteine pair. Finally the latter is 
reoxidised by the transfer of electrons to the FAD cofactor, and subsequently to molecular oxygen 
resulting in the formation of hydrogen peroxide [74]. 
 
Despite this assistance, folding in the ER is slow and inefficient and a proportion of nascent proteins 
never reach the native form [75]. As the correct structure and PTMs are crucial, proteins are subject 
to a quality control process to ensure only those correctly folded can exit the ER [76]. Those that do 
not pass the strict requirements are retrotranslocated back into the cytosol where they are targeted 
to the ubiquitin-proteasome to be eliminated through ER-associated degradation [53].  
 
1.3.2 Endoplasmic reticulum-associated degradation 
 
Endoplasmic reticulum-associated degradation (ERAD) can be described as a four step process, 
although there are many variations within this general mechanism [75]. Aberrant proteins are 
identified, retrotranslocated from the ER to the cytosol, polyubiquitinated and finally degraded by 
the 26S proteasome [77].  
 
There are no unifying rules for substrate recognition; indeed, a variety of ER resident proteins have 
been implicated and even the signal for recognition is unknown [78]. There are at least three different 
pathways: ERAD-L, ERAD-M and ERAD-C for aberrant lumenal, membrane and cytosolic proteins 
respectively [79]. That being said, there has been a suggestion that glycoproteins are recognised by 
the lectin-like protein Yos9p while non-glycosylated proteins are delivered through interaction with 
Kar2 [80]. 
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Following recognition, the aberrant protein is directed to the ER membrane and retrotranslocated 
into the cytoplasm. Initially, the C-terminus of ubiquitin is activated in an ATP-dependent reaction 
with the ubiquitin-activating enzyme E1 in the cytoplasm. Secondly, a transesterification reaction 
shifts the active ubiquitin to the conserved active site cysteine of the ubiquitin-conjugating enzyme, 
E2. Thirdly, the ubiquitin-protein ligase E3 binds the previous complex; and finally, the ubiquitin is 
transferred from the E2 to the substrate [81]. The components of the ER membrane complex which 
orchestrate this are, to an extent, substrate specific and function in different pathways. For instance, 
12 E2s and 60 to 100 E3s have been identified in Saccharomyces cerevisiae [82]. There does, however, 
appear to be some conservation of key participants (Figure 4). 
 
 
Figure 4 – Aspects of the ERAD mechanism based on [A] Hrd1 and [B] Doa10 
ERAD is an encompassing term for a wide range of mechanisms; the components displayed are those generally 
conserved across different substrates. Here, the chaperone Kar2 acts as the detector of terminally misfolded 
protein and escorts it to the ERAD complex. This is composed of Ubx2, Cue1, Ubc7, Cdc48 and an E3 enzyme.  
 
Ubc7 is an ubiquitin-conjugating enzyme (E2) which accepts the activated ubiquitin from the 
cytoplasmic E1; it is tethered to the ER membrane by Cue1 [83]. Ubc7 in turn binds the ubiquitin 
ligase (E3), of which Hrd1 [84] and Doa10 [85] are the best described. Hrd1 has an additional 
component, Hrd3, which stabilises and regulates its activity [86]. Considering the diversity in the E3 
enzymes, they are prime candidates for specifying the system to a degradation target. The E3 has a 
recognition role, and transfers ubiquitin from Ubc7 to the substrate. In addition to the ubiquitination 
of the substrate, ERAD requires the AAA ATPase complex Cdc48 comprising Cdc48, Npl4 and Ufd1. 
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This is secured to the ER membrane through interactions with the membrane protein Ubx2 [87]. 
 
Finally, the aberrant protein is degraded by the 26S proteasome. This consists of a 20S catalytic 
domain and a 19S regulatory particle, both of which are complexes themselves; the former contains 
four heteroheptameric rings while the latter consists of at least 19 different particles and can be split 
into two subcomplexes which flank the catalytic domain [88].  
 
As ERAD functions by recognising and degrading misfolded proteins, it becomes particularly 
important during heterologous protein production as the ER becomes exceptionally crowded and 
misfolding occurs more frequently [89]. Indeed, when the protein content of the ER surpasses the 
homeostatic threshold, the unfolded protein response (UPR) is activated. This stress response 
regulates the capacity of the ERAD pathway. 
 
1.3.3 Unfolded protein response  
 
The unfolded protein response (UPR), which is conserved across all eukaryotes, is activated by an 
increase in unfolded proteins beyond a threshold in the lumen of the ER (Figure 5). In yeast it hinges 
on the interaction of Ire1, HAC1 and Kar2. 
 
 
Figure 5 – The unfolded protein response under [A] normal and [B] stressed conditions 
[A] Normally, the chaperone Kar2 (purple) is bound to the ER transmembrane stress sensor Ire1 (pink). Under 
proteostasis, unfolded proteins (red) enter the ER and are bound by surplus Kar2. Once folded, the proteins 
exit the ER. [B] If, however, the influx of unfolded protein is much greater it sequesters all the free Kar2. This 
promotes the dissociation of the complex between Ire1 and Kar2, allowing unfolded protein to bind Ire1. This 
induces the oligomerisation of Ire1 and the activation of its endoribonuclease domain through 
phosphorylation. Subsequently, the intron in HAC1 mRNA (green) is spliced allowing functional translation. The 
Hac1 protein retrotranslocates to the nucleus where, as a transcription factor, it up-regulates a large 
transcriptional response to the stress. 
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Under normal, non-stressed conditions Kar2 is bound to the lumenal domain of Ire1, an ER 
transmembrane kinase/endonuclease [64,90]. Until recently, the prevailing model suggested that an 
increase in the concentration of unfolded protein caused Kar2 to dissociate from Ire1, triggering Ire1 
to dimerise and phosphorylate. However, analysis of an Ire1 mutant with no Kar2 binding site 
conflicted with this activation scheme: the UPR was still operational suggesting Kar2 could not be 
the decisive regulator [91]. Structural studies suggested a groove within Ire1, with similarities to the 
peptide binding domain of the major histocompatibility complex I, indicating that Ire1 may directly 
bind unfolded protein [54] which has now been observed in vitro [92]. Therefore, the current working 
model proposes that an influx of unfolded protein induces the dissociation of Kar2, but it is the 
binding of unfolded protein to Ire1 that triggers the UPR. 
 
The rest of the signalling cascade is clearer; the activated endonuclease domain splices the 
constitutively expressed cytoplasmic HAC1 mRNA [93]. Removal of an intron and subsequent ligation 
by the tRNA ligase Rlg1p allows translation to proceed. The Hac1 protein, a transcription factor, 
retrotranslocates to the nucleus [94]. There it activates a large transcriptional program, of around 5% 
of the genome, by binding genes containing a 22 bp element designated the UPR response element 
(UPRE) [54,62]. The aggregate effect of these genes is to return the ER to homeostasis through 
membrane expansion and increasing the protein folding, ERAD and secretion capacity [95,96].  
 
The majority of our understanding, and the explanation above, is based on S. cerevisiae studies [97]. 
The analysis of different yeast species, however, has highlighted subtle differences in the structure 
and regulation of the HAC1 gene. For instance, the HAC1 introns of closely related species Yarrowia 
lipolytica and Candida albicans are much shorter than that of S. cerevisiae or P. pastoris, at 29 [90], 19 
[98], 252 [99] and 322 [100] bases respectively. Despite this, cross-species functionality has been 
demonstrated as constitutive expression of the spliced S. cerevisiae HAC1 mRNA permanently up-
regulates the UPR in P. pastoris [28]. 
 
In terms of regulation, two conflicting papers have been published regarding HAC1 splicing in P. 
pastoris. Although both identified the same splice site, the first found HAC1 mRNA to be 
constitutively spliced regardless of stress conditions [101] while the latter clearly identified the non-
spliced mRNA [100]. As both research groups used the Invitrogen P. pastoris GS115 (his4) strain and 
analysed the presence or absence of the intron from mid-exponential cells grown in the same rich 
media, these discrepancies are curious. Logically, the evidence for the non-spliced form is more 
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convincing than a lack thereof; therefore, here it has been assumed that P. pastoris splices HAC1 in 
response to stress. 
 
1.3.4 Protein glycosylation and transport through the Golgi network 
 
In addition to protein folding, the process of glycosylation is also initiated in the ER. Three forms are 
relevant here: N-linked and O-linked glycosylation, and C-mannosylation [102]. N-linked glycosylation 
deals with the addition of large, highly branched glycans to asparagine residues. During protein 
translocation, the core glycan GlcNAc2Man9Glc3 is transferred from a dolichol-pyrophosphate carrier 
embedded in the ER membrane by oligosaccharyltransferase onto Asn-X-Ser/Thr residues in the 
polypeptide [103]. These core glycans are subsequently processed in the ER as three glucose and one 
mannose residue are consecutively removed by glucosidases I and II and mannosidase I [102,103]. 
Contrastingly, O-linked glycosylation attaches short, linear glycans to serine or threonine residues 
while the rarer type, C-mannosylation, appends an α-mannopyranosyl residue to tryptophan 
residues [102].  
 
The protein is then transferred to the Golgi network via the transitional ER, a subdomain within the 
ER responsible for the production of coat protein complex II (COPII) vesicles [104]. In yeast, core 
glycans are appended with mannose residues [105] as they progress through the cis, medial, trans and 
Trans-Golgi network (TGN) cisternae of the Golgi apparatus [106]. From the TGN, the proteins are 
sorted into different types of carriers and directed to their various destinations including the plasma 
membrane. Those vesicles destined for exocytosis are transported by actin fibres and bound at the 
plasma membrane by a 19.5S complex known as the exocyst, which contains eight proteins: Sec3p, 
Sec5p, Sec6p, Sec8p, Sec10p, Sec15p, Exo70p and Exo84p [107,108]. Regulation is thought to occur 
through small GTPases, including members of the Rab, Rho and Ral families [109-111]. 
 
1.4 Increasing specific productivity of heterologous protein production in P. pastoris 
 
While the overall yield can be increased through optimising fermentation conditions, previous 
studies aimed at increasing the specific productivity have focused on bioengineering. Although some 
have employed random chemical mutagenesis [112], the majority of bioengineering research targets a 
specific part of the pathway: transcription, translation, folding or secretion. 
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1.4.1 Transcription 
 
The mRNA level is a product of the transcription and degradation rate. Studies that have aimed to 
increase specific productivity by altering the transcript level have targeted the production rate as the 
sequence features affecting mRNA stability are not as fully understood. 
 
Production is derived from the strength of the promoter and the number copies of the heterologous 
gene. For the former, synthetic variations have been designed: three tandem copies of an upstream 
activating sequence in the AOX1 promoter was shown to increase expression of the reporter gene 
GFP such that protein and mRNA levels increased 157% and 135% respectively [49]. In terms of the 
latter, multiple copies of the heterologous gene are regularly cloned in tandem or separately in 
order to generate a higher transcript level [113-118]. 
 
While using a strong promoter and generating multicopy strains are the most frequent strategies, an 
alternative path would be to harness epigenetic effects. Although not currently characterised in P. 
pastoris, an 8.7 fold difference in lacZ production between chromosomal loci in S. cerevisiae has 
been observed [119]. 
 
1.4.2 Translation 
 
Similar to transcription, the nascent protein level is a balance between production and degradation. 
Production is a function of mRNA availability, ribosomal capacity and codon usage bias – the latter 
being a popular target for modification. 
 
The genetic code is degenerate, allowing multiple codon sequences to encode the same amino acid. 
Different codons for the same amino acid are used in varying frequencies both within and between 
organisms leading to the phenomenon of codon usage bias (Figure 6) [120-122]. Codon biases can be 
instrumental in the expression of heterologous proteins; if, for instance, the non-native gene utilises 
rare codons translation will be inefficient. 
 
Considering the importance of codon bias, there are two options to improve heterologous 
translation, directed at either the host or the gene. In the first instance, the tRNA pool of the host 
can be expanded. The commercial Rosetta™ strains (Merck Millipore, Darmstadt, Germany) are E. 
coli transformed with plasmids encoding rarely used tRNAs for the expression of eukaryotic proteins. 
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In the second instance, the gene itself can be codon optimised [49,123-131] – that is, redesigned with a 
sequence of codons better suited to the codon bias of the expression system. This is more frequently 
adopted, as although optimised strains are useful, such an approach is currently only applicable to 
bacterial expression hosts and not P. pastoris. 
 
 
Figure 6 – Heat map of the codon usage bias within and between three model organisms 
The relative synonymous codon usage of 50 randomly selected genes across Escherichia coli, Saccharomyces 
cerevisiae and Homo sapiens; the 61 codons are in columns at the top and the genes are in rows. Codon usage 
ranges from zero (complete absence), through one (no bias) to six (complete bias). Figure amended from 
Plotkin & Kudla, 2011 
[122]
. 
 
1.4.3 Folding and glycosylation 
 
While proteins can fold spontaneously, this is slow and inefficient leaving nascent polypeptides 
vulnerable to non-native interactions and misfolding. To counteract this, chaperones and foldases 
can be simultaneously overexpressed; the quintessential strategy employs Kar2 and PDI either 
separately or in combination. One such study sought to increase expression of Necator americanus 
secretory protein by overexpressing PDI, as increasing gene copy number had reduced secretion [132]. 
A clone with two copies of the heterologous protein gene and seven copies of PDI produced 3.55 
relative amounts of extracellular protein. A similar study, investigating the expression of a fusion 
protein comprising interleukin-1 receptor antagonist and human serum albumin, reproduced the 
beneficial effect of PDI overexpression on yield, although they also observed an increase in yield 
with gene copy number [116]. They also up-regulated Kar2, however, this had no effect on yield; a 
reflection, perhaps, that their product contained 18 disulphide bonds. Contrastingly, single-chain 
antibody fragment expression (containing two disulphide bonds) showed no effect of PDI up-
regulation, but a three-fold increase in yield when Kar2 was up-regulated [63]. The effect of Kar2 was 
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even mitigated when PDI was co-overexpressed, a result which the authors attribute to the cellular 
stress induced when three separate proteins are expressed using the strong AOX1 promoter. Clearly, 
overexpression of chaperones and foldases is product specific and needs to allow for the capacity of 
the system. 
 
Additionally, recombinant proteins can be fused to a protein which folds easily. The maltose binding 
protein, a 40 kDa product of the malE from E. coli K12, has often been used for this purpose as it has 
a dual functionality. In addition to acting as an in-frame chaperone, it can be used in downstream 
purification [133]. The tag is subsequently cleaved with a site specific protease to release the final, 
native product. Such a strategy has been shown to improve yields of recombinant proteins from P. 
pastoris [134], although an instance of aberrant proteolysis suggests further characterisation of 
endogenous protease activity may be required [135]. 
 
Although a wide variety of PTMs occur, that which receives the most academic and industrial 
attention is N-linked glycosylation. Although these pathways have been humanised in P. pastoris [29], 
they will doubtless require optimisation.  
 
1.4.4 Secretion and the extracellular environment 
 
Initially, secretion from P. pastoris requires the recombinant protein to be tagged with a secretion 
signal. Frequently, studies employ the signal from the α-mating factor of S. cerevisiae as initial P. 
pastoris expression studies did not benefit from the availability of a genome sequence. While the 
non-native secretion signal can function efficiently [136], native P. pastoris secretion signals have now 
been explored and shown to improve yields of recombinant protein [137]. 
 
A final consideration is the endogenous extracellular protease activity, derived from secreted 
proteases, cell-bound proteases and intracellular proteases recently released by lysed cells [138]. 
These proteases can attack the recombinant protein, causing degradation. Cultivation strategies 
including altering the pH and adding protease inhibitors to the medium can aid yield, although the 
former is product specific and the latter is not cost effective at an industrial scale [138] Alternatively, 
strains have been genetically engineered to produce fewer endogenous proteases: the SMD strains 
(Invitrogen, Paisley, UK) have pep4, encoding proteinase A, deleted. There are suggestions, however, 
that the protease deficient strains have a lower viability, slower growth rate and are more difficult to 
transform [139]. 
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1.4.5 Simultaneously targeting multiple parts of the protein production pathway 
 
Despite frequent implementation, none of the strategies outlined above have been consistently 
successful. The system has evolved a fine balance and the targeting of only one factor disturbs this, 
as revealed by the previously mentioned Necator americanus secretory protein expression study. 
Increasing the gene copy number had a deleterious effect on secretion such that one, two, three and 
four copies produced 1.00, 0.82, 0.50 and 0.25 relative amounts of extracellular protein respectively. 
The overexpression of PDI increased yield, but only shifted the bottleneck from pre-translation to 
folding in the ER as a clone with two copies of the heterologous protein gene and seven copies of 
PDI produced 3.55 relative amounts of extracellular protein. This exemplifies the need for a 
consideration of the many factors affecting productivity of the system.  
 
1.5 Modelling as a guide to increasing protein production in P. pastoris 
 
Yield is controlled by a network of factors, all of which interact to various degrees. This thwarts any 
attempts to intuitively engineer the system. To experimentally characterise the interactions through 
multifactorial experimental design would require an impossibly lengthy, and costly, programme of 
experiments. Alternatively, mathematical models can be used to analyse the data and derive 
predictions from these complex phenomena [140]. A computational modelling approach could identify 
factors most crucial to productivity, providing a logical basis for targeting experimental work. It 
would also allow in silico experiments to aid our understanding of how the factors interact. Most 
advantageously, however, a model analysis of this problem could allow for an optimisation strategy 
that takes into account all the elements of the pathway which have been included. 
 
1.5.1 Mathematical modelling in biology  
 
The aim of computational biology is to deduce a simplified version of a biological phenomenon using 
equations and computer code [140]. A full reaction mechanism, requiring all the elementary and 
intermediate steps in the process, would initially seem ideal; however it might increase the 
computational requirements beyond that which is practicable. Moreover, mimicking a complex 
system with a complex model – neither of which is understood – is counterproductive. Finally, data 
for the full reaction mechanism is rarely available and so model formulation is constrained by what is 
available in the literature and can be measured [140,141]. Therefore, models tend to focus on the aim 
of the research and indispensable features of the process.  
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1.5.2 Dynamic modelling 
 
In contrast to the static models of bioinformatics, dynamic modelling describes how various aspects 
of a system change over time [140]. There are a variety of approaches to the modelling of protein 
production in cells; each is better at capturing a different feature of the data and consequently 
generates a different hypothesis. Should the cell be considered structured or unstructured? A 
structured model will take into account the compartmentalisation within a cell, but if this is not 
important to the research it only adds computational complexity. Then there is the question of scale: 
is the behaviour represented in a single cell, or is it an emergent property of a population? Can such 
populations be characterised as homogeneous or heterogeneous? Again, a population approach – 
especially one which incorporates the heterogeneity inherent in biology – would be more realistic, 
but if the question to be answered does not dictate these additional computational complexities 
then the simpler approach is to be preferred. 
  
The final consideration relates not to the particulars of the model but the way in which it is solved. 
Deterministic models assume changes are continuous; in other words, trajectories are a reflection of 
the initial conditions and the rate constants applied to them. At low concentrations, however, the 
assumption of continuity cannot be applied, and probability has a large effect on the behaviour of 
the system. These problems are approached with stochastic models; although this comes at a 
computational cost and make their application to larger systems impracticable [142]. Many cell 
models are deterministic, presented as a series of ordinary differential equations (ODEs) which can 
vary with respect to either time or space. If both dimensions are required, partial differential 
equations (PDEs) can be employed; however, these are less common in published cell models (as 
described below). Generally, experimental characterisation focuses on how targets change with 
respect to time, and not space, consequently the current models reflect this.  
 
1.5.3 Stages in model development 
 
Generally, model development can be divided into four stages [143]. Initially, the system is described 
by mathematical equations, taking either a ‘bottom up’ or a ‘top down’ approach. For the former, all 
known biological reactions are included resulting in a highly detailed, mechanistic description of the 
system. Contrastingly, the latter attempts to group reactions into fewer descriptions to which 
further detail is added as limitations in predictive power are highlighted by experimental data. 
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Independent of the approach, in the second step the model is subject to analysis, for the most part 
dictated by a sensitivity analysis. The mathematical formulae implemented in dynamic models 
require initial concentrations of components and rate constants, which are often inferred from 
literature [144]. Consequently, it is important to understand not only the dynamic trajectories of the 
state variables but also the effect of perturbations to these on model predictions. In this respect, 
sensitivity analysis ranks the parameters in terms of importance thus identifying those which need 
accurate determination [145]. Interestingly, sensitivity analysis can also be used to assess the 
robustness of a model by providing a parameter value range throughout which a model outcome will 
not change (where large ranges provide robustness and small highlight fragility). 
 
Much like model formulation, there are a variety of approaches to sensitivity analysis which can be 
taken, including factor screening, local sensitivity and global sensitivity analysis [143]. Factor screening 
deals with models requiring hundreds of input factors; as such, it trades computational economy for 
quantitative results. Therefore, it only ranks factors in order of importance and cannot provide 
information on robustness. Contrastingly, local sensitivity analysis only analyses the effect of 
perturbations to a single parameter during a simulation and provides quantitative information on 
the immediate parameter space [144]. Global sensitivity analysis bridges the gap between these two 
analysis techniques, allowing quantitative results from perturbations to the entire range of 
parameter values.  
 
The third stage in model development is the design of experiments, data from which can confirm 
model validity. As mentioned previously, model formulation predominantly uses literature data 
which often does not entirely conform to the specifics of the model. The previous sensitivity analysis 
highlights parameters which are crucial to model accuracy; ideally, the dynamics of parameters and 
the system components would be assessed with high-resolution techniques under many conditions, 
however, labour and cost constraints make this prohibitive. Therefore, optimal experimental design 
can determine the experimental conditions, such as the magnitude of a perturbation and 
appropriate sampling times, with which will yield the most informative data to enable accurate 
parameter estimation [143,144]. 
 
In the final stage of model development, parameter estimation and model validation, the data from 
the designed experiments is fed back into the model. This starts an iterative process, whereby 
improved parameter estimates are used to increase model accuracy until sufficient agreement 
between model predictions and experimental data is reached. 
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1.5.4 Previous models 
 
Metabolic models 
 
The majority of the processes in the protein production pathway, as outlined in Section 1.3.1, 
require energy. Consequently, one well studied approach to investigating limitations in specific 
productivity is to analyse cellular metabolism and the impact of recombinant protein production 
therein. Such an approach traditionally employs a metabolic model, which can be built from 
constituent pathways. Early static models of P. pastoris adopted reduced metabolic models of S. 
cerevisiae according to the limited available data [146]. Expanding on earlier metabolic models, Çelik 
at al. [147] used metabolic flux analysis on a stoichiometry-based model containing 102 metabolites 
and 141 reaction fluxes to provide metabolic evidence supporting co-substrate feeding with sorbitol 
during recombinant protein production.  
 
The publication of the P. pastoris genome in 2009, along with the advent of “omics” data, has now 
allowed genome-scale metabolic models. One such genome scale reconstruction included 668 
metabolic genes, 361 reactions and 1,177 metabolites segregated into the cytosol, ER, extracellular 
matrix, Golgi, mitochondria, nucleus, peroxisome and vacuole [148]. The authors showed that, in the 
classic two-phase expression of P. pastoris, glycerol was the best substrate for the biomass phase as 
it generated a higher flux to amino acid production, which could be capitalised on during 
recombinant protein production. Most recently, a metabolic model has been applied to strains of P. 
pastoris expressing recombinant protein to different degrees, in order to better analyse the impact 
of expression [149]. The research showed that energy generation through the TCA cycle was increased 
during protein production, but that there an upper limit to this. Interestingly, the same group has 
previously shown similar findings for E. coli [150], suggesting that this may be a common limitation to 
recombinant protein production. The results suggested supplementing with amino acids, which they 
show increased the productivity two-fold in P. pastoris. 
 
The majority of metabolic studies incorporating the effect of recombinant protein production do so 
by including equations representing the ATP flux towards amino acid synthesis and the generation of 
polypeptide bonds. This simplification is necessary as metabolic models require the participating 
enzymes and metabolites which have only been partially determined for protein production and 
secretion, along with the stoichiometry and fluxes which are difficult to define or not yet 
measurable. Consequently, system-wide approaches to protein production are still in early 
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development, with the first genome-scale model for the yeast secretory machinery published in 
2013 [151]. The model included 162 proteins and one RNA, with 137 reactions covering aspects of 
translocation, folding, PTMs and transport in addition to the pathways of glycosylation precursor 
synthesis and glycosylphosphatidylinositol (GPI) attachment. The research provided estimates for 
the metabolic demands of individual parts of the secretory machinery, such as folding and the three 
ERAD pathways discussed in Section 1.3.2.  
 
Models of the protein production pathway 
 
The genome scale model of the yeast secretory machinery has started to expand on the metabolic 
requirements of the protein production and secretory machinery, but as mentioned earlier, this 
approach is limited by the complexity of this subsystem and the lack of characterisation with which 
to analyse it. Consequently, an alternative approach considers the protein production pathway 
disconnected from metabolism, and aims to understand solely how the participating proteins and 
cofactors interact.  
 
To rationalise codon optimisation, an algorithm was introduced to mechanistically model the steady 
state protein synthesis rate by expressing elongation as a function of tRNA availability [152]. It 
iteratively identifies and replaces the rate-limiting codons until the maximum rate of elongation is 
achieved.  
 
Although useful, the efficiency of translation needs to be increased with respect to the co-
translational folding limit. The latter was considered in a kinetic model which predicts the probability 
of nascent protein folding as a function of translation rate; simulations suggested an inverse 
correlation between translation rate and domain folding [153]. Indeed, substituting a ‘fast’ codon in 
the sequence decreases the probability of a slowly translated protein folding and vice versa. It could 
be informative to couple it to the previous model in order to predict the best codon sequence for 
maximal elongation rates before folding efficiency is compromised. 
 
The requirement for chaperone and foldase overexpression is unique, and there is a demand for 
tools that can predict this. In response, the Hsp70 chaperone DnaK from Escherichia coli was the 
focus of a kinetic model, CHAMP70, aiming to quantify the competition between protein folding and 
chaperone binding [154]. The model allowed the prediction of chaperone interaction, both during 
folding and after, for 59 model substrates.  
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While valuable for predicting chaperone requirements, the model considers an in vitro system. 
Intracellularly, however, there are dynamic fluxes of unfolded protein demanding an expansion to 
include this. Early models, such as FoldEx, initially linked elements of chaperone-dependent folding, 
degradation of misfolded protein and export allowing an analysis of their relative contributions [155]. 
Interestingly, it demonstrated larger proteins, which fold slowly, are more vulnerable to degradation 
– regardless of thermodynamic stability.  
 
A further model focusing on P. pastoris has been generated with similar groupings of fluxes in and 
out of the ER [156]. Such a tactic of grouping steps in a pathway is also the basis for top-down 
modelling, employed to model single-chain antibody fragment production in Saccharomyces 
cerevisiae [157]. Gradually mechanistic detail was added until the required behaviour, a dependence 
of folding on the concentration of chaperones and foldases, was reproduced.   
 
The most comprehensive model currently available is FoldEco, focussing on protein production in 
the cytosol of E. coli [158].   It integrates translation, three folding (GroEL/GroES, DnaK/DnaJ/GrpE and 
ClpB/DnaK/DnaJ/GrpE) and two degradation pathways (Lon and a ClpAP-type protease). To 
demonstrate applicability, they use the model to investigate a variety of general experimental 
observations, such as the benefit of the DnaK/DnaJ/GrpE and GroEL/GroES systems to vulnerable 
proteins. Crucially, the authors tested the model predictions against a study analysing the effect of 
protein synthesis rates on the folding of firefly luciferase [159].  
 
Despite this, FoldEco assumes no growth, stress responses or changes in ATP levels. Indeed, few 
models focus on analysing the diversion of replication resources from the host cell even though yield 
and quality are compromised in stressed cells. In respect of this, a phenomenological model 
focussed on quantifying the consumption of host resources by heterologous elements [160]. 
Simulations confirm that there is a maximum capacity, which the authors estimate to be 46% of RNA 
and 33% of total protein.  
 
Although a helpful upper bound, the model does not describe the pathways activated in stressed 
cells such as the UPR. An important model of this pathway was generated to aid delineation of UPR 
dynamics and generate useful predictions in the understanding of the signalling mechanism 
Interestingly, the deactivation kinetics of Ire1 bound to unfolded protein could only be modelled 
with a non-linear function, alluding to the biological observation that Ire1 signals emanate from 
oligomeric clusters. Moreover, the model provided a role for Kar2 by reproducing the experimental 
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finding that a mutant Ire1, which cannot bind Kar2, is more susceptible to stress.  
 
1.5.5 Strategy for modelling protein production in P. pastoris 
 
Considering the requirement for an optimisation strategy, the model will need to incorporate crucial 
features limiting protein production within the cell. Taking inspiration from the typical methods to 
increase specific productivity (Section 1.4), aspects of transcription were included to account for the 
effect of multicopy strains. Similarly, an expression for translation was included to allow for rate 
changes induced by codon optimisation. Pathways for protein folding, using the chaperone Kar2 and 
the foldase PDI, were also included and these proteins are often up-regulated to increase 
production. A model including similar kinetic expressions exists for S. cerevisiae [157], but here it will 
be expanded to also incorporate ERAD and the UPR. This was necessary as the UPR is frequently 
induced during heterologous protein production in P. pastoris and regulates the level of Kar2 and 
PDI; moreover, as a controller of E3 levels it regulates the rate of protein degradation through ERAD. 
As P. pastoris is not a model organism, however, published data on the underlying molecular kinetics 
of heterologous protein production is lacking. The computational approach, therefore, requires a 
parallel experimental system to provide the data to be integrated into the model. Consequently, a 
strain of P. pastoris secreting a heterologous protein is required.  
 
1.6 Single-chain antibody fragments: an industrially relevant and informative protein 
platform to explore cellular capacity 
 
The dominant biopharmaceutical currently in production is the monoclonal antibody (mAb). These 
are Y-shaped complexes comprised of four chains: two heavy, consisting of one variable and several 
constant domains, and two light, consisting of one variable and one constant domain [161]. The 
variable domains are responsible for antigen binding while the constant domains mediate 
interactions with the immune system [161]. Various derivatives have also been developed, including: 
(i) minibodies, with reduced constant domains; (ii) monovalent fragments, for instance the antigen-
binding fragment and single-chain antibody fragment; and (iii) various oligomeric fragments, such as 
diabodies, triabodies and tetrabodies (Figure 7) [161].  
 
Single-chain antibody fragments (scFvs) represent the smallest functional unit of an antibody, 
consisting simply of the variable region of one heavy and one light chain coupled together by a 
protein linker sequence. Its small size and simplicity are well suited to expression in cost-effective 
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microbial systems. scFvs are also beneficial clinically; intact antibodies have long serum half-lives 
increasing non-specific toxicity and their size also increases the time taken to penetrate tumours [161]. 
Moreover, as scFvs are relatively small they can form fusion proteins, adding to their functional 
capacity; examples include biosensors [162] and immunotoxins. For the latter, a fully functional fusion 
of the RNAse T1 and an scFv targeting the A33 antigen of human colorectal cells has been produced 
in P. pastoris with yields of 5 to 10 mg L-1 [163]. Although no scFvs have been approved by the FDA to 
date, they are a promising candidate for future biopharmaceuticals. Indeed, nine patents were 
granted for scFvs in the EU between 2010 and 2011 [164].  
 
 
Figure 7 – Schematic of an intact monoclonal antibody and two prevalent derivatives 
A wide variety of smaller fragments have been generated from the monoclonal antibody (mAb) structure. The 
antigen-binding fragment (Fab) is comprised of one heavy and one light chain of the constant and variable 
domains; the single-chain antibody fragment (scFv) is comprised of one heavy and one light chain of the 
variable domain. All of the molecules maintain variable regions and therefore retain full antigen binding; 
indeed scFvs constitute the smallest functional unit of an antibody. Not all can interact with the immune 
system, however, as this requires the constant domains. VH: heavy-chain variable domain; VL: light-chain 
variable domain; CH: heavy-chain constant domain; CL: light-chain constant domain. Image source of 3D Ab 
structure: Stefan Dübel, Technical University of Braunschweig. 
 
In addition to their industrial relevance, scFvs have the added bonus of being an informative 
platform for investigating cellular capacity. Specific productivity can be affected by the heterologous 
protein; indeed, some heterologous proteins are harder to express than others. A study analysing 
the secretion rate of enhanced green fluorescent protein and the aglycosylated and glycosylated 
forms of a human Fc fragment in P. pastoris showed the rates for the latter two proteins, requiring 
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chaperone interaction, were lower [156]. Here, scFvs have been selected as they are considered to be 
difficult to produce, as exemplified by their systematically low yields, so that analysing the 
bottlenecks in their production is likely to yield more targets for optimisation. The two selected for 
this research are BC1 and MFE23. 
 
1.6.1 BC1 
 
Fibronectin is an important glycoprotein found in the extracellular matrix and within body fluids. 
Several isoforms occur: although encoded by a single gene, it generates polymorphism through the 
alternative splicing of three areas: IIICS, ED-A and ED-B [165]. BC1 specifically targets fibronectin 
isoforms containing the ED-B region, which is much more prevalent in transformed human and 
tumour cells [165].  
 
1.6.2 MFE23 
 
The carcinoembryonic antigen (CEA) is a cell surface glycoprotein displayed in the foetal colon and 
colon adenocarcinoma to a much greater extent than normal adult tissues [166]. Studies have shown 
CEA to characterise most gastrointestinal and some breast, lung and ovarian cancers; indeed, it is 
one of the most widely used markers worldwide [166,167]. Consequently, a variety of antibodies and 
antibody fragments have been developed to target CEA including the scFv MFE23. Indeed, MFE23 
was the first scFv to be used in patients for imaging purposes [168]. 
 
The benefit of analysing two scFvs is as follows: although this group of proteins generally produce 
lower yields, the two in this study have greatly contrasting expression levels; specifically, BC1 
expresses to a higher level than MFE23 (M. Deonarain, pers. comm.). Deciphering the bottlenecks in 
production between them may help to tease out some of the finer points of how the heterologous 
protein can affect specific productivity. 
 
1.7 Aims and objectives 
 
The aim of this study was to develop a model of single-chain antibody fragment production in P. 
pastoris, informed by experimental analysis, to predict engineering strategies to increase specific 
productivity.  
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The objectives, therefore, were as follows: 
 
 Derive a dynamic model of scFv production in P. pastoris 
The model was to include aspects of: (i) transcription, (ii) translation and (iii) protein folding 
in the ER, as these processes are frequently targeted in typical strategies to increase yield. 
The two stress pathways, the UPR and the ERAD, would also be incorporated as key 
regulators. Values would initially be derived from the literature and predictions qualitatively 
compared to phenomena observed in the literature. 
 
 Generate P. pastoris strains expressing the scFvs BC1 and MFE23 
The scFv genes BC1 and MFE23 were to be cloned into P. pastoris to generate experimental 
strains from which data would be gathered for the model. Assumptions of the model, 
including the omission of glycosylation reactions, were to be experimentally confirmed.  
 
 Characterise the recombinant strains in terms of traditional regulators of productivity 
LC-MS/MS and RT Q-PCR would be used to analyse the strains in terms of traditional 
regulators of productivity and the results contrasted with the model predictions. Frequently, 
the chaperones Kar2 and PDI are overexpressed as a strategy to increase productivity, and 
this was to be undertaken here. The experimental analysis, in comparison to model 
simulations, would help clarify our understanding of traditional strategies to increase yield 
and guide future engineering strategies to recombinant protein production. 
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2. Materials and methods 
2.1 Strains and plasmids 
 
Table 2 – Strains and plasmids used in this study 
ICL: Imperial College London 
Name Details Source 
Escherichia coli strains 
JM109 
F’ (traD36, proAB+ lacI
q
, Δ(lacZ)M15) endA1 recA1 
hsdR17(rk
-
, mk
+
) mcrA supE44 λ
-
 gyrA96 relA1 Δ(lac-
proAB)thi-1 
Promega 
BL21-Gold (DE3) B F
-
 ompT hsdS(rB
–
 mB
–
) dcm
+
 Tet
r
 gal λ(DE3) endA Hte Dr. Polizzi, ICL 
BL21 (DE3) argA lysA 
As above, with argA and lysA genes knocked out 
conferring dual auxotrophy 
Prof. Hay, University of 
Dundee 
[169]
 
HB2151 Δ lac-pro ara 
Nalr
 thi F' (proAB 
lacIq
 lacZ Δ M15) Dr. Deonarain, ICL 
Pichia pastoris strains 
GS115 his4 Invitrogen 
GS115[BC1]L his4, low secretion of the single-chain antibody BC1 This study 
GS115[BC1]H his4, high secretion of the single-chain antibody BC1 This study 
GS115[BC1-PIK]H 
As above, with up-regulated Kar2 and PDI expression 
conferred through chromosomal integration of pIB2-PIK 
vector 
This study 
GS115[MFE23]L his4, low secretion of the single-chain antibody MFE23 This study 
GS115[MFE23]H his4, high secretion of the single-chain antibody MFE23 This study 
GS115[MFE23-PIK]H 
As above, with up-regulated Kar2 and PDI expression 
conferred through chromosomal integration of pIB2-PIK 
vector 
This study 
Plasmids 
pET28a 
N-terminal polyhistidine tag, expression driven by the T7 
promoter, kanamycin resistance 
Novagen 
pET28a[KAR2] pET28a, with KAR2 cloned under the T7 promoter Dr. Polizzi, ICL 
pET28a[PDI] pET28a, with PDI cloned under the T7 promoter Dr. Polizzi, ICL 
pUC119[BC1] 
pUC origin, lac promoter, ampicillin resistance, BC1 
expression 
Dr. Deonarain, ICL 
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pcDNA4a[MFE23] 
pUC origin, CMV promoter, ampicillin resistance 
(bacteria), zeocin resistance (mammalian cells), MFE23 
expression 
Dr. Deonarain, ICL 
pPICZαA 
Integrating vector with pUC origin, polyhistidine tag, c-
Myc epitope tag, AOX1 promoter, Saccharomyces 
cerevisiae α-factor secretion signal, zeocin resistance 
gene (Streptoalloteichus hindustanus ble) 
Invitrogen 
pPICZαA[BC1] pPICZαA, with BC1 cloned under the AOX1 promoter This study 
pPICZαA[MFE23] pPICZαA, with MFE23 cloned under the AOX1 promoter This study 
pIB2 
Integrating vector with pUC origin, GAP promoter and 
ampicillin and HIS4 for selection in E. coli and P. pastoris 
GS115 respectively. 
Dr. Glick, University of 
Chicago 
[170]
 
pIB2[KAR2] pIB2, with KAR2 cloned under the GAP promoter This study 
pIB2[PDI] pIB2, with PDI cloned under the GAP promoter This study 
pIB2[PDI.Stop] pIB2[PDI], with three extra stop codons following PDI  This study 
pIB2[PDI.Stop-IRES] 
pIB2[PDI.Stop], with an IRES sequence from S. cerevisiae 
following PDI 
This study 
pIB2[PIK] 
pIB2[PDI.Stop-IRES], with both PDI and KAR2 cloned 
under the GAP promoter in a bicistronic format linked 
with an IRES element from Saccharomyces cerevisiae 
This study 
   
 
2.1.1 Antibiotics 
 
For E. coli kanamycin (Sigma, Dorset, UK) was used at 30 μg mL-1, while ampicillin (Sigma, Dorset, UK) 
and zeocin (Source BioScience Autogen, Nottingham, UK) were used at 100 μg mL-1 respectively. For 
P. pastoris, zeocin was used at 100 μg mL-1. 
 
2.1.2 Glycerol stocks 
 
Both bacterial and yeast strains were stored in 40% (v/v) glycerol from a 5 mL overnight culture. 
Stocks were kept in cryogenic vials (Thermo Scientific Nalgene, Loughborough, UK) and stored at -
80°C.  
 
2.1.3 Sterilisation 
 
All media, solutions, instruments and containers were sterilised by autoclaving at 121°C/103 Pa.  
Any heat labile components were filtered using 0.22 μm Sartorius Stedim Biotech Minisart filters 
(VWR International Ltd., Leighton Buzzard, UK).  
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2.2 Media 
 
2.2.1 Bacterial media 
 
Routine bacterial cultures were carried out in Luria-Bertani (LB) media; containing 1% (w/v) 
tryptone, 0.5% (w/v) yeast extract and 1% (w/v) NaCl. For solid media 2% (w/v) agar was added. As 
zeocin is incompatible with high salt concentrations, bacterial cultures in the presence of this 
antibiotic were carried out in low salt LB media with only 0.5% (w/v) NaCl. 
 
Minimal media, for the expression of isotopically labelled protein standards, contained 0.4% (w/v) 
glucose, 10 mM NH4Cl, 1 X Gutnick salts, 1 X Trace elements solution, 0.5 mM amino acids, 1 mM L-
arginine-13C6,
15N4HCl and 1 mM L-lysine-
13C6,
15N2 hydrochloride (Sigma Isotec, Dorset, UK). 5 X 
Gutnick salts: 23.3 g L-1 KH2PO4, 67.5 g L
-1 K2HPO4, 5 g L
-1 K2SO4 and 0.5 g L
-1 MgSO4·7H2O. 1000 X 
Trace elements solution: 2.85 g L-1 H3BO3, 1.80 g L
-1 MnCl2·4H2O, 1.36 g L
-1 FeSO4·7H2O, 1.77 g L
-1 
Na2C4H4O6, 26.5 mg L
-1 CuCl2·2H2O, 20.8 mg L
-1 ZnCl2, 46.4 mg L
-1 CoCl2·6H2O, 25.2 mg L
-1 
Na2MoO4·2H2O, 20 mg L
-1 Na2SeO3, 0.5 g L
-1 C10H16N2O8, 1.84 g L
-1 H2SO4. Amino acids: Alanine, 
aspartate, asparagine, cysteine, glutamate, glutamine, glycine, histidine, isoleucine, leucine, 
methionine, phenylalanine, proline, serine, threonine, tryptophan, tyrosine and valine. 
 
2.2.2 Yeast media 
 
Routine yeast cultures were propagated in yeast peptone dextrose (YPD) media; containing 2% 
(w/v) peptone, 1% (w/v) yeast extract and 2% (w/v) dextrose solution. For solid media, 2% (w/v) 
agar was added.  
 
Buffered minimal glycerol/methanol (BMG/BMM) media contained 100 mM potassium phosphate 
(pH 6), 1.34% (w/v) yeast nitrogen base, 4 x 10-5% (w/v) biotin and 1% glycerol. BMM had the same 
composition; however, the glycerol was substituted with 0.5% (v/v) methanol. 
 
Buffered glycerol/methanol complex (BMGY/ BMMY) media contained 1% (w/v) yeast extract, 2% 
(w/v) peptone, 100 mM potassium phosphate (pH 6), 1.34% (w/v) yeast nitrogen base, 4 x 10-5% 
(w/v) biotin and 1% glycerol. BMMY had the same composition; however, the glycerol was 
substituted for 0.5% (v/v) methanol. For solid media, 2% (w/v) agar was added.  
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Selection of histidine prototrophs required regeneration dextrose (RD) media; containing 1 M 
sorbitol, 2% (w/v) dextrose, 1.34% (w/v) yeast nitrogen base, 4 x 10-5% (w/v) biotin and 0.005% (w/v) 
of the following amino acids: L-glutamic acid, L-methionine, L-lysine, L-leucine and L-isoleucine. For 
solid media, 2% (w/v) agar was added.  
 
2.2.3 Measurement of cell density 
 
The cell density of cultures was quantified by absorbance readings at 600 nm using a Synergy™ HT 
Multi-Mode Microplate Reader and associated KC4™ software (Bio-Tek, Potton, UK). Samples were 
loaded into a 96 well plate (Fisher Scientific, Loughborough, UK). Measurements were taken from 
duplicate dilutions.  
 
2.3 Molecular biology methods 
 
2.3.1 Agarose gel electrophoresis 
 
Gels comprised 0.8% or 1% (w/v) agarose, dissolved by heating in 1 x TAE solution (0.04 M Tris base, 
0.114% (v/v) acetic acid and 1 mM EDTA pH 8.0). The DNA stain SYBR® Safe (Invitrogen, Paisley, UK) 
was added to a final concentration of 1 in 20,000 once the agarose solution had cooled to 50°C. 
 
DNA samples were mixed with 6 x DNA loading dye (0.25% (w/v) bromophenol blue, 0.25% (w/v) 
xylene xyanol, 40% (w/v) sucrose in deionised water). All gels used 0.5 μg of GeneRuler™ 1kb DNA 
ladder (Fermentas, York, UK) to reference size (Figure 8). Electrophoresis was conducted in BioRad 
Gel Electrophoresis tanks (BioRad, Hemel Hempstead, UK) at 120 V for 45 minutes.  
 
Gels were imaged using the short wave UV light of a G:BOX with associated GeneSNAP software 
(Syngene, Cambridge, UK). If required, DNA analysed by gel electrophoresis was extracted using 
Zymo Research Zymoclean™ Gel DNA Recovery kit (Cambridge Biosciences Ltd., Cambridge, UK) 
according to the manufacturer’s instructions. 
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Figure 8 – Reference for estimation of DNA size 
A 1% agarose gel, in 1 X TAE, with 5 μL of GeneRuler™ 1kb DNA ladder (Fermentas, York, UK).  
 
2.3.2 Plasmid DNA extraction 
 
A 5 mL culture was grown overnight at 37°C, 250 rpm. Extraction was carried out using the QIAprep® 
Spin Miniprep Kit (Qiagen, Crawley, UK) according to the manufacturer’s instructions. Samples were 
stored in filter sterilised autoclaved water or TE Buffer (10mM Tris-HCL pH 7.5, 1mM EDTA) at -20°C. 
 
2.3.3 Yeast genomic DNA extraction 
 
A 10 mL yeast culture was grown overnight at 30°C, 250 rpm. A 200 μL aliquot was centrifuged at 
13,000 x g for 1 minute. The supernatant was discarded and the pellet resuspended in 50 μL of 67 
mM KH2PO4 at pH 7.5. To induce spheroplast formation, 10 μL of zymolase (Sigma, Dorset, UK) (5 U 
mL-1 in 0.01 M Na2HPO4 and 50% glycerol) was added and the cells incubated without shaking at 
37°C for an hour.  
 
Extraction was then concluded with the DNeasy® Plant Mini Kit (Qiagen, Crawley, UK), according to 
the manufacturer’s instructions: “Purification of total DNA from plant tissue (mini protocol)” from 
step 7. Samples were stored in filter sterilised autoclaved water or TE Buffer (10mM Tris-HCL pH 7.5, 
1mM EDTA) at -20°C. 
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2.3.4 Yeast RNA storage, extraction and quality analysis 
 
For RNA extraction, 600 μL of culture was diluted into 3 mL Ambion RNAlater® (Applied Biosystems, 
Warrington, UK) and incubated at room temperature for an hour. The suspension was centrifuged at 
4,000 rpm and 4°C for five minutes, and the pellet resuspended in 1 mL RNAlater®. The sample was 
divided into two aliquots and stored at -80°C until extraction. 
 
RNA was extracted using Ambion RiboPure™ Yeast Kit (Applied Biosystems, Warrington, UK) 
according to the manufacturer’s instructions. Samples were stored at -20°C for up to 1 to 2 months, 
or at -80°C long-term.  
 
The quality and concentration of the preparation was analysed using the Experion RNA Std Sens 
system (Bio-Rad, Hemel Hempstead, UK) according to the manufacturer’s instructions.  
 
2.3.5 Restriction digests  
 
All restriction enzymes, purchased from Fermentas (York, UK), were carried out with digest reaction 
compositions according to the manufacturer’s recommendations. Reactions were incubated at 37°C 
for 3 hours. 
 
2.3.6 Ligations 
 
Ligations used T4 DNA ligase (Fermentas, York, UK) and conducted according to the manufacturer’s 
instructions. Each reaction comprised of a 3:1 molar ratio of gene insert to plasmid based on 100 ng 
of vector DNA, 2 μL 10 x T4 DNA ligase buffer, 1 μL 10 mM ATP, 1 μL T4 DNA ligase and was made up 
to 20 μL with filter sterilised, autoclaved deionised water. The ligation was incubated without 
shaking at room temperature for 1 hour.  
 
2.3.7 DNA purification 
 
DNA was purified using Zymo Research DNA Clean and Concentrator-5™ kit (Cambridge Biosciences 
Ltd., Cambridge, UK) according to the manufacturer’s instructions. 
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2.3.8 DNA quantification 
 
DNA was quantified by absorbance readings at 260 nm using the Synergy™ HT Multi-Mode 
Microplate Reader and associated KC4™ software (Bio-Tek, Potton, UK). Samples were loaded into a 
Greiner Bio-One 384 UV/Vis multi-well plate (Scientific Laboratory Supplies, Nottingham, UK).  
 
2.3.9 DNA sequencing 
 
Sequencing of DNA samples was carried out by Eurofins MWG Operon (Ebersberg, Germany). 
Sample preparation was carried out in accordance with their guidelines. 
 
2.3.10 End-point polymerase chain reaction (PCR) and primer details 
 
The Phusion® Hot Start II High Fidelity DNA Polymerase (Finnzymes, Espoo, Finland) system was used 
to amplify genes for cloning. The reaction mix comprised of 10 μL 5 x Phusion HF buffer, 4 μL 10 mM 
dNTPs (Bioline, London, UK), 2.5 μL 10 μM forward and reverse primers, 1.5 μL 100% DMSO, 0.5 μL 
Phusion Hot Start DNA Polymerase and 1 μL of the DNA template. It was then made up to a final 
volume of 50 μL with autoclaved, filter sterilised deionised water and subjected to the following 
cycling conditions: 98°C for 30 seconds then 34 cycles of denaturing at 98°C for ten seconds, 
annealing at a temperature 3°C below the lowest melting temperature of the primers for 30 seconds 
and extension at 72°C for 15 seconds per kilobase of product. A final step of 72° for ten minutes 
concluded the profile and the reactions were analysed on a 1% agarose gel. 
 
All primers used in this study (Table 3), were manufactured by Invitrogen (Paisley, UK).  
 
Colony PCR to test E. coli transformants 
Each colony was inoculated into a reaction mix consisting of 10 μL 2 x BioMix™ Red (Bioline, London, 
UK), 0.4 μL 10 μM forward and reverse primers and made up to 20 μL with autoclaved, filter 
sterilised deionised water. The cycling conditions were as follows: 98°C for five minutes, then 29 
cycles of denaturing at 98°C for ten seconds, annealing at a temperature 3°C below the lowest 
melting temperature of the primers for 30 seconds and extension at 72°C for 15 seconds per 
kilobase of product. A final step of 72°C for three minutes concluded the profile and the PCR 
reactions were analysed on a 1% agarose gel. 
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Colony PCR to test P. pastoris transformants 
A medium sized colony was inoculated into 30 μL 0.2% (w/v) sodium dodecyl sulphate (SDS) 
solution, vortexed for 15 seconds, incubated for four minutes at 90°C and centrifuged at 13,000 x g 
for one minute. 1 μL of supernatant was transferred to a reaction mix of 4 μL 5 x Phusion HF buffer, 
2 μL 10mM dNTPs (Bioline, London, UK), 0.75 μL 50 mM MgCl2, 1 μL 10 μM forward and reverse 
primers, 0.25 μL Phusion Hot Start DNA Polymerase (Finnzymes, Espoo, Finland), and made up to 20 
μL with autoclaved, filter sterilised deionised water. The following cycling conditions were applied: 
98°C for three minutes, then 34 cycles of denaturing at 98°C for ten seconds, annealing at a 
temperature 3°C below the lowest melting temperature of the primers for 30 seconds and extension 
at 72°C for 15 seconds per kilobase of product. A final step of 72°C for ten minutes concluded the 
profile and the PCR reactions were analysed on a 1% agarose gel. 
 
 
Table 3 – Primers for end-point PCR 
Primers for end-point PCR are in upper case with restriction sites underlined, where ‘F’ and ‘R’ indicate 
forward and reverse primers respectively. The melting temperature (Tm) was derived using the nearest 
neighbour method in the online calculator OligoCalc 
[171]
. 
Name Sequence Tm (°C) Purpose 
Cloning the SCFV genes for expression in P. pastoris 
BC1_F 
GGAATTCGAGGTGCAGCTGGT
GCAGTC 
64 Clone huBC1 into pPICZαA; EcoRI. 
BC1_R 
GCTCTAGACTATGCGGCCCCAT
TCAGATC 
65 Clone huBC1 into pPICZαA; XbaI. 
MFE_F 
GGAATTCCAGGTGAAACTGCA
GCAGTCTG 
63 Clone huMFE23 into pPICZαA; EcoRI. 
MFE_R 
GCTCTAGAGCGGCCGCCCGTT
TCAG 
67 Clone huMFE23 into pPICZαA; XbaI. 
Α_F TACTATTGCCAGCATTGCTGC 55 Confirm scFv integration into pPICZαA. The 
forward primer binds 3’ end of α-factor; the 
reverse binds the UTR of AOX1. AOX_R GCAAATGGCATTCTGACATCC 52 
Cloning KAR2 and PDI for overexpression in P. pastoris scFv strains 
KAR2_F1 
AACTGCAGAACATGCTGTCGTT
A 
56 Clone KAR2 into pIB2; PstI. 
KAR2_R1 
AAACCGGTAACTACAACTCATC
ATG 
54 Clone KAR2 into pIB2; AgeI. 
KAR2_SeqF1 GGTTTCTCCTGACCCAAAGAC 52 
Confirm KAR2 integration into pIB2. Primer F1 
binds pIB2 before the insert; R1 binds internally; 
F2 binds before R1 providing overlap and R2 
binds the pIB2 vector after the insert.  
KAR2_SeqR1 TTGTTCAACTGGTTTCAGTGTC 51 
KAR2_SeqF2 GATTGACTCTTTCGTCGACGGT 56 
KAR2_SeqR2 AAATGAAGCCTGCATCTCTCAG 55 
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PDI_F 
CGGAATTCCGATAATGCAATTC
AAC 
56 Clone PDI into pIB2; EcoRI. 
PDI_R CCCAAGCTTGGGTTAAAGCTC 54 Clone PDI into pIB2; HindIII. 
PDI_SeqF TGGTTTCTCCTGACCCAAAGAC 48 Confirm PDI integration into pIB2; binds pIB2 
vector before and after insert. PDI_SeqR AGTGCCCAACTTGAACTG 52 
PDI.Stop_R 
TGTAAGCTTATATTATCATTAT
TAAAGCTCGTC 
58 
Clone PDI with three extra stop codons into pIB2; 
HindIII. 
IRES_F 
CCCAAGCTTGGGTTTGAGTTG
GAGAGT 
61 Clone IRES into pIB2-PDI; HindIII. 
IRES_R 
CAACCGGTAAGCCCTCTTGTTT
TTCTTTTTC 
60 Clone IRES into pIB2-PDI; AgeI. 
KAR2_F2 
AAACCGGTAAAACATGCTGTC
GTTAAAACC 
59 
Clone KAR2 into pIB2-PDI/IRES; AgeI. 
KAR2_R2 
CCACCGGTAACTACAACTCATC
ATGATCAT 
60 
KAR2_SeqF3 
AGAGGGCAAACCGGTAAAACA
TGCT 
59 
Confirm correct orientation of KAR2 into pIB2-
PDI.S-IRES construct. Primers overlap the join 
between KAR2 and the backbone and will only 
amplify those inserted in the correct orientation.  
KAR2_SeqR3 
GAATCTAGCAAGACCGGTAAC
TACAACTC 
59 
PDI_SeqF2 
GTGCTGCTGCTGCCGATATTAT
TA  
59 Confirm PDI integration into pIB2-PDI.S-IRES-
KAR2 (pIB2-PIK). Both primers bind internally with 
F2 preceding R2 to allow for overlap. PDI_SeqR2 
GTCTTGAGGAACTCCAAACTTC
TT 
54 
 
2.3.11 Reverse-transcriptase quantitative PCR (RT Q-PCR) analysis and primer details 
 
cDNA was prepared from RNA using the high capacity cDNA reverse transcription kit (Applied 
Biosystems, Warrington, UK) according to the manufacturer’s instructions. RNA samples were 
diluted to 1 μg in 10 μL using molecular biology grade water (Thermo Scientific Hyclone, 
Loughborough, UK), converted to cDNA and subsequently further diluted to a concentration of 5 ng 
μL-1. 
 
The RT Q-PCR reaction mix comprised of 10 μL 2 X SYBR® Green JumpStart™ Taq ReadyMix™ (Sigma, 
Dorset, UK), 1 μL 5 μM forward and reverse primers, 5 μL sample and 3 μL molecular biology grade 
water (Thermo Scientific Hyclone, Loughborough, UK). The reactions were placed in a SuperPlate 96-
well PCR Plate (Thermo Scientific ABgene, Loughborough, UK), sealed with a MicroAmp® optical 
adhesive film (Applied Biosystems) and centrifuged at 2,000 x rpm for ten seconds. The thermal 
cycling conditions were as follows: 96°C for five minutes, then 39 cycles of 96°C for 30 seconds, 60°C 
for 30 seconds and 72°C for 30 seconds, then 72° for ten minutes. A melting curve, reading from 55 
to 95°C every 0.2°C, concluded the cycling profile.  
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RT Q-PCR primers were designed according to the following requirements. For each target, a 
minimum of two pairs of primers were designed according to: (i) primer size between 18 and 23 
base pairs; (ii) melting temperature between 58 and 62°C; (iii) GC content between 30 and 80%; and 
(iv) an amplicon size of between 70 and 150 bp. Each primer was subsequently inputted to the NCBI 
nucleotide database to ensure specificity to the target gene.  
 
Each of the primer pairs was then analysed by generating Ct values for concentrations of P. pastoris 
GS115, GS115[BC1]H and GS115[MFE23]H genomic DNA with 260/280 ratios between 1.7 and 2.0 
ranging from 0.001 ng to 100 ng in triplicate reactions. The average Ct values were plotted against 
the DNA concentration, previously transformed by taking the Log10, and a linear regression 
performed. The resulting gradient (g) was entered into the following formula to calculate efficiency: 
 
           ( )   [   (
 
  
)]       
 
The pair of primers for each target with the highest efficiency subsequently underwent optimisation 
through a gradient RT Q-PCR targeting the annealing temperature. Again, Ct values were generated 
for concentrations of P. pastoris GS115, GS115[BC1]H and GS115[MFE23]H genomic DNA with 
260/280 ratios between 1.7 and 2.0 ranging from 0.001 ng to 100 ng. Due to machine limitations, 
each DNA concentration was analysed in only one reaction. The gradient of Ct values against Log10 
(DNA concentration) produced the efficiency at different annealing temperatures, and the one 
closest to 100% was selected for validation. A full efficiency analysis, as described above, was 
subsequently undertaken at the optimised annealing temperature. Finally, to ensure that the correct 
amplicon was produced, products were subjected to a melting curve analysis and agarose gel 
electrophoresis. Optimised and validated RT Q-PCR primers for each target can be found in Table 3, 
as are the internal controls (beta actin and glucoamylase GLU1 precursor) which were used to 
remove artefacts caused by differences in RNA concentration.  
 
Where relative quantification was appropriate, the Pfaffl method was used [172]. Where absolute 
quantification was required, a standard curve was generated from linear, double stranded molecules 
of DNA. The copy number was calculated by first ascertaining the weight of one molecule by 
inputting its sequence into the DNA Molecular Weight Calculator [173].  
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The following formula was then used to find the copy number: 
 
            
 .        (           )                (      )
                (      )
 
 
Standard curves were subsequently generated from 210 copies μL-1 to 2 copies per μL-1 for 
amplification by Q-PCR. A linear regression was then conducted on the Ct values against a Log10 
transformation of the copy number. The Ct values obtained from cDNA samples were converted to 
Log10(copy number) using the equation derived from a linear regression, and the inverse Log10 taken 
to produce absolute copy number. The following formula was used to calculate the number of 
copies per cell, where there are 25 ng of cDNA per reaction and 0.71 pg RNA per average yeast cell 
[174]: 
 
                      
                            
         
 .     
 
 
Table 4 – Primers for RT Q-PCR 
Primers for RT-Q PCR are in lower case, where ‘F’ and ‘R’ indicate forward and reverse primers respectively. 
The melting temperature (Tm) was derived using the salt adjusted method in the online calculator OligoCalc 
[171]
. 
Name Sequence Tm (°C) Purpose 
RT Q-PCR primers for the analysis of SCFV transcription in P. pastoris 
qBC1_F atcccagacaggttcagtgg 61 BC1; produces a 80 bp amplicon with an 
efficiency of 91.8%. qBC1_R gcaaaatcttcaggctccag 58 
qMFE23_F ggagtggattggatggattg 58 MFE23; produces a 149 bp amplicon with an 
efficiency of 92.7%. qMFE23_R aatagacggcagtgtcctcag 61 
RT Q-PCR primers for analysis of the UPR in P. pastoris 
qKAR2_F tcaaagacgctggtgtcaag 58 KAR2 (XM_002490982) encodes an ER 
chaperone Kar2; produces a 151 bp amplicon 
with an efficiency of 89%. qKAR2_R tatgcgacagcttcatctgg 58 
qHAC1_F cgactacattactacagctccatca 64 HAC1 (XM_002489994) encodes the 
transcription factor Hac1p; produces a 124 bp 
amplicon with an efficiency of 89.2%. qHAC1_R tgctgtaatgtgtaaagatgaatcc 61 
qPDI_F gccgttaaattcggtaagca 56 PDI (XM_002494247) encodes an ER foldase; 
produces a 145 bp amplicon with an efficiency 
of 89.84%. qPDI_R tcagctcggtcacatctttg 58 
- MATERIALS AND METHODS - 
 
- 62 - 
RT Q-PCR primers for analysis of the ERAD in P. pastoris 
qE1_F accgttcttgaccaaactgg 58 E1 (XM_002493042) encodes a ubiquitin 
activating enzyme; produces a 78 bp amplicon 
with an efficiency of 94.6%. qE1_R cattgtcacggttccatctg 58 
qUBC7_F catcctccaggaaatgatcc 58 UBC7 (XM_002493116.1) encodes a ubiquitin 
conjugating enzyme; produces a 137 bp 
amplicon with an efficiency of 90.6%. 
qUBC7_R tctatgttggcaccgctttc 58 
qHRD1_F gcacagatttgtgtccgaag 58 Major component of HRD1 complex 
(XM_002493213); produces a 127 bp amplicon 
with an efficiency of 92.8%. 
qHRD1_R cccttcctgccaaatacaac 58 
qDOA10_F tcttttcacgccgctacttc 58 DOA10 (XM_002492722) encodes a ubiquitin-
protein ligase; produces a 119 bp amplicon 
with an efficiency of 92.7%. 
qDOA10_R ctttgtgcttccttccttgc 58 
qCDC48_F gcttcaggcacagaaaatgg 58 CDC48 (XM_002494315) encodes an ATPase; 
produces a 94 bp amplicon with an efficiency 
of 92.4%. 
qCDC48_R tggcatcgtcaactatcagc 58 
RT Q-PCR primers for the internal controls 
qACT_F gctttgttccacccatctgt 58 ACT (XM_002492401.1); produces a 164 bp 
amplicon with efficiency of 88.76%. qACT_R tgcatacgctcagcaatacc 58 
qSGA1_F tatcgtgcactgtccgtttc 58 SGA1 (XM_002493972) encodes an 
intracellular sporulation-specific 
glucoamylase; produces a 131 bp amplicon 
with an efficiency of 92.68% 
qSGA1_R tcggctccttgcatataacc 58 
 
2.3.12 Preparation and heat shock transformation of TSS competent E. coli cells 
 
TSS competent cells were generated from E. coli strains JM109 and BL21 (DE3) ΔArgA ΔLysA. Cells 
were grown in 50 mL LB at 37°C, 250 rpm until an OD600 0.2 - 0.5 then incubated on ice for ten 
minutes and centrifuged at 1,500 x g, 4°C for ten minutes. The supernatant was discarded and the 
pellet resuspended in 5 mL of 4°C TSS (10 g PEG 8000, 3 mL 1 M MgCl2, 2.5 mL DMSO to 100 mL with 
LB media). Aliquots of 100 μL were transferred to ice-cold 1.5 mL microcentrifuge tubes and stored 
at -80°C [175,176]. 
 
The cells were thawed on ice, incubated with 100 ng DNA for ten minutes on ice, heated to 42°C for 
45 seconds and returned to ice for two minutes. The cells were recovered in 1 mL LB media at 37°C 
250 rpm for one hour, spread onto an LB plate containing the appropriate antibiotic and incubated 
without shaking at 37°C for 16 hours.  
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2.3.13 Preparation and transformation of electrocompetent P. pastoris GS115 cells 
 
A 100 mL YPD culture was inoculated with GS115 and incubated at 30°C, 250 rpm until an OD600 1.3 - 
1.5. The culture was then centrifuged four times at 1,500 x g, 4°C for five minutes: the first pellet 
was resuspended in 100 mL ice-cold dH20, the second in 50 mL ice-cold dH20, the third in 2 mL ice-
cold 1M sorbitol and the final in 200 μL ice-cold 1M sorbitol. The cells were stored on ice and used 
immediately. 
 
For transformation 80 μL of cells was mixed with 5 - 10 μg of DNA linearised with MssI and 
transferred to an ice-cold 0.2 cm electroporation cuvette (Geneflow, Fradley, UK). The reaction was 
incubated on ice for five minutes and then pulsed using a Gene Pulser Xcell Microbial System (Bio-
Rad, Hemel Hempstead, UK) at 2000 V, 200 Ω and 25 μF. Immediately after 1 mL of ice-cold 1 M 
sorbitol was added to the cuvette and the contents transferred to a sterile 15 mL centrifuge tube. 
The cells were incubated without shaking at 30°C for two hours and selected on a YPD plate 
containing 100 μg mL-1 zeocin for six days. 
 
2.3.14 Southern blot analysis 
 
DIG labelled probes were generated by amplifying BC1 and MFE23 from pPICZαA[BC1/MFE23] with 
primers BC1_F and BC1_R, and MFE23_F and MFE23_R, respectively. The DNA concentration of the 
PCR products was quantified and 1 μg of amplicon was labelled overnight using the DIG High Prime 
DNA Labelling and Detection Starter Kit II (Roche, Burgess Hill, West Sussex, UK) according to 
manufacturer guidelines. 
 
Genomic DNA from GS115[BC1]H, GS115[BC1]L, GS115[MFE23]H and GS115[MFE23]L was isolated 
according to Section 2.3.3. For BC1 and MFE23 strains, 1 μg DNA was digested with PshAI or KpnI for 
24 hours at 37°C, respectively. The samples were further digested with NdeI for 24 hours at 37°C 
and separated on a 0.8% agarose gel.  
 
The gel was soaked in 300 mL 0.25 M HCl for ten minutes at room temperature with gentle shaking. 
After brief rinsing in deionised water, the gel was twice soaked in 300 mL of denaturation solution 
(0.5 M NaOH and 1.5 M NaCl) for 15 minutes at room temperature with gentle shaking. Following a 
further brief rinse in deionised water, the gel was twice soaked in 300 mL of neutralisation solution 
(1.5 M NaCl, 0.5 M Tris-HCl pH 7.2 and 1 mM EDTA) for 15 minutes at room temperature with gentle 
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shaking. Finally the DNA was transferred from the gel to Amersham Hybond-N+ membrane (GE 
Healthcare UK, Little Chalfont, UK), pre-soaked in neutralisation solution for two minutes, overnight 
at room temperature. DNA was subsequently fixed to the membrane with a 0.4 M NaOH treatment 
for 20 minutes, and finally rinsed in 5 X SSC solution (20 X SCC: 3 M NaCl and 300 mM sodium citrate, 
pH 7.0 with HCl). 
 
Hybridisation of the DIG-labelled DNA probe to the membrane, and immunological detection of the 
probe, was carried out according to the DIG High Prime DNA Labeling and Detection Starter Kit II 
(Roche, Burgess Hill, West Sussex, UK). Chemiluminescence was detected by exposing the 
membrane for 20 minutes to a G:BOX and associated GeneSNAP software (Syngene, Cambridge, UK). 
 
2.4 Protein methods 
 
2.4.1 SDS-PAGE protein gels 
 
Table 5 – Composition of 10%, 12% and stacking gels used in SDS-PAGE 
Component 
Volume (mL) 
10% 12% Stacking gel 
Deionised H2O 1.9 1.6 0.68 
30% (w/v) acrylamide mix 1.7 2.0 0.17 
1.5 M Tris-HCl (pH 8.8) 1.3 1.3 0.0 
1.5 M Tris-HCl (pH 6.8) 0.0 0.0 0.13 
10% (w/v) SDS 0.05 0.05 0.01 
10% (w/v) ammonium persulfate 0.05 0.05 0.01 
Tetramethylethylenediamine 0.002 0.002 0.001 
 
Sample preparation 
Cell lysate and culture supernatants were mixed with SDS-PAGE loading buffer (2.5% (w/v) 2 M Tris-
HCl pH 6.8, 2% (w/v) SDS, 0.6% (v/v) glycerol, 0.05% (v/v) β-mercaptoethanol, 0.416% (w/v) 
bromophenol blue) and incubated at 95°C for 5 minutes. Cell pellets from 1 mL bacterial culture 
were vortexed with 200 μL SDS-PAGE loading buffer, incubated at 95°C for 10 minutes and 
centrifuged at 13,000 x g for three minutes. The supernatant was subsequently loaded onto the 
prepared gel. For yeast cells, pellets were subject to a mild alkali treatment before being boiled in 
SDS-PAGE loading buffer [177]. 
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Electrophoresis conditions 
Each gel was loaded with 5 μL unstained protein molecular weight marker (Fermentas, York, UK). 
Electrophoresis was conducted in SDS-PAGE running buffer (25 mM Tris-base, 192 mM glycine and 
0.1% (w/v) sodium dodecyl sulfate) at a constant 150 V for approximately one hour and fifteen 
minutes. Protein visualisation used either Coomassie Blue or if at a low concentration, SimplyBlue™ 
(Invitrogen, Paisley, UK). For the former, gels were washed in deionised water, immersed in 
Coomassie Blue stain solution (0.2% (w/v) Coomassie Blue, 7.5% (v/v) acetic acid and 50% (v/v) 
ethanol) and incubated with shaking at room temperature for approximately 30 minutes. The gels 
were de-stained with Coomassie Blue de-stain solution (10% (v/v) acetic acid and 30% (v/v) ethanol) 
and returned to the shaker until the background stain had been removed. For the latter, staining 
followed the manufacturers’ guidelines. 
 
Gels were imaged using the white light of a G:BOX and associated GeneSNAP software (Syngene, 
Cambridge, UK). 
 
2.4.2 Native-PAGE protein gels 
 
Table 6 – Composition of 10%, 12% and stacking gels used in Native-PAGE 
Composition 
Volume (mL) 
10% 12% Stacking gel 
Deionised H2O 1.9 1.6 0.68 
30% (w/v) acrylamide mix 1.7 2.0 0.17 
1.5 M Tris-HCl (pH 8.8) 1.3 1.3 0.0 
1.5 M Tris-HCl (pH 6.8) 0.0 0.0 0.13 
10% (w/v) ammonium persulfate 0.05 0.05 0.01 
Tetramethylethylenediamine 0.002 0.002 0.001 
 
Sample preparation 
Samples were mixed with Native-PAGE loading buffer (10% (v/v) glycerol, 62.5 mM Tris-HCl pH 6.8 
and 0.00375% (w/v) bromophenol blue). 
 
Electrophoresis conditions 
Each gel was loaded with 10 μL PageRuler™ prestained protein ladder (Fermentas, York, UK). 
Electrophoresis was conducted in Native running buffer (25 mM Tris-base and 192 mM glycine) at a 
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constant 10 mA for approximately one hour and thirty minutes. Protein visualisation used either 
Coomassie Blue or if at a low concentration, SimplyBlue™ (Invitrogen, Paisley, UK) as described 
previously. 
 
2.4.3 Protein quantification 
 
Total protein concentration was determined using the Bio-Rad DC Protein Assay (Bio-Rad, Hemel 
Hempstead, UK) according to the manufacturer’s protocols for the microplate assay. A calibration 
curve was constructed with concentrations of lysozyme (Sigma-Aldrich, Dorset, UK) dissolved in the 
sample buffer ranging from 0.2 to 1.2 mg mL-1. Sample buffer was used as the blank.  
 
2.4.4 Dialysis 
 
Cellulose dialysis tubing, with a molecular weight cut-off of 8 kDa (BioDesign, New York, USA), was 
soaked in deionised water for 15 to 30 minutes and subsequently rinsed in the exchange buffer. 
Samples were added to the tubing, sealed, and dialysed against the exchange buffer at 4°C for 20 
hours. The volume of exchange buffer was 100 times that of the sample, and one buffer change was 
conducted after three to four hours.  
 
2.5 Dot-blot detection of expression level of transformants 
 
Following electroporation, 30 transformants from each scFv were inoculated into 10 mL of YPD and 
incubated at 30°C, 250 rpm for 24 hours. At such time the cultures were standardised to the lowest 
OD600, centrifuged at 4,000 x rpm for five minutes, resuspended in 10 mL BMM and returned to 
incubation for 72 hours. At 24 and 48 hours methanol was added to a final concentration of 0.5% 
(v/v). The cultures were centrifuged at 4,000 x rpm for five minutes and the supernatant stored at -
20°C.  
 
Samples were processed using a 96 well dot blotting unit (VWR International Ltd., Leighton Buzzard, 
UK). An Immobilon-FL polyvinylidene fluoride membrane (Millipore, Watford, UK) was pre-wetted as 
follows: immersed in 100% methanol for 15 seconds, deionised water for two minutes and transfer 
buffer (12.5 mM Tris-base, 96 mM glycine, 0.05 (w/v) sodium dodecyl sulfate, 20% (v/v) methanol) 
for ten minutes. It was embedded in the dot-blot apparatus, and 500 μL of supernatant in 500 μL 
transfer buffer was applied to the membrane under vacuum. The membrane was allowed to dry, 
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rinsed in Tris-buffered saline (TBS: 50 mM Tris-base, 150 mM NaCl, pH 7.6) and incubated in blocking 
buffer (5% (w/v) non-fat milk powder in TBS-T (0.05% (v/v) Tween-20 in TBS)) at room temperature, 
with shaking, for 1 hour. The membrane was rinsed in TBS-T and subsequently incubated overnight 
at 4°C with anti-Myc clone 9E10 (Santa Cruz Biotechnology, California, USA) diluted 1 in 1000 with 
blocking buffer. The membrane was rinsed twice in TBS-T, washed three times for five minutes in 
TBS-T with shaking, then incubated with WesternBreeze® anti-mouse antibody conjugated to 
alkaline phosphatase (Invitrogen, Paisley, UK) for one hour at room temperature with shaking. The 
membrane was again rinsed twice in TBS-T, washed three times for five minutes in TBS-T with 
shaking and washed twice for five minutes in TBS. For chemiluminescence, the membrane was 
coated with Novex® AP Chemiluminescent Substrate (Invitrogen, Paisley, UK) for five minutes and 
then exposed for 40 minutes using a G:BOX and associated GeneSNAP software (Syngene, 
Cambridge, UK). 
 
2.6 Analysis of scFv glycosylation 
 
Small scale chromatography from culture supernatant 
Talon® metal affinity resins (Clontech Laboratories, Saint-Germain-en-Laye, France) were used for 
small scale purification of BC1 and MFE23. For each, 2 mL resin was equilibrated in 
Equilibration/Wash buffer (50 mM NaPO4, 300 mM NaCl pH 7). For BC1 and MFE23, culture 
supernatant was processed through a 0.2 μm Sartorius Stedim Biotech Minisart filters (VWR 
International Ltd., Leighton Buzzard, UK), dialysed overnight at 4°C against Equilibration/Wash buffer 
and added to the equilibrated resin. Binding occurred through gentle agitation on ice for 30 minutes. 
The supernatant was removed by centrifugation and the resin washed in 10 mL Equilibration/Wash 
buffer for ten minutes while gently agitated on ice. The resin was further washed in 10 mL 
Equilibration/Wash buffer, and twice in Wash-2 buffer (50 mM NaPO4, 300 mM NaCl, 7.5 mM 
imidazole pH 7) to remove non-specifically bound protein. The target proteins were eluted in 2 mL 
Elution buffer (50 mM NaPO4, 300 mM NaCl, 150 mM imidazole pH 7) and samples were stored at -
20°C. 
 
Enzymatic N-linked deglycosylation with PNGase F 
Purified scFv were concentrated using Vivaspin 500 columns with a 5 kDa molecular weight cut-off 
(GE Healthcare UK, Little Chalfont, UK) and the buffer exchanged with reaction buffer (100 mM 
sodium phosphate buffer pH 7.2, 0.5 M EDTA). A positive control of fetuin from foetal calf serum 
(Sigma Dorset, UK) dissolved in reaction buffer was also included. Samples were heat denatured with 
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2% SDS at 95°C for 3 minutes. After cooling, 0.5% NP40 and 6 μL PNGase F (Roche, Burgess Hill, West 
Sussex, UK) were added and the reaction incubated at 37°C for overnight. Deglycosylation was 
analysed through migration on a 12% SDS-PAGE gel, stained with SimplyBlue™. 
 
2.7 Culture conditions 
 
P. pastoris glycerol stocks were inoculated into 10 mL BMGY and grown at 30°C, 250 rpm overnight. 
The cultures were diluted to an OD600 of 1 in 40 mL fresh BMGY in a 250 mL baffled shake flask 
(SciLabware Ltd, Staffordshire, UK) and returned to incubate to reach stationary phase. At 22 and 23 
hours samples were taken for RNA and mass spectrometry, and the OD600 was measured. At 24 
hours, the culture was centrifuged at 4,000 x rpm 30°C for five minutes, the pellet resuspended in 40 
mL of 100 mM potassium phosphate buffer, pH 6, pre-warmed to 30°C and the centrifuge step 
repeated. The pellet was finally resuspended in 40 mL BMMY, pre-warmed to 30°C and returned to 
incubate for six hours. Further RNA, mass spectrometry and OD600 samples were taken at 0, 2, 4 and 
6 hours and stored at -80°C until analysis. 
 
2.8 Generation of isotopically labelled peptides for LC-MS/MS 
 
2.8.1 Whole protein standards  
 
Expression 
E. coli BL21 (DE3) ΔArgA ΔLysA strains with either pET28a[KAR2] or pET28a[PDI] were inoculated into 
labelled minimal media and incubated at 37°C, 250 rpm until an OD600 of 0.5 was reached. At such 
time, a 1 mL pre-induction sample was taken and centrifuged at 13,000 x g for one minute. The 
supernatant was discarded and the pellet stored at -20°C. Each strain was then induced according to 
conditions derived following an optimisation experiment (Section 5.2.2). The strain expressing Kar2 
was induced with 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and returned to incubate at 
30°C; the strain expressing PDI was induced with 0.125 mM IPTG and returned to incubate at 37°C. 
After five hours the cultures were centrifuged twice at 4°C, 1,500 x g for 30 minutes: the first pellet 
was resuspended in 100 mL ice-cold 50 mM Tris-HCl pH 7.5, the supernatant from the second 
discarded and the pellet stored at -20°C. 
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Lysis 
For lysis, cell pellets were resuspended in 5 mL Buffer A (25 mM NaPO4 pH 7, 500 mM NaCl with 5% 
glycerol) containing Protease Inhibitor Cocktail (Roche, Burgess Hill, West Sussex, UK), and disrupted 
with a SLM Aminco French Pressure Cell Press (SLM Aminco, Rochester, USA) operating at 20,000 
psi. Smaller volumes were lysed with a Vibra-Cell VCX 130 (Sonics & Materials Incorporated, 
Newtown, USA). Cell pellets were resuspended in 1 mL Buffer A containing Protease Inhibitor 
Cocktail (Roche, Burgess Hill, West Sussex, UK) and subjected to 10 minutes of pulsing comprising 2 
seconds on, 2 seconds off at 40% amplitude. 
 
To isolate soluble protein, the total cell lysate was centrifuged at 13,000 x g 4°C for 30 minutes and 
the supernatant removed and stored at -20°C. The pellet was resuspended in 2 mL Buffer A and 8 M 
urea and incubated at 30°C overnight with shaking. The digest was centrifuged at 13,000 x g for 30 
minutes and the insoluble protein isolated from the supernatant. 
 
Small scale chromatography 
Talon® metal affinity resin (Clontech Laboratories, Saint-Germain-en-Laye, France) in a 5 mL 
polypropylene column (Qiagen, Crawley, UK) was used for small scale purification of Kar2 and PDI. 
For each protein, 2 mL resin was equilibrated in Equilibration/Wash buffer (50 mM NaPO4, 300 mM 
NaCl pH 7). Cell extract was diluted in Equilibration/Wash buffer and added to the resin. Binding 
occurred through gentle agitation on ice for 30 minutes. The supernatant was removed by 
centrifugation and the resin washed in 10 mL Equilibration/Wash buffer for ten minutes while gently 
agitated on ice. The resin was further washed in 10 mL Equilibration/Wash buffer, and twice in 
Wash-2 buffer (50 mM NaPO4, 300 mM NaCl, 7.5 mM imidazole pH 7) to remove non-specifically 
bound protein. The target proteins were eluted in 2 mL Elution buffer (50 mM NaPO4, 300 mM NaCl, 
150 mM imidazole pH 7), dialysed against 50 mM NaPO4 pH 7 overnight, and samples were stored at 
-20°C.  
 
Fast protein liquid chromatography (FPLC) 
For larger quantities of Kar2 and PDI, purification was scaled up with fast protein liquid 
chromatography (FPLC). Cell lysate was loaded onto a 1 mL HisTrap® HP affinity column (GE 
Healthcare UK, Little Chalfont, UK) connected to an ÄKTA™ FPLC running Unicorn™ 5.11 software 
(Amersham Pharmacia Biotech, Little Chalfont, UK). Buffer A (25 mM NaPO4 pH 7, 500 mM NaCl with 
5% (v/v) glycerol) was flowed through the system at 1 mL min-1 to remove all unbound protein; 
subsequently a wash of buffer A with 3% buffer B (25 mM NaPO4 pH 7, 500 mM NaCl, 1 M imidazole 
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with 5% glycerol) was conducted to remove all protein bound non-specifically to the column. Finally, 
proteins were eluted with an increasing gradient of buffer B into 1 mL fractions. Insoluble proteins 
were purified similarly, with the addition of 1 M urea to both buffer A and buffer B. Eluates were 
dialysed against 50 mM NaPO4 pH 7 overnight, and samples were stored at -20°C.  
 
Extraction of whole proteins from polyacrylamide gels 
 
Chemical:  
Six protein samples, three of each target, were analysed by 12% SDS-PAGE, as described previously, 
and stained with SimplyBlue™. According to manufacturer’s instructions, the appropriate bands 
were removed from the gel, soaked in 30% ethanol for 20 minutes and rinsed in deionised water to 
de-stain bands for MS analysis (Invitrogen, Paisley, UK). Each gel slice was crushed, and subject to 
one of the following extraction methods: incubated in 40 μL 1:3:2 (v/v/v) formic acid, deionised 
water and 2-propanol at room temperature for six hours [178]; incubated in 40 μL 0.1% SDS at room 
temperature overnight [179]; and incubated in 40 μL 0.1 M NaOH at room temperature for ten 
minutes [180]. Following extraction, the supernatant was isolated and analysed by 12% SDS-PAGE. 
 
Electroelution:  
Six protein samples were analysed by 12% SDS-PAGE, as described previously. The polyacrylamide 
gel was cut to separate the molecular weight marker and the first protein sample, and this section 
was stained. The remainder of the gel was left in electrophoresis running buffer. The stained and 
unstained gel pieces were re-aligned, and the former used as a guide to cut the target protein out of 
the latter, as it had been suggested that non-stained proteins electroelute much faster [181]. A gel 
slice was placed into an elution chamber of a GE 200 SixPac Gel Eluter (Hoefer, Holliston, USA) and 
eluted into 300 μL 4 X electrophoresis running buffer, according to manufacturer’s instructions: 50 
V, 0.5 mA for 120 minutes. After completion, the buffer was concentrated through a Vivaspin 500 
column with a 5 kDa molecular weight cut-off (GE Healthcare UK, Little Chalfont, UK) and the protein 
content analysed by 12% SDS-PAGE. 
 
2.9 SpikeTides™ TQL peptides 
 
Custom peptides were produced by JPT Peptide Technologies (Berlin, Germany) in the SpikeTides™ 
TQL format using SPOT synthesis [182]. These peptides are synthesised using L-arginine-13C6,
15N4 and 
L-lysine-13C6,
15N2 and contain a C-terminal cleavable ‘Quantitag’. This tag has two functions: firstly, 
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the signature peptide is only released following tryptic digestion (thus acting as a more realistic 
internal standard); and secondly, UV absorption allowed exact quantification of the peptide.  
 
2.10 LC-MS/MS quantification of Kar2 and PDI  
 
Protein extraction from P. pastoris for quantitative proteomics 
Cultures were expressed as previously detailed in Section 2.7. At each time point, a 600 μL sample 
was centrifuged at 13,000 x g for two minutes. The supernatant was discarded, and the sample 
stored at -80°C. Protein from samples was extracted with glass bead lysis. Specifically, cell pellets 
were resuspended in 300 μL 50 mM sodium phosphate buffer with 1 mM EDTA, pH 7.4 with 
Protease Inhibitor Cocktail (Roche, Burgess Hill, West Sussex, UK). Acid washed glass beads (Sigma, 
Dorset, UK) were added to two thirds of the volume, and the cells lysed through vortexing for 40 
minutes at 4°C. The samples were centrifuged for 5 minutes at 13,000 x g and the supernatant 
isolated. 
 
The concentration of soluble protein was determined using the Bio-Rad DC Protein Assay (Bio-Rad, 
Hemel Hempstead, UK). For each sample, 30 μg total protein was diluted in 82.3 μL phosphate 
buffer, reduced with 1 mM DTT for 30 minutes at 30°C and alkylated with 40 mM iodoacetimide in 
the dark at room temperature for 30 minutes. Routinely, 2.5 μL 1 μM peptide mix (0.2 μM each 
peptide) was added to the reaction before 0.3 μg Trypsin Gold (Promega, Southampton, UK) was 
added and left to incubate at 37°C overnight.  
 
Digests were processed through Peptide Cleanup C18 Spin Tubes (Agilent, Wokingham, UK) and 
eluted in 40 μL 70% acetonitrile with 0.1% formic acid. The samples were dried to completion with a 
SC210P1-230 SpeedVac™ vacuum concentrator (Thermo Scientific, Loughborough, UK), re-
solubilised in 0.1% formic acid and stored at -20°C until analysis. Immediately prior to analysis, 
peptides were defrosted, centrifuged at 13,000 x g for five minutes and transferred to 2 mL glass 
HPLC vial containing a 150 μL glass vial insert (Agilent, Wokingham, UK).  
 
LC-MS/MS protocol 
Mass spectrometry analysis was conducted by Mark Bennett, Department of Biology, Imperial 
College London. Specifically, multiple reaction monitoring (MRM)-triggered MS/MS analysis with 
absolute quantification in relation to an isotopically labelled internal standard was carried out. In the 
first instance this requires the in silico identification of a set of signature peptides which can be used 
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to identify the target proteins and act as a surrogate for quantification. Signature peptides need to 
be unique to the target protein, detectable, and produce the highest response for the protein [183]. 
 
The identification of appropriate signature peptides was initiated with an in silico tryptic digest of 
the target proteins, Kar2 and PDI, using MRMPilot™ Software (Applied Biosystems) and a MIDAS™ 
Workflow Designer. This produces a set of tryptic peptides which can subsequently be ranked 
according to their enhanced signature peptide prediction score, a computational method which 
predicts their usefulness based on physicochemical properties [183]. Potential peptides were also 
searched against the Global Proteome Machine, a database of peptides which have been previously 
detected, to add experimental weight to the in silico prediction. Finally, the peptides were verified as 
unique to the target protein using BLASTp searches.  
 
Although the computational prediction software generates a suite of potential signature peptides, 
the ionization efficiency and fragmentation require experimental validation. Initial analysis targeted 
unlabelled peptides from E. coli strains overexpressing Kar2 and PDI following the collision energy 
(CE) and collision cell exit potential (CXP) suggested by the MRMPilot™ Software during in silico 
analysis. Ten signature peptides, with the best responses, were taken through to the next stage of 
analysis: detection in situ where the concentrations are likely to be lower. GS115[BC1]H was 
analysed over a range of CE and CXPs to maximise the response generated. Finally, the response of 
signature peptides derived from pure labelled standards was analysed and compared to that 
generated with a background of P. pastoris cell lysate. 
 
The final method was as follows: processed digests of P. pastoris lysates with SpikeTide peptides 
were separated by liquid chromatography on an Eksigent Ekspert™ nanoLC 400 system using an 
Agilent SB 5 μm 0.5 mm x 150 mm column (Agilent, UK). The total flow rate was set to 15 μL min-1 
with an injection volume of 5 μL. The gradient protocol, where mobile phases consisted of solvent A 
(dH2O with 0.1% formic acid (v/v)) and solvent B (95% acetonitrile, 5% dH2O (v/v)), is described in 
Table 7. 
 
MS data were collected using a Turbo Spray IonDrive source on a QTRAP® 6500 Linear Ion Trap 
Quadrupole LC/MS/MS Mass Spectrometer (AB Sciex, Warrington, UK). Scheduled MRM scans were 
conducted, in positive mode, with a detection window of 150 seconds. Parameters for each 
transition are presented in Table 8.  
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Table 7 – Analytical gradient profile for liquid chromatography 
Solvent A: dH2O with 0.1% formic acid (v/v); Solvent B: 95% acetonitrile, 5% dH2O (v/v) 
Time (minutes) Solvent A (%) Solvent B (%) 
0 100 0 
15 50 50 
16 10 90 
18 10 90 
19 100 0 
20 100 0 
 
Transition peaks were integrated using quantitation procedures in the Analyst® 1.6 Software (AB 
SCIEX, Warrington, UK). Absolute quantification was derived from the following formula: 
 
                     (  )   
               
                          
                         
 
Standardising each sample to 30 μg of protein per digest was necessary to allow for differences in 
lysis efficiency and so that the C18 columns were not overloaded. During induction, however, the 
intracellular protein content increases due to production of the scFv. Therefore, induction samples 
showed a proportional decrease in Kar2 and PDI concentration. To account for this, the percentage 
increase in total protein concentration was applied to the final Kar2 and PDI concentration 
experimentally measured. 
 
2.11 Statistical analysis 
 
For RT Q-PCR data analysis of variance (ANOVA) tests were conducted to assess whether target 
expression changes significantly with time, where p < 0.05. Significant ANOVA results were subject 
to further multiple comparisons with the Tukey-Kramer method [184]. For comparisons between 
strains, two-sample one tailed t tests were conducted. Statistical significance is indicated on graphs 
with the use of asterisks; for brevity details of test results have been placed in Appendix V.  
 
  
- MATERIALS AND METHODS - 
 
- 74 - 
Table 8 – MRM transitions and instrument parameters for quantification of Kar2 and PDI 
For each target, the table lists the signature peptides along with their internal standards, denoted by ‘is’. CE: 
collision energy, DP: de-clustering potential; CXP: collision cell exit potential.  
Protein Peptide 
Q1 Mass 
(Da) 
Q3 Mass 
(Da) 
Retention time 
(minutes) 
CE  
(V) 
DP  
(V) 
CXP 
(V) 
Kar2 YAAEDAALR-a 490.2 745.4 7.9 25 80 7 
 
YAAEDAALR-b 490.2 816.4 7.9 30 80 7 
 
YAAEDAALR-c 490.2 545.3 7.9 30 80 7 
 
YAAEDAALR-is-a 495.2 755.4 7.9 25 80 7 
 
YAAEDAALR-is-b 495.2 826.4 7.9 30 80 7 
 
YAAEDAALR-is-c 495.2 555.3 7.9 30 80 7 
 
VEILANDQGNR-a 614.8 774.3 8.5 35 80 7 
 
VEILANDQGNR-c 614.8 703.3 8.5 30 80 7 
 
VEILANDQGNR-d 614.8 887.4 8.5 30 80 8 
 
VEILANDQGNR-is-a 619.8 784.3 8.5 35 80 7 
 
VEILANDQGNR-is-c 619.8 713.3 8.5 30 80 7 
 
VEILANDQGNR-is-d 619.8 897.4 8.5 30 80 8 
 
IAYPITSK-a 446.8 545.4 8.8 25 80 4 
 
IAYPITSK-b 446.8 708.5 8.8 20 80 6 
 
IAYPITSK-c 446.8 779.4 8.8 25 80 5 
 
IAYPITSK-is-a 450.8 553.4 8.8 25 80 4 
 
IAYPITSK-is-b 450.8 716.5 8.8 20 80 6 
 
IAYPITSK-is-c 450.8 787.4 8.8 25 80 5 
PDI FIAGEAEPIVK-a 649.8 872.4 9.3 30 80 5 
 
FIAGEAEPIVK-b 649.8 1082.6 9.3 30 80 9 
 
FIAGEAEPIVK-d 649.8 775.4 9.3 30 80 7 
 
FIAGEAEPIVK-is-a 653.8 880.4 9.3 30 80 5 
 
FIAGEAEPIVK-is-b 653.8 1090.6 9.3 30 80 9 
 
FIAGEAEPIVK-is-d 653.8 783.4 9.3 30 80 7 
 
SEPIPEIQEEK-a 587.3 913.6 9.9 35 80 9 
 
SEPIPEIQEEK-b 587.3 842.5 9.9 30 80 9 
 
SEPIPEIQEEK-d 587.3 656.4 9.9 30 80 8 
 
SEPIPEIQEEK-is-a 591.3 921.6 9.9 35 80 9 
 
SEPIPEIQEEK-is-b 591.3 850.7 9.9 30 80 9 
 
SEPIPEIQEEK-is-d 591.3 664.6 9.9 30 80 8 
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3. Modelling scFv production 
 
3.1 Introduction  
  
In light of the need for optimisation strategies which take into account multiple features of scFv 
production in P. pastoris, a model was developed to understand how a subset of factors interact to 
determine productivity. This chapter describes the mathematical formulation, parameters and 
inherent dynamics of the model, supported by simulation results. 
 
At the outset, it was important to decide the remit of the model. Considering the dependence of 
protein production and cellular responses on time, a dynamic model was better suited to describing 
the system than a static one. Furthermore, the model size and concentrations of molecules make 
stochastic modelling computationally intractable and extraneous; therefore a deterministic 
approach was taken, presenting the system as a series of ordinary differential equations (ODEs) with 
respect to time. Here, the spatial distribution of molecules has been omitted, producing an 
unstructured model to minimise model parameters associated with transport fluxes. Similarly, the 
behaviour has been reduced to a single cell, excluding population dynamics, for simplicity. Finally, a 
bottom up approach to model formulation incorporating the full mechanistic detail of reactions from 
transcription initiation to vesicular transport and secretion out of the cell was beyond the scope of 
this research. Therefore a top down approach to formulation was taken, which has also been 
successfully employed by related studies [155-157].  
 
The crucial features of protein production, ER-associated degradation and the UPR were 
incorporated (Figure 9). Specifically, the model was based on the traditional expression strategy 
employed with Pichia pastoris: the heterologous gene is integrated into the yeast chromosome 
under the control of an inducible promoter, pAOX1. Therefore, a lumped term for transcription was 
included: conforming to the inducible expression strategy, scFv production in the model was 
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switched on and off by altering the rate of transcription. To allow protein production to cease when 
transcription was switched off, mRNA degradation was included as an outlet for SCFV mRNA.  
 
Considering the model output was recombinant protein yield, the next important features to include 
were translation and folding. The majority of the subsequent reactions target those occurring in the 
ER, as this is thought to predominantly limit protein production in yeast, including P. pastoris [185,186]. 
Therefore, proteins could fold with the chaperone Kar2 and the foldase PDI. The proteins could also 
misfold, which here was assumed to be independent of protein-protein interactions, but no inclusion 
of aggregation reactions was included. To provide an outlet for misfolded protein, the ERAD pathway 
was included – although reduced to the action of the E3 ligase. Finally, aspects of the unfolded 
protein response were included for two reasons: (i) the response regulates the concentration of 
Kar2, PDI and E3 which alter the rate of folding in the ER; and (ii) it is well documented that 
recombinant protein production induces this response in P. pastoris [28,187-189].  
 
The simulations in this chapter incorporate two hours of equilibration before six hours of scFv 
induction, where the system found a new steady state, and a further two hours to analyse post-
induction kinetics. They were performed using gPROMS version 3.4.0 (Process Systems Enterprise 
Ltd, London, UK) using the DAE solver “DASOLV” and parameter values derived from literature. Full 
details of the final deterministic single cell model, including equations, parameters and initial 
conditions, can be found in Appendix I. As the single cell model does not take volume into account, 
the species and parameters are given in number of molecules, and number of molecules per second, 
respectively.   
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Figure 9 – Schematic of the scFv production model 
Key features include the protein production pathway [green], where the SCFV gene (SCFVG) is transcribed to 
nuclear mRNA (SCFVN) before being exported to the cytoplasm (SCFVC). The SCFVC is translated and unfolded 
protein (UP) folds into the 3D scFv structure in two stages (FPIntra and FPInter). This process is aided by the 
binding of the foldase PDI. A second folding pathway was also incorporated [blue] where unfolded protein can 
bind Kar2 and PDI to form FPIntra, and again bind Kar2 before forming FPInter. The ER associated degradation 
(ERAD) was also included [red], representing degradation of misfolded protein (MP) by ubiquitin ligase (E3). 
Finally, the unfolded protein response (UPR) was included [purple]. The stress sensor Ire1 is normally bound to 
Kar2, however, under conditions of stress the Kar2 dissociates allowing Ire1 to oligomerise (Ire1O). This 
structure activates by binding UP (Ire1A), in turn producing spliced HAC1 mRNA (HAC1S). This leads to the up-
regulation of targets, including E3, Kar2 and PDI, which help to return the ER to homeostasis.  
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3.2 Model definition 
 
3.2.1 Transcription 
 
Biologically speaking, scFv production is initiated when transcription of the heterologous gene is 
induced in the nucleus, producing nuclear SCFV mRNA. The newly transcribed mRNA undergoes 5’ 
capping, splicing and 3’ polyadenylation before being packaged with RNA binding proteins and 
targeted to nuclear pore complexes [190]. When the mRNA reaches the cytoplasm, it can be degraded 
through a variety of different pathways [191]. Here, the nuclear (SCFVN), cytoplasmic (SCFVC) and 
degraded SCFV mRNA levels have been modelled with mass action kinetics: 
 
        
 t
                                  
1.  
        
 t
                              
2.  
 
Where the state variables SCFVG, SCFVN and SCFVC represent genomic, nuclear and cytoplasmic 
SCFV genetic data respectively; and the parameters kTscript, kExp and kmDeg represent the rate of 
transcription, mRNA export and mRNA degradation respectively. 
 
The use of mass action kinetics is appropriate as it summarised functionality without over-
complicating the model. Strictly speaking, transcription, export and degradation are all enzymatic 
processes requiring a cascade of factors and complexes; however, not all of them have been 
identified let alone kinetically characterised preventing the valid use of Michaelis-Menten kinetics. 
The employment of mass action kinetics maintained the aspects of the system which required 
representation: use of the AOX1 promoter necessitated a transcriptional switch to produce a 
constant SCFVN level when induced. The level had to be regulated by the number of copies of the 
heterologous gene and the strength of induction. The above expressions captured this: there is no 
SCFV mRNA present in the system until the value of kTscript was positive and the value of kTscript can be 
tailored to the induction scheme or promoter strength.  
 
The use of mass action kinetics did, however, have one major drawback: the pathways do not 
saturate. While there is a maximum capacity for transcription within the cell, this model assumed 
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that pathways in the ER will saturate before this representation becomes inaccurate. 
 
The expressions were solved using the following parameters:  
 SCFVG = 1 
Simulations assumed a single copy of the SCFV gene was integrated into the yeast 
chromosome; 
 
 kTscript = 0.391 molecules s
-1 
The parameter kTscript was an amalgamation of various steps including transcription 
initiation, elongation and termination. A range of elongation rates have been experimentally 
determined, the closest approximation of which is S. cerevisiae RNApol II on a yeast vector 
template, at 20 to 25 nucleotides per second [192]. Kinetic values for the other stages are 
difficult to determine and the elongation rate alone does not account for the strength of the 
promoter or variations induced by growth conditions. Consequently, a value of 0.391 
molecules s-1 was estimated to produce a steady state value of 610 transcripts, in accord 
with estimations that the AOX1 promoter yields 5% [193] of the total 12,220 mRNA transcripts 
in a yeast cell [194].  
 
 kExp = 1.80 molecules s
-1 
A previous model of scFv expression in S. cerevisiae calculated the nuclear export rate to be 
1.8 molecules s-1 [157], and this was assumed here.  
 
 kmDeg = 6 x 10
-4 molecules s-1 
A study conducted by Munchel et al. [195] analysed global S. cerevisiae mRNA half-lives, 
finding an average of 20.1 minutes, corroborated by Wang et al. [196]. Genes required for 
galactose fermentation, however, had a shorter average half-life of 18 minutes during 
growth on galactose; this was assumed to apply to methanol induction here.  
 
Simulations revealed a transcriptional switch, representing the methanol induction of pAOX1 at zero 
hours (Figure 10). The time taken to reach the steady state value, around two hours, concurred with 
that observed in eukaryotic cells in vivo [197]. When transcription was turned off, a similar two hour 
period was required for degradation to eliminate SCFV transcripts and derive a new steady state.  
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Figure 10 – SCFV mRNA profile in the nucleus and cytoplasm 
The induction of scFv production at zero hours results in a steady state value of 0.217 molecules of SCFV 
nuclear mRNA, a consequence of the high nuclear export rate. The cytoplasmic SCFV mRNA accumulates to a 
steady state of 610 molecules, where production is matched by degradation. At six hours, transcription stops 
and the level of cytoplasmic mRNA decreases through degradation. 
 
3.2.2 Translation  
 
Following transcription, mRNA is translated producing unfolded protein – the nascent polypeptide, 
which has neither folded nor misfolded. This process consists of four stages: firstly, initiation 
whereby the translatory complex assembles on the mRNA; secondly, elongation whereby the 
ribosome moves down the mRNA recruiting the appropriate amino acids and joining them with 
peptide bonds; thirdly, termination where a stop codon in the mRNA causes release of the nascent 
polypeptide; and finally, recycling where the ribosome subunits are dissociated and the mRNA is 
released such that a further round of translation may be initiated [198].  
 
Here, translation was modelled with mass action kinetics such that the influx of unfolded protein to 
the system is based both on the availability of SCFVC and the rate of translation: 
 
                              
3.  
 
Where FTranslation represents the flux of unfolded protein to the system from translation; the state 
variable SCFVC represents cytoplasmic SCFV mRNA; and the parameter kTranslation represents the 
rate of translation. 
 
Just like transcription, mRNA export and degradation, the use of mass action kinetics simplified the 
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model: translation is an enzymatic process employing a cascade of factors. Again, a major 
assumption is that the production of unfolded protein is limited only by the concentration of SCFVC 
and not ribosomal capacity. 
 
The expression was solved using the parameter:  
 
 kTrans = 1.138 molecules s
-1 
An initial value for the parameter kTrans was derived in a similar scheme to that shown in the 
Hildebrandt study [157]. The authors calculated a ribosome density of 1 per 100 nucleotides; 
at 1,083 nucleotides, there are 10.83 ribosomes per mRNA transcript. With a translation rate 
of 5.5 amino acids s-1 [199], unfolded protein molecules are produced at a rate of 0.165 
molecules s-1. Simulations employing this figure, however, produced a steady state of 
2,174,040 molecules – only 4.34% of the total number of soluble proteins in a yeast cell [200]. 
The AOX1 promoter has been shown to produce up to 30% total soluble protein [193]. On this 
basis, the rate of translation was increased 6.9 times to 1.138. This produced a steady state 
of 14,994,288 – just fewer than 30% of total protein (Figure 11). This is 24,581 protein 
molecules per mRNA transcript, within the range of 0.14 to 40,110 [199]. Although kTscript could 
have been increased to solve this deficit, the steady state value of transcripts was already 
within the biological range, justifying the targeting of kTrans. 
 
A further assumption is that the same rate of translation is applicable to both scFvs. While 
they are of comparable size and have the same peptide linker, the variable domains contain 
a different sequence of codons – some of which may be rarer than others. To ascertain any 
differences, BC1 and MFE23 were analysed for similarity in codon usage to the host 
organism, P. pastoris, using the Graphical Codon Usage Analyser [201]. This was on the basis 
that if either gene employed a very different codon usage to the host strain, this would slow 
translation. The BC1 gene showed marginally more codon usage difference than MFE23, at 
17.31% to 15.94%, respectively. 
 
Simulations revealed a constant translation rate, the consequence of the transcriptional switch and 
mass action kinetics (Figure 11). As there was no outlet for unfolded protein, the species 
accumulated linearly to a final value of 14,994,287.  
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Figure 11 – Translation and the linear accumulation of unfolded protein during induction. 
The cytoplasmic SCFV mRNA is translated at a steady state rate of 694 molecules per second. With no 
downstream reactions, unfolded protein accumulates in the system reaching a final value of 14,994,287. 
 
3.2.3 Protein folding 
 
Unfolded protein enters the ER, the organelle in which it folds into its native three-dimensional 
structure, co-translationally. Although proteins can fold spontaneously, this process is exceptionally 
slow and incompatible with the time scale of secretion in vivo [57]. As the unique three-dimensional 
structure of proteins is crucial to their biological function, ensuring proper folding quickly is 
necessary [58]. Therefore, cells utilise a complement of enzymes to assist the nascent proteins folding 
including PDI, a foldase and isomerase which donates a single disulphide bond to each substrate [59].  
 
Here, a two-state folding pathway was assumed: (i) each variable domain folded, before (ii) the 
domains associated to form the native structure. As each variable domain contains a disulphide 
bond, interaction with two active PDI molecules was required: this was initially modelled with 
Michaelis-Menten kinetics. They were modified, however, to account for the low amount of 
substrate at induction [1]: 
 
            
 
 
       (        I        √(        I       )          I ) 
4.  
 
Where FUP_Folding represents the flux of unfolded protein folding; the state variables UP and PDI 
represent unfolded protein and protein disulphide isomerase respectively; and the parameters 
kcatPDI and kmPDI represent the catalytic constant and Michaelis constant for PDI, respectively. 
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This expression neglected the re-oxidation of PDI by Ero1 and subsequent shuttling of electrons 
generating hydrogen peroxide. It assumed PDI was continuously active, supported by results from 
studies in S. cerevisiae [202] and P. pastoris [203], the latter of which suggested that not only is it found 
primarily in the oxidised state but that Ero1 is not the rate limiting factor for protein production. 
 
The expression was solved using the parameters:  
 
 kcatPDI = 0.175 molecules s
-1 
The turnover rate of PDI was taken from a study using atomic force microscopy to quantify 
the folding rate of the 27th immunoglobulin domain from human cardiac titin using the A1 
catalytic domain of human PDI [204]; considered to be a suitable model for the scFv variable 
domain. The immunoglobulin structure contains a single internal disulphide bond, therefore 
the catalytic rate representing the rate of protein folding and disulphide formation was 
divided in two. 
 
 kmPDI = 27,330 molecules 
The Michaelis constant for PDI was estimated by fitting the data set from Lyles and Gilbert 
[205] to the system. The rate of RNAse renaturation catalysed by PDI, as a function of RNAse 
concentration, was extracted and expressed as a percentage of the total. This was applied to 
the maximum rate of PDI catalysis, kcatPDI multiplied by the total number of PDI molecules, 
and the substrate range which was assumed to be in a one-to-one ratio with PDI. This 
provided a data set for construction of a Lineweaver-Burke plot, from which kmPDI was 
estimated as 
 
     
 . 
 
Initial simulations focused on analysing how the modification to the Michaelis-Menten kinetics 
affected the behaviour of the system (Figure 12). The difficulty with employing standard Michaelis-
Menten kinetics in this particular problem is that they describe how an increasing concentration of 
substrate increases the rate of reaction, until the available enzyme is saturated, with the assumption 
of a constant enzyme concentration [1]. In this system, however, both the number of substrate 
molecules and the amount of available enzyme fluctuated, especially with UPR activation.  
 
Figure 12 [A] shows standard Michaelis-Menten kinetics compared to the modified version under 
high substrate concentrations; according to convention, the rate of folding increased with higher 
concentrations of the substrate (unfolded protein) until the enzyme (PDI) is saturated. The modified 
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expression decreased the rate, extending the substrate concentration before which PDI becomes 
limiting. At very low numbers of substrate molecules (Figure 12 [B]), however, the standard 
Michaelis-Menten expression scales linearly with the enzyme concentration because the substrate 
concentration is far below value of kmPDI. This cannot be accurate, as the substrate concentration 
should limit the rate of reaction. Therefore, the modified expression is more appropriate. As the 
number of substrate molecules increased, however, the modified expression more closely resembles 
the conventional Michaelis-Menten kinetics (Figure 12 [C]) until high substrate concentrations, 
where the behaviour was identical Figure 12 [D]). Although the modified expression showed a 
shallower profile in [A], its saturation behaviour at low substrate concentrations made it better 
suited to this system than standard Michaelis-Menten kinetics. 
 
 
Figure 12 – Comparison of modified (MM_E) 
[1]
 and standard Michaelis-Menten (MM) kinetics  
The MM_E expression was implemented and compared to MM results. [A]: The new expression was assessed 
for saturation behaviour in comparison to standard MM kinetics: it had a longer linear relationship between 
the substrate amount and the rate of reaction. At 209,600 molecules of UP, the enzyme to substrate ratio is 
1:1, causing the rate to plateau. [B]: In contrast to MM, the MM_E expression allows saturation behaviour at 
low substrate numbers when UP limits the reaction rate. [C]: As the concentration of substrate increased, the 
two expressions were more closely related until [D]: very high substrate, where they overlapped. 
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In contrast to the folding of each variable domain, their association is a spontaneous process that 
requires no external interaction; consequently, the reaction was modelled with mass action kinetics: 
 
                             
5.  
 
Where FAssociation represents the flux of FPIntra association (the final stage of protein folding); the 
state variable FPIntra represents the folding intermediate; and the parameter kAssoc represents the 
rate of variable domain association. 
 
Where: 
 
 kAssoc = 8 x 10
-4 molecules s-1 
A study investigating the folding kinetics of scFv molecules observed two phases: fast (0.324 
± 0.11 min-1) and slow (0.048  ± 0.0022 min-1) [206]. Although single variable domains exhibit 
the fast phase, the slow phase is only observed in the whole scFv fragment; therefore, this 
was assumed to be the domain association constant. 
 
 
Figure 13 – The slow phase of variable domain association 
The association of the two variable domains leads the folding intermediate, FPIntra, to form the native protein 
confirmation. The rate of association is slow, causing a time delay, but with no competing reactions the same 
steady state rate of reaction is achieved.  
 
The rate constant of unfolded protein forming disulphide bonds is over 200 times faster than domain 
association; however, with no competing reactions FUP_Folding and FAssociation are equal at steady state 
(Figure 13). 
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3.2.4 Protein misfolding 
 
Misfolded protein, defined as a heterogeneous population with conformational states that are non-
native but sufficiently stable [155] is unavoidable (Figure 14). Proteins fold in order to minimise free 
energy and maximise thermodynamic stability; to do so, different amino acids interact in a trial and 
error manner. Contacts that offer enhanced stability remain, while those which do not are broken. 
Such a process can produce small populations of proteins which have incorrect interactions but that 
proffer enough stability to prevent efficient reversal. 
 
 
Figure 14 – Schematic of the protein folding energy landscape 
A decrease in free energy, and concomitant increase in thermodynamic stability, occurs as a protein finds the 
native contacts through a trial and error folding process: unfolded protein, ‘U’, gradually migrates to folded 
protein ‘F’. A small population of misfolded protein, ‘M’, has formed multiple non-native contacts. The 
increase in energy to move back to either the unfolded population or towards the folded population is too high 
to be efficient; consequently the population has a non-native but stable conformation. Figure modified from 
Wiseman et al., 2007 
[155]
. 
 
Here, the rate of misfolding was modelled with mass action kinetics, as a function of the amount of 
substrate: 
 
                         
6.  
                                    
7.  
 
Where FUP_Misfolding and FFPIntra_Misfolding represent the flux of unfolded protein and the folding 
intermediate misfolding respectively; the state variables UP and FPIntra represent unfolded protein 
and the folding intermediate respectively; and the parameter kmFold represents the rate of 
misfolding. 
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These expressions assumed that both unfolded protein and the folding intermediate were capable of 
misfolding, a consequence of the protein folding energy landscape (Figure 14). They also assumed 
that they misfold with the same rate constant – a consequence of limited literature data and the 
benefit of simplicity. 
 
 
Figure 15 – Incorporating protein misfolding into the system 
[A]: Misfolding does not alter the rate of unfolded protein folding (FUP_Folding); [B]: but does decrease yield of 
the final protein product. [C]: Simulations with the misfolding reaction reveal that the loss of FPInter is due to 
flux from the folding intermediate, which has time to misfold as the final association step is so slow. [D]: 
Increasing the speed of the association step greatly reduces the rate of misfolding. 
 
The expressions were solved using the parameter:  
 
 kmFold = 1.34 x 10
-4 molecules s-1 
The spontaneous rate of misfolding was derived from data obtained in a single molecule 
fluorescence study analysing the misfolding of tandem immunoglobulin domains from titin 
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[207]. The authors show 5.5% of all molecules misfold in vitro. Considering the reaction as first 
order: 
 
            
( .              )                        
   .         
 
The incorporation of misfolding to the system did not change the flux to FPIntra (Figure 15 [A]) as PDI 
was not saturated and the rate constant of folding was 1,306 times faster than misfolding – 
consequently, unfolded protein folded before it could misfold. The overall yield was, however, 
reduced (Figure 15 [B]) due to misfolded protein deriving from FPIntra (Figure 15 [C]). This was 
attributed to the slow final folding step, as increasing kAssoc greatly reduced this (Figure 15 [D]). 
 
3.2.5 Adding chaperones to the system 
 
In the ER, the chaperone Kar2 can bind unfolded protein and folding intermediates by recognising 
sequences of exposed hydrophobic amino acids [208]. This reversible binding sequesters the protein, 
immobilising it and preventing misfolding – providing a second folding pathway for UP|Kar2 and 
FPIntra|Kar2. The incorporation of these, however, prevented the use of the amended Michaelis-
Menten kinetics as the same enzyme acted on two separate substrates. If the two substrates were 
combined in the same expression then the rate at which Kar2 was returned to the system could not 
be described; if separate expressions were used for each substrate, the amount of PDI available 
would be duplicated. Consequently, the kinetics were split into enzyme binding and catalysis: 
 
                                         I  
8.  
                                           a      I  
9.  
 
Where FUP|PDI_Association and FUP|Kar2|PDI_Association represent the flux of unfolded protein and unfolded 
protein bound to Kar2 binding protein disulphide isomerase, respectively; the state variables UP, 
PDI and UP|Kar2 represent unfolded protein, protein disulphide isomerase and unfolded protein 
bound to Kar2, respectively; and the parameter kPDI_Association represents the rate protein 
disulphide isomerase binding substrate molecules. 
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                        I  
10.  
                            a     I  
11.  
 
Where FUP_Folding and FUP|Kar2_Folding represent the flux of unfolded protein and unfolded protein 
bound to Kar2 to the folding intermediate, respectively; the state variables UP|PDI and 
UP|Kar2|PDI represent unfolded protein and unfolded protein bound to Kar2 in complex with 
protein disulphide isomerase, respectively; and the parameter kcatPDI represents the catalytic 
constant for protein disulphide isomerase. 
 
This provided a single pool of PDI molecules for two different substrates, and allowed the return of 
Kar2 to be described by FUP|Kar2_Folding. Crucially, it maintained key features of the previously 
employed kinetics: the rate of folding was determined by the substrate when the amount of the 
latter was low, and displays saturation kinetics when the amount was high. It did, however, add a 
further assumption – that the binding of PDI was irreversible.  
 
Incorporating Kar2 also allowed a second folding pathway for FPIntra: 
 
                                  a    
12.  
 
Where FAssociation_Kar2 represents the flux of the folding intermediate bound to Kar2 to the fully 
folded state; the state variable FPIntra|Kar2 represents the folding intermediate bound to Kar2; and 
the parameter kAssoc represents the rate of variable domain association. 
 
The previous parameters were employed, with the addition of kPDI_Association: 
 
 kPDI_Association = 2.3 x 10
-7
 s
-1.  
A previous model of scFv expression in S. cerevisiae calculated the binding rate of scFv 
molecules to PDI as 2.3 x 10-7 molecules s-1 [157], and this was assumed here.  
 
Within the ER, PDI binding to unfolded protein competes with misfolding reactions and the binding 
of chaperones (as described in the following section). Splitting the folding pathway into association 
and catalysis allowed a kinetic representation of this competition (Figure 16). Indeed, the constant at 
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which unfolded protein bound Kar2 was higher than the constant applied to PDI (7.42 x 10-6 and 2.3 
x 10-7, respectively). This predisposal to binding Kar2 reflected the literature evidence suggesting 
unfolded protein binds Kar2 on entry to the ER, and the binding of PDI is secondary. 
 
 
Figure 16 – Splitting PDI dependent folding into association and catalysis steps.  
Incorporating the second folding pathway necessitated splitting the PDI folding into protein association and 
disulphide bond catalysis steps. [A]: Compared to MM_E, splitting the steps slowed the rate of UP folding. [B]: 
The rate was slower as it was limited by the generation of UP|PDI complexes, as shown by the equal rates of 
UP folding and PDI association.  
 
In addition to binding unfolded protein and folding intermediates, Kar2 binds misfolded protein 
preventing aggregation and targeting it to the ERAD pathway. Under normal conditions, Kar2 is 
associated with the stress sensor Ire1, but when unfolded protein levels exceed a threshold this 
complex dissociates. The monomeric Ire1 oligomerises and binds unfolded protein, generating the 
active receptor Ire1A. 
 
In summary, there are a number of protein-protein interactions in the ER which are reversible in 
nature: 
 
    a         a   
    a        a   
         a              a   
I e   a     I e   a   
  I e       I e   
 
Where the state variables UP, MP, FPIntra and Kar2 represent unfolded protein, misfolded protein, 
the folding intermediate and the chaperone respectively; Ire1 and Ire1A represent the inactive 
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and activate stress sensor, respectively; and vertical lines denote the formation of complexes. 
 
As reversible reactions, these processes are best represented by equilibrium kinetics. To do so, the 
reactions were grouped into matrices: 
 
              a     I e    
13.  
                             a    
14.  
              a    
15.  
        a         a              a     I e   a         a    
16.  
       I e    I e   a       I e    
17.  
 
Where MUP, MFPIntra, MMP, MKar2 and MIre1 represent the five matrices for unfolded protein, the 
folding intermediate, misfolded protein, the chaperone and the stress sensor respectively; the 
state variables UP, FPIntra, MP and Kar2 represent unfolded protein, the folding intermediate, 
misfolded protein and the chaperone respectively; the state variables Ire1 and Ire1A represent 
inactive and active Ire1 respectively; and vertical lines denote the formation of complexes. The 
factor of eight employed in Eq. 17 accounts for the oligomerisation of Ire1. 
 
Material balances were derived describing how each matrix changed with respect to time: 
 
    
 t
              (                                                        ) 
18.  
 
Where MUP represents the matrix for unfolded protein; FTranslation represents the flux of unfolded 
protein from translation; FUP|PDI_Association represents the flux of unfolded protein binding to PDI; 
FUP|Kar2|PDI represents the flux of unfolded protein bound to Kar2 binding to PDI; and FUP_Misfolding 
represents the flux of unfolded protein misfolding. 
 
         
 t
 (                          )  (                                                  ) 
19.  
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Where MFPIntra represents the matrix for the folding intermediate; FUP_Folding and FUP|Kar2_Folding 
represent the flux of unfolded protein, and unfolded protein bound to Kar2, to the folding 
intermediate respectively; FAssociation and FAssociation_Kar2 represent the flux of the folding 
intermediate and the folding intermediate bound to Kar2 to folded protein; and FFPintra_Misfolding 
represents the flux of the folding intermediate to misfolding. 
 
    
 t
                                   
20.  
 
Where MMP represents the matrix for misfolded protein; FUP_Misfolding is as per Eq. 18; and 
FFPintra_Misfolding is as per Eq. 19. 
 
      
 t
 (                           )  (                                ) 
21.  
 
Where MKar2 represents the matrix for Kar2; FKar2_Influx is the flux of Kar2 into the system; 
FUP|Kar2_Folding is the flux from unfolded protein bound to Kar2 folding; FKar2Deg represents the flux of 
Kar2 to degradation; and FUP|Kar2|PDI_Association is the flux of protein to unfolded protein, Kar2 and 
PDI in complex. 
 
      
 t
   
22.  
 
 Where MIre1 represents the matrix for Ire1. 
 
Finally, the distribution of protein between different species and complexes was determined by 
equilibrium constants: 
 
          
     a   
      a   
 
23.  
               
          a   
           a   
 
24.  
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     a   
      a   
 
25.  
            
 I e   a   
 I e  (  a             
             
    )
 
26.  
             
 I e   
 I e      
 
27.  
 
Where KcUP|Kar2, KcFPIntra|Kar2, KcMP|Kar2, KcIre1|Kar2 and KcIre1_Active represent the equilibrium constants 
for complexes between unfolded protein and Kar2, the folding intermediate and Kar2, misfolded 
protein and Kar2, Ire1 and Kar2 and Ire1 and unfolded protein, respectively; UP, MP, FPIntra and 
Kar2 represent unfolded protein, misfolded protein, the folding intermediate and the chaperone, 
respectively; Ire1 and Ire1A represent the inactive and active stress sensor respectively; and 
vertical lines indicate complexes between these species. 
 
The equilibrium expression for Ire1|Kar2 has been slightly modified. A pitfall of using the equilibrium 
expressions was that as soon as Kar2 decreased, Ire1|Kar2 similarly decreased. This allowed Ire1A to 
form prior to significant free Kar2 depletion. Consequently, the expression had a ratio incorporated 
into it to buffer the decrease in free Kar2 until free Kar2 approached the kKar2_Threshold (Figure 17).   
 
Although similar free Kar2 depletion was observed between simulations employing the two 
expressions; that with the modified equilibrium description displayed a shallower gradient for the 
decrease in Ire1|Kar2 – consistent with a time delay for free Kar2 depletion.  
 
Within these equations were some important assumptions. Firstly, it was assumed that Kar2 bound 
unfolded, disassociated and misfolded protein in a one to one stoichiometry; this was both 
simplifying and typical of Hsp70 chaperones [209]. Secondly, the cycle of ATP hydrolysis (concomitant 
with peptide binding is ATP binding at the N-terminal; the inherent, weak ATPase activity of Kar2 
hydrolyses ATP which initiates protein release [64,65]) has been neglected. The model assumed that 
ATP was not limiting and that the number of Kar2 molecules, not the ability to regenerate, limited 
folding. Finally, although production and degradation terms were included for scFv protein and Kar2, 
they were neglected for Ire1 for simplicity.  
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Figure 17 – Amending the Kar2 equilibrium expression to account for threshold activation  
Using equilibrium kinetics to describe the dynamics of protein to protein association was limited in terms of 
building robustness into the system: as soon as free Kar2 started to decrease, so would Ire1|Kar2 complexes. 
To counteract this, and allow for decreases in free Kar2 before a threshold to be acceptable, the equilibrium 
expression for Ire1|Kar2 was amended. The model was simulated with [A]: a conventional equilibrium 
expression; and [B]: the modified expression (Eq. 26). The modified expression allows free Kar2 to decrease to 
a threshold before Ire1|Kar2 dissociation. 
 
The expressions were solved using the following parameters, each estimated from the ratio of 
products to reactants:  
 
         
 A   
 A    
 
 
 KcUP|Kar2, KcFPintra|Kar2, KcMP|Kar2 = 7.42 x 10
-6 
where there is one molecule of Kar2 in complex, one molecule of UP, FPIntra and MP and 
134,542 molecules of free Kar2 (initial conditions); 
 
 KcIre1|Kar2 = 1.92 x 10
-3 
where there are 258 molecules of Ire1 bound to Kar2, one molecule of free Ire1 and 134,542 
molecules of free Kar2 (non-UPR conditions); 
 
 KcIre1Active = 2.64 x 10
-4 
where there are 32 molecules of Ire1 bound to UP (based on eight Ire1 monomers 
comprising an Ire1 oligomer [210]), one molecule of free Ire1 and 121,320 molecules of UP or 
MP. The latter assumes that the stress condition will occur when there is enough UP or MP 
to reduce free Kar2 to 10% of its initial value.  
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Figure 18 – The addition of Kar2 to the system.  
[A]: Surprisingly, adding Kar2 tripled the rate of FUP_Misfolding; [B]: but decreased FFPintra_Misfolding. [C]: Overall, the 
addition made no significant difference to yield. [D & E]: This result was due to 93% of total Kar2 being titrated 
by misfolded protein; [F]: consequently activating the UPR. Simulations were run with Eq. 26 modified to a 
conventional equilibrium expression as a decrease in free Kar2 significantly below the threshold, as occurred 
here, terminated the numerical solver due to the value of 
             
      
 increasing beyond one. 
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The consequence of splitting PDI association and catalysis was a reduced FUP_Folding (Figure 16 [A]), 
which subsequently caused an increase in the rate of UP misfolding despite the addition of Kar2 to 
the system (Figure 18 [A]). Although this decreased FPIntra misfolding (Figure 18 [B]), there was no 
significant difference in the overall total yield (Figure 18 [C]). The negligible effect of Kar2 can be 
attributed to the accumulation of MP, which titrated most of the chaperone molecules (Figure 18 
[D]). This reduced the Kar2 in the system beyond the threshold level (Figure 18 [E]), activating the 
UPR (Figure 18 [F]). 
 
When kTscript switched off at 6 hours, the small return of Kar2 from the folding pathway caused a 
significant reduction in Ire1A molecules – but not enough to return the system to pre-induction 
levels. Interestingly, a recent study showed data that suggested the UPR de-activates even while 
there is still a significant unfolded protein burden [211]. The authors’ hypothesise that this could be 
the result of a small, and in their experimental system, undetectable, return of free Kar2; a theory 
corroborated by this model. 
 
3.2.6 Removing misfolded protein from the system through ERAD 
 
The high amount of misfolded protein sequestered Kar2 and negated its positive effect and 
therefore required an outlet, namely, degradation through the ERAD pathway. In the model, the 
complex of MP|Kar2 was recognised by the ubiquitin-protein ligase E3 enabling protein degradation, 
a process modelled with modified Michaelis-Menten kinetics: 
 
      
 
 
      (     a             
 √(     a             )        a       ) 
28.  
 
Where FERAD represents the flux of misfolded protein bound to Kar2 to the ERAD degradation 
pathway; the state variables MP|Kar2 and E3 represent misfolded protein bound to Kar2 and the 
E3 ubiquitin ligase respectively; and the parameters kcatE3 and kmE3 represent the catalytic 
constant and Michaelis constant for E3, respectively. 
 
There are various assumptions implicit in the above relationship. Firstly, Kar2 was assumed to be the 
recognition substrate for misfolded protein. The recognition complex for misfolded substrates is not 
fully characterised and a variety of proteins have been implicated, including Kar2. Considering 
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experimental evidence that elevated Kar2 levels caused by the UPR are essential for clearing 
misfolded protein in ERAD [212], Kar2 recognition of misfolded protein was a simple and necessary 
mechanistic link between the two.  
 
The second major assumption was the simplification of the ERAD cascade to the kinetics of one 
enzyme: the ubiquitin-protein ligase E3. The current understanding of this process is incomplete and 
what is known is too complicated to reliably include explicitly in the model; the misfolded protein in 
the system, however, required an outlet. Therefore the process of ERAD has been reduced to a more 
a manageable, but less realistic, representation. This enzyme completes the final step in 
ubiquitinylation, that is, catalytic transfer of ubiquitin to the target substrate. There are two 
heterogeneous families of E3 known, those with HECT domains and those with RING domains [85]. Of 
the 60 to 100 E3 enzymes in S. cerevisiae, only six have HECT domains while the rest are all members 
of the RING family [82]. Two of these, Hrd1/Der3 and Doa10, are better characterised. Crucially, 
overexpression of either has been shown to increase degradation such that the levels of these 
enzymes appear to be rate-limiting in vivo [84,85,213]. In a multistep reaction the overall rate cannot 
exceed that of the rate-limiting step and therefore the kinetics of the ERAD cascade can be reduced 
to those of the E3 enzymes [214].  
 
The expression was solved using the parameters:  
 
 kcatE3 = 1.3 molecules s
-1 
The turnover rate for the E3 enzyme was inferred from a study quantifying the transfer of 
ubiquitin by the cullin-RING ubiquitin ligase SCFCdc4, considering ubiquitin as the substrate in 
the reaction [215].  
 
 kmE3 = 360 
The Michaelis constant for E3 was estimated by fitting the data set from Petroski and 
Deshaies [215] to the system. The rate of diubiquitin formation, as a function of ubiquitin 
concentration, was extracted and expressed as a percentage of the total. This was applied to 
the maximum rate of E3 degradation, kcatE3, multiplied by the total number of E3 
molecules, and the substrate range which was assumed to be in a 1:1 ratio with E3. This 
provided a data set for construction of a Lineweaver-Burke plot, from which kmE3 was 
estimated as  
 
    
 . 
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This outlet necessitated the amendment of the matrix of misfolded protein, replacing Eq. 20: 
 
    
 t
 (                                 )        
29.  
 
Where MMP represents the matrix for misfolded protein; FUP_Misfolding represents the flux of 
unfolded to misfolded protein; FFPintra_Misfolding represents the flux of the folding intermediate to 
misfolded protein; and FERAD represents the flux of misfolded protein bound to Kar2 to 
degradation. 
 
As expected, the addition of ERAD greatly decreased the sequestration of Kar2 by misfolded protein 
(Figure 19[A]); however the availability of Kar2 was not concurrently increased suggesting that there 
was not enough Kar2 in the system to cope with scFv production (Figure 19 [B]). In support of this, 
production of scFv still activated the UPR (Figure 19[C]) and the rate of protein misfolding only 
slightly decreased (Figure 19[D & E]). Consequently, the addition of ERAD had a negligible effect on 
yield (Figure 19[F]). Considering the induction of scFv caused the activation of the UPR response, the 
next step was to include its downstream effects.  
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Figure 19 – The addition of the ERAD pathway 
To prevent the MP|Kar2 accumulating, an outlet for MP was required for which the ERAD pathway was 
introduced. [A]: ERAD decreased the amount of misfolded protein bound to Kar2.[B & C]: This allowed the Kar2 
and Ire1|Kar2 numbers to return to pre-induction levels as MP was cleared from the system, but scFv 
production still caused significant stress. [D & E]: The rate of misfolding was still quite high; [F]: so the addition 
of ERAD had no significant effect on yield.  
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3.2.7 Up-regulation of UPR targets 
 
Active Ire1, Ire1A, splices HAC1U consequently triggering the UPR. The response up-regulates around 
5% of the genome [96] with the objective of returning the ER to homeostasis. Such up-regulation was 
clearly too expansive to include in the model, therefore here the focus was Kar2, PDI and E3.  
 
The reaction was modelled with mass action kinetics, based on the amount of the enzyme Ire1A:  
 
   A    
 t
                    
30.  
                  I e    
31.  
                     A     
32.  
 
Where HAC1S represents the spliced HAC1S mRNA; FSplicing and FHAC1_deg represent fluxes of spliced 
HAC1 mRNA production and degradation respectively; the state variable Ire1A represents the 
active Ire1 endoribonuclease; and the parameters kSplice and kHAC1_Deg represent the rate of active 
Ire1 splicing and HAC1S degradation, respectively.  
 
The enzymatic reaction of Ire1A splicing HAC1U might be expected to be represented with Michaelis-
Menten kinetics, where the rate of reaction is dependent on the number of molecules of the enzyme 
and the substrate. In this case, however, the substrate is constitutively expressed [101] at a higher 
level [216] than the enzyme. Additionally, as HAC1U is a target for the UPR, it up-regulates itself. On 
this basis, HAC1U was assumed to not limit the rate of reaction, simplifying the kinetics. This also 
circumvented a lack of kinetic data, but maintained the saturation kinetics required as Ire1A is 
limited by equations 17 and 22. 
 
The expressions were solved using the parameters:  
 
 kSplice = 3.69 x 10
-3 s-1  
The first order rate of splicing was derived from a study measuring the HAC1 mRNA splicing 
in yeast in response to varying concentrations of DTT [216]. Data was extracted from analysis 
of the percentage of spliced HAC1 mRNA over time for three concentrations of DTT: 1.5 mM, 
- MODELLING SCFV PRODUCTION - 
 
- 101 - 
2.2 mM and 5 mM. While the return to steady state differed for the three concentrations, 
the initial response was invariant – therefore, this initial rate of 47.5% in 13.3 minutes was 
assumed to be the maximum rate of splicing. Assuming 200 molecules of HAC1U are 
available [216], this gave a rate of 0.119 molecules s-1, corroborated by Rubio et al. (2011) who 
measured a kobs around 0.1 s
-1 [217]. The maximum rate of splicing occurs when all Ire1 
molecules have been activated, therefore kSplice = 
 .   
  
. 
 
 kHAC1_deg = 3.65 x 10
-2 s-1 
The first order degradation rate of HAC1S was inferred from a study using RT Q-PCR to 
investigate the half-life of HAC1 mRNA in yeast following transcription inhibition [218]. The 
result, 19 minutes, was assumed for the spliced form [219].  
 
Each target required an influx, attributable to the UPR, and a degradation term which allowed the 
variables to return to homeostasis after stress. Consequently, each UPR target was described as 
follows: 
 
    I 
 t
                            
33.  
     
 t
                          
34.  
 
Where the state variables PDI and E3 represent protein disulphide isomerase the E3 ubiquitin 
ligase, respectively; FPDI_Influx and FE3_Influx represent fluxes of PDI and E3 into the system, 
respectively; and FPDI_Degradation and FE3_Degradation represent fluxes of PDI and E3 to degradation, 
respectively. The rate of change of Kar2 is described in the material balances (Eq. 21). 
 
In order to balance the degradation during non-UPR conditions, the influx term was a composite of 
the UPR and a basal production rate. The UPR-derived influx has been represented in the model by 
making the influx of each target a function of HAC1S, subject to Michaelis-Menten kinetics: 
 
            
              A    
             A    
            
35.  
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             A    
            A    
           
36.  
          
            A    
           A    
          
37.  
 
Where FKar2_Influx, FPDI_Influx and FE3_Influx represent the flux of chaperone, protein disulphide 
isomerase the E3 ubiquitin ligase into the system, respectively; the state variable HAC1S 
represents spliced HAC1 mRNA; the parameters vmaxKar2_UPR, vmaxPDI_UPR and vmaxE3_UPR represent 
the maximum rate of Kar2, PDI and E3 influx from the UPR, respectively; the parameters 
kmKar2_UPR, kmPDI_UPR and kmKar2_E3 represent the Michaelis constant for Kar2, PDI and E3 influx 
from the UPR, respectively; and kKar2_Basal, kPDI_Basal and kE3_Basal represent the basal influx rate of 
Kar2, PDI and E3 respectively. 
 
In addition to HAC1U, these equations also exclude: (i) HAC1S translation, (ii) Hac1 retrotranslocation 
to the nucleus, (iii) binding to the UPRE of target genes and activation of transcription, (iv) export of 
the subsequent mRNA, and – if required – (v) translation. These steps have been removed for 
simplicity and model accuracy as experimental, kinetic characterisation of these intermediates has 
not yet been conducted. Although they could be estimated from literature data, a mechanistic 
model would render this a data fitting exercise. 
 
The expressions were solved using the parameters:  
 
 vmaxKar2_UPR = 74.6 s
-1, kmKar2_UPR = 7.80 molecules, kKar2_basal = 12.6 molecules s
-1 
 vmaxPDI_UPR = 556
 s-1, kmPDI_UPR = 2.74 molecules, kPDI_basal = 303 molecules s
-1 
 vmaxE3_UPR = 0.263 s
-1, kmE3_UPR = 3.01 molecules, kE3_basal = 0.273 molecules s
-1 
 
As an artificial construct, the vmax and km parameters were estimated assuming a 2.75-fold 
increase for Kar2 [220], a two-fold increase for PDI [220] and a 1.5-fold increase in E3 [28]. The basal 
production rate was also estimated to balance the half-life of the proteins generating a steady state 
under non-UPR conditions.  
 
The degradation terms were modelled with mass action kinetics: 
 
                           a    
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38.  
                          I  
39.  
                          
40.  
 
Where FKar2_Degradation, FPDI_Degradation and FE3_Degradation represent the flux of chaperone, protein 
disulphide isomerase the E3 ubiquitin ligase to degradation, respectively; the state variables Kar2, 
PDI and E3 represent the chaperone, protein disulphide isomerase the E3 ubiquitin ligase, 
respectively; and the parameters kKar2_Deg, kPDI_Deg and kE3_Deg represent the rate of Kar2, PDI and E3 
degradation, respectively. 
 
The expressions were solved using the parameters:  
 
 kKar2_Deg = 9.31 x 10
-5 s-1 
The degradation has been assumed to follow first order kinetics, allowing the parameter to 
be calculated based on the half-life of 124 minutes [221,222] and the relationship t
 
  
   ( )
 
. 
 
 kPDI_Deg = 1.44 x 10
-3 s-1 
As above, based on the half-life of 8 minutes [221]. 
 
 kE3_Deg = 2.57 x 10
-4 s-1 
As above, based on the half-life of 45 minutes [221]. 
 
Simulations revealed that the activation of the UPR caused an influx of Kar2, PDI and E3 to the 
system (Figure 20 [B]), allowing a small reduction in stress during protein production (Figure 20 [D]). 
Only a few molecules of HAC1S were present at steady state (Figure 20 [A]) – a result of the 
degradation rate being an order of magnitude higher than the production rate. Consequently, 
production of HAC1S was tightly linked to active Ire1A molecules. While there are no literature values 
for the absolute quantification of spliced HAC1 mRNA, this was not an unrealistic finding: the mRNA 
of most physiologically relevant transcription factors are present at as low a value as 1000th of a copy 
per cell [223].  
 
Two differences were observed in up-regulation of Kar2, PDI and E3 (Figure 20 [B]): firstly, the 
magnitude of the response; and secondly, the time taken to return to non-UPR conditions. The 
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former was based on literature values which suggest Kar2 is up-regulated to a greater extent than 
PDI, which, in turn, is up-regulated more than E3. The latter is a consequence of the protein half-life: 
the higher degradation rate constant for PDI causes its profile to mimic HAC1S whereas the long half-
life of Kar2 ensures the ER is more resilient to stress in the immediate hours following stress. 
 
According to model simulations (Figure 20 [D]), the level to which UPR targets are up-regulated is 
not sufficient to ameliorate the stress of scFv production. Induction saturates the capacity of the 
system, suggesting that engineering strategies are required to increase productivity of scFvs from P. 
pastoris. 
 
 
Figure 20 – HAC1U splicing and the UPR response 
[A]: Formation of the Ire1A complex directly induced production of HAC1S with maximum values of 16 and 1.57 
respectively. [B]: HAC1S in turn up-regulated PDI, Kar2 and E3, with amplitudes matching literature values The 
differing profiles during the return to baseline is a consequence of varying protein half-lives. [C & D]: The influx 
of Kar2 slightly ameliorated the dissociation of Ire1|Kar2 and the formation of Ire1A, but was not sufficient to 
ameliorate the stress of scFv induction. 
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3.2.8 Initial conditions 
 
An initial condition was required for each of the differential equations. The variables relating to scFv 
(SCFVN, SCFVC, SCFVD, MUP, MMP, MFP_Intra, MPD and FPInter) were set to zero on the basis of an 
inducible promoter. HAC1S was also set to zero on the assumption that, prior to induction, the 
system was unstressed.  
 
The final initial conditions were primarily derived from a global proteome analysis of S. cerevisiae 
using epitope tagging and immunodetection [222]. This study found 337,000 molecules of Kar2, 2660 
molecules of Hrd1 (an example E3 ubiquitin ligase) and 259 molecules of Ire1 per cell. A previous 
model employed a value of 524,000 molecules of PDI per cell [157], which produced a similar ratio of 
Kar2 to PDI as that observed experimentally [224]. It was assumed that all cellular Kar2, PDI, E3 and 
Ire1 is found in the ER, which has been shown for Kar2 [30]. The values have, however, been reduced 
in an attempt to account for the native protein transit through the ER.  
 
As the AOX1 promoter produces around 30% of the total soluble protein [193], the scFv may have 
access to 30% of the total Kar2, PDI and E3. However, not all total soluble protein transits the ER 
whereas all scFv does; therefore, the proportion was increased to 40%: 
 
      ( )                      molecules 
 
     ( )                      molecules 
 
    ( )                 molecules 
 
The value for Ire1 was not similarly adjusted as it was assumed that only scFv induced stress in the 
system.  
 
3.2.9 Emergent properties 
 
One of the most widely used strategies to increase the yield of expression systems is to integrate 
multiple copies of the heterologous gene. This does not always increase yield, however, and 
experimentally two trends are observed: firstly, yield can increase with gene dosage until capacity is 
saturated [225-227]; alternatively, gene dosage can have a negative impact on secretion [118]. Above and 
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beyond secretion, copy number quite frequently has a negative impact on activity [117,227,228]  though 
this is not always the case [226,229,230].  
 
While initial simulations showed saturation behaviour (Figure 21 [A]), a negative influence of copy 
number on yield was not observed. The saturation behaviour observed here is a consequence of PDI 
limitation (Figure 21 [B]). In order to observe the saturation behaviour at low copy numbers, the rate 
of PDI catalysis (kcatPDI) was lowered by an order of magnitude. The effect of gene dosage depends 
on characteristics of the protein expressed and the expression strategy itself (such as the strength of 
promoter); consequently, the aim here was to qualitatively reproduce the behaviour observed 
experimentally.  
 
 
Figure 21 – Secretion saturation 
[A]: Increasing the copy number increased the yield, although this was subject to diminishing returns and 
started to plateau at five copies, [B]: based on PDI limitation. Simulations were run with Eq. 26 modified to a 
conventional equilibrium expression as the complete titration of free Kar2 terminated the numerical solver. 
Experimental data derived from Inan et al., 2006 
[132]
, Sha et al., 2013 
[227]
 and Menendez et al., 2013 
[226]
. 
 
In order to try to capture the negative influence of copy number on expression, a variety of kinetic 
expressions to increase the rate of misfolding were employed. This was based on the hypothesis that 
a higher FTranslation would generate more misfolded protein, which itself would increase the rate of 
misfolding – indeed, as misfolded protein alone cannot be degraded or exported, it would crowd the 
ER [89]. This did not result in a negative influence of copy number on yield, however, and a different 
approach was taken: as yield correlates with PDI, the negative influence could come from misfolded 
protein titrating PDI and thus reducing the flux through the folding pathway. This has experimental 
evidence: PDI can bind peptides irrespective of the presence of cysteines [68], has acted as a 
chaperone in several studies [69-71] and was found to contribute to the ERAD of proteins [231]. 
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Consequently, the model was revised to incorporate misfolded protein binding to PDI, a reversible 
reaction represented by equilibrium kinetics: 
 
     I       I 
 
Where MP and PDI represent misfolded protein and protein disulphide isomerase, respectively; and 
MP|PDI represents the complex formed between the two. 
 
As PDI becomes an equilibrium species, the association of PDI with UP and UP|Kar2 was revised 
replacing equations 8 and 9: 
 
     I       I 
    a     I      a     I 
 
Where UP and PDI represent unfolded protein and protein disulphide isomerase, respectively; 
UP|Kar2 represents the complex formed between unfolded protein and the chaperone; UP|PDI 
represents the complex formed between unfolded protein and protein disulphide isomerase; and 
UP|Kar2|PDI represents the complex formed between unfolded protein, chaperone and protein 
disulphide isomerase. 
 
This strengthened the model, by removing the assumption that PDI binds irreversibly. Three of the 
matrices were amended (Equations 13, 15 and 16) to incorporate these new species, and a further 
one for PDI was added: 
 
              a     I e          I       a     I  
41.  
              a          I  
42.  
        a         a              a     I e   a         a         a     I  
43.  
        I        I       a     I        I  
44.  
 
Where MUP, MMP, MKar2 and MPDI represent the matrices for unfolded protein, misfolded protein, 
chaperone and protein disulphide isomerase respectively; the state variables UP, FPIntra, MP, Kar2 
and PDI represent unfolded protein, the folding intermediate, misfolded protein, chaperone and 
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protein disulphide isomerase respectively; the state variables Ire1 and Ire1A represent inactive 
and active Ire1 respectively; and vertical lines denote the formation of complexes. 
 
New differentials for each of the matrices were derived: 
 
    
 t
              (                                        ) 
45.  
 
Where MUP represents the matrix for unfolded protein; FTranslation represents the flux of unfolded 
protein from translation; FUP_Folding and FUP|Kar2_Folding represent the flux of unfolded protein, and 
unfolded protein bound to Kar2, to the folding intermediate respectively; and FUP_Misfolding 
represents the flux of unfolded protein misfolding. 
 
         
 t
 (                          )  (                                                  ) 
46.  
 
Where MFPIntra represents the mass balance for the folding intermediate; FUP_Folding and FUP|Kar2_Folding 
are as per Eq. 44; FAssociation and FAssociation_Kar2 represent the flux of the folding intermediate and the 
folding intermediate bound to Kar2 to folded protein; and FFPintra_Misfolding represents the flux of the 
folding intermediate to misfolding. 
 
    
 t
 (                                 )        
47.  
 
Where MMP represents the mass balance for misfolded protein; FUP_Misfolding is as per Eq. 44; 
FFPintra_Misfolding is as per Eq. 45; and FERAD represents the flux of misfolded protein through the 
ERAD degradation pathway. 
 
      
 t
                      
48.  
 
Where MKar2 represents the mass balance for Kar2; FKar2_Influx is the flux of Kar2 into the system; 
and FKar2Deg represents the flux of Kar2 to degradation. 
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 t
                    
49.  
 
Where MPDI represents the mass balance for PDI; FPDI_Influx is the flux of PDI into the system; and 
FPDI_Deg represents the flux of PDI to degradation. 
 
      
 t
   
50.  
Where MIre1 represents the mass balance for the stress sensor Ire1. 
 
Additionally, new relationships describing the equilibrium between PDI and its various substrates 
were derived: 
 
         
      I 
       I 
 
51.  
              
     a     I 
     a      I 
 
52.  
         
      I 
       I 
 
53.  
 
Where KcUP|PDI, KcUP|Kar2|PDI and KcMP|PDI represent the equilibrium constants for complexes 
between unfolded protein and protein disulphide isomerase, unfolded protein, chaperone, and 
PDI, and misfolded protein and PDI, respectively; UP, MP, Kar2 and PDI represent unfolded 
protein, misfolded protein, chaperone and protein disulphide isomerase, respectively; and 
vertical lines indicate complexes between these species. 
 
Finally, the equilibrium constants for PDI binding to unfolded and misfolded protein, and the 
complex of unfolded protein bound to Kar2, were estimated from initials conditions: 
 
 KcUP|PDI, KcUP|Kar2|PDI, KcMP|PDI = 4.77 x 10
-6 
where there is one molecule of PDI in complex, one molecule of UP, MP and UP|Kar2 and 
209,600 molecules of free PDI; 
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Altering the kinetics of PDI, from mass action association to equilibrium, had little effect on the rate 
of substrate folding or saturation of the enzyme (Figure 22). The model did, however, simulate both 
secretion saturation and a negative effect of gene dosage on yield, though the model could not 
completely describe experimental results (Figure 23). 
 
 
Figure 22 – Conversion of PDI kinetics from mass action to equilibrium 
[A]: The alteration had little effect on the rate of unfolded protein folding, reducing it by just over 1 molecule s
-
1
. [B]: Similarly, the change in kinetics barely changed the rate of unfolded protein, bound to Kar2, folding.  
 
 
Figure 23 – Secretion saturation and the negative influence of high copy number on yield 
Simulations were run with Eq. 26 modified to a conventional equilibrium expression as the complete titration 
of Kar2 terminated the numerical solver. Experimental data was derived from Zhu et al., 2009 
[118]
. 
 
Although the model showed a negative effect of high gene dosage, it does not qualitatively match 
the bell curve found experimentally. As discussed in Section 3.3.2, the model does not include 
aspects of protein aggregation, autophagy [189,232] and vacuolar degradation [233] which could account 
for a direct decrease in yield. Moreover, the majority of the processes included in the model require 
energy but this has not been included, such that any metabolic burden [118] of high unfolded protein 
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production cannot be simulated. Finally, at high gene copy numbers there is a stronger likelihood of 
the recombinant component competing with host cells proteins at the level of transcription, 
translation and translocation, further processes which were excluded from the model for simplicity. 
Consequently, the effects of very high copy numbers cannot be simulated with the current model. 
Here, however, the focus was a single gene integrant and so the qualitative accuracy at low copy 
numbers was appropriate.  
 
Finally, scFvs were selected as the model protein based on their industrial relevance and – crucially – 
they systematically express at low yields. The analysis of such a ‘difficult’ protein may generate more 
targets for cell line optimisation. Consequently, the model was simulated with a better folding 
protein to characterise differences and see what engineering solutions could be utilised. The final 
model structure was simulated with a kAssoc of 1 molecule s
-1 to represent this. Reducing the kAssoc 
parameter revealed the relationship of protein ‘complexity’ and yield, and the stress induced not by 
the level of expression but by the efficiency of folding (Figure 24).  
 
Proteins which fold more easily will have an increased yield (Figure 24 [A]) as the number of folding 
intermediates is lower (Figure 24 [B]), maintaining a higher level of available Kar2 (Figure 24 [C]) and 
reducing misfolding. Interestingly, the reduction in stress was not complete (Figure 24 [D]), 
considering the amount of free Kar2. This is a result of unfolded protein binding to Ire1 to activate it: 
the faster kAssoc increases flux from FPIntra, but does not alter the flux from unfolded protein directly. 
It does increase the availability of Kar2 to bind unfolded protein, but cannot titrate it completely. As 
Ire1A is formed from the presence of unfolded protein, and increasing the flux from FPIntra only 
partially decreased this, there was still significant stress in the system. 
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Figure 24 – Proteins difficult to fold induce more stress 
[A]: Reducing kAssoc increased the yield; [B]: as this reduced the number of molecules of FPIntra from which the 
majority of misfolded protein derives. [C]: Fewer folding intermediates and misfolded protein increased the 
available Kar2 which [D]: ultimately, reduced (but did not eradicate) ER stress in the system.  
 
To counteract the stress induced by proteins that require multiple steps or fold inefficiently, the 
number of molecules of Kar2 and PDI could be increased. Indeed, this strategy has been used – with 
mixed results – to increase the yield of scFv from P. pastoris [63]. Initially, the model was simulated 
with ten times the native amount of Kar2, resulting in an increase in yield (Figure 25 [A]). 
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Figure 25 – Artificially increasing the number of Kar2 molecules 
[A]: Increasing the Kar2 amount increased the yield; [B]: as there was a moderately increased flux from 
unfolded protein to the folding intermediate, the latter of which could bind the excess Kar2 instead of 
misfolding. [C & D]: The excess Kar2 allowed a significant reduction in stress on the system. Simulations used 
the following amended parameters: MKar2 = 1,348,000, kKar2_basal = 126 molecules s-1 and vmaxKar2_UPR = 
740.6 s-1. 
 
While the total FPIntra is moderately higher when Kar2 is artificially increased, as the flux through the 
second folding pathway from unfolded protein is greater, crucially more FPIntra was bound to the 
additional Kar2 (Figure 25 [B]). As a great deal more Kar2 is available, stress in the system is 
ameliorated (Figure 25 [C & D]). Although the influx still caused a slight increase in Ire1A molecules, 
this was not sufficient to raise the Kar2 amount significantly. 
 
A tenfold increase in PDI, on the other hand, had no obvious effect on yield (Figure 26). Specifically, 
up-regulation slightly increased the folding rate of unfolded protein, from 692 to 694 molecules s-1, 
and decreased its misfolding rate (Figure 26 [A & B]). Combined, this effect pushed the flux through 
to the slow association stage. Here, the rate of FPIntra misfolding was increased (Figure 26 [C]) leading 
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to the yield decrease. If aggregation effects were included, and the negative effects of PDI 
production, this would exaggerate the minor negative effect observed here. This interesting result 
highlights the issues arising from increasing flux through a pathway that is not rate-limiting, 
exacerbating the one which is. It also underlines the need to understand the specific pathway to be 
optimised, as opposed to a trial and error approach employing the traditional strategies for yield 
increase. 
 
 
Figure 26 – Artificially increasing the number of PDI molecules 
[A]: Increasing the PDI amount slightly decreased the yield; [B]: as it pushed flux from unfolded protein to the 
folding intermediate, reducing FUP_Misfolding; [C]: this increased FFPintra_Misfolding as there was not enough Kar2 to 
manage the increased flux from PDI folding pathways; [D]: decreasing the yield. Simulations used the following 
amended parameters: MPDI = 2,096,000, kKar2_basal = 3,026 molecules s-1 and vmaxKar2_UPR = 5,556 s-1. 
 
Simultaneously up-regulating both Kar2 and PDI, however, could not further increase the positive 
effect of yield shown by Kar2 alone (Figure 27[A]). Having said that, the up-regulation of PDI does 
reduce the ER stress shown in the system (Figure 27[B]) as it increased flux from unfolded protein 
decreasing the availability of unfolded protein to bind to Ire1.  
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Figure 27 – Artificially increasing the number of both Kar2 and PDI molecules 
[A]: Increasing the Kar2 and PDI amount increased the yield; and [B]: reduced stress in the system. Simulations 
used the amended parameters as per Figure 25 and Figure 26. 
 
3.3 Discussion 
 
The aim was to derive a model of scFv production in a single cell of P. pastoris, with literature data, 
to try to understand the factors that determine productivity. The final version constituted 41 
equations (1: 3, 5:7, 10: 12; 14, 17, 23: 52) and 30 parameters, listed in Appendix I. 
 
3.3.1 Model analysis 
 
The developed model recapitulated some features of experimental data, such as the negative effect 
of copy number on yield and the phenomenon of secretion saturation. Some of the parameters were 
found to produce values for state variables in line with literature estimates; where disparities 
occurred, the parameter values were amended (within reason). For instance, only literature values 
for the elongation rate of RNApol II could be found, which neglected the rate of transcription 
initiation and termination, and did not account for the strength of the promoter. Therefore, a value 
of 0.391 molecules s-1 was estimated to produce a steady state value of 610 transcripts, in accord 
with estimations that the AOX1 promoter yields 5% [193] of the total 12,220 mRNA transcripts in a 
yeast cell [194].  
 
The parsimonious approach to model development tried to focus on parts of the pathway for which 
experimental data was available; however, there were some exceptions such as Ire1A. The next stage 
of model development would traditionally employ a sensitivity analysis to rank parameters in terms 
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of their importance to determining model trajectories. This can guide the subsequent experimental 
analysis.  
 
Here, however, no sensitivity analysis was conducted as it required a level of confidence in the 
model structure. With the number of assumptions currently employed (Section 3.3.2), the structure 
could not be relied upon. Moreover, the literature values were often taken from closely related, but 
different, heterologous proteins and species. Therefore, the results of the experimental analysis 
were to be used for deriving estimates and biological ranges for parameters, from which a more 
accurate model could be produced. This could then be subject to a sensitivity analysis. 
 
3.3.2 Model assumptions 
 
 Transcription and translation 
Transcription and translation were modelled with mass action kinetics, reducing each 
multistep cascade to a single parameter. This was necessary for the parsimonious approach 
to the model where, based on literature evidence, reactions within the ER were assumed to 
limit specific productivity. The mass action kinetics employed introduced error into the 
model, as there was no threshold for these reactions.  
 
 Translocation into the endoplasmic reticulum 
Proteins destined for the secretory pathway are signalled to the ER by a signal peptide 
encoded at the N terminus of the mRNA. Initial translation occurs in the cytosol, before the 
signal peptide stalls the ribosome, allowing the signal recognition particle (SRP) to bind. The 
complex moves to the ER membrane where it binds the SRP receptor on the ER membrane. 
This directs the nascent polypeptide into the ER concurrent with translation [53,54]. These 
steps were not included in the model as the limitation was assumed to occur within the ER; 
however, they are important targets for future studies. 
 
 Folding in the endoplasmic reticulum 
The ER contains a vast diversity of chaperones, foldases and quality control proteins which 
cooperate with sensors to maintain proteostasis in the ER (a recent interaction map has 
been published for the mammalian ER [234]). Here, this complexity has been reduced to the 
action of Kar2 and PDI. This is also a simplification, as yeast express at least four PDI family 
members [235], and cofactors are known to assist the Hsp70 proteins [236]. The proteins Kar2 
- MODELLING SCFV PRODUCTION - 
 
- 117 - 
and PDI were selected for two reasons: (i) they are the best characterised members, in terms 
of quantitative data, method of action and protein-protein interactions; and (ii) strategies 
focusing on increasing specific productivity by increasing flux through the ER overexpress 
these. Cofactors were assumed to not limit the action of the proteins.  
 
 Glycosylation and the Golgi apparatus 
One of the major functions of the ER is the transfer of oligosaccharides from the dolichol 
carrier to asparagine residues of nascent polypeptides containing the consensus sequence 
“N-X-S/T” for glycosylation. Subsequently, the initial oligosaccharide is trimmed and 
extended with different sugar residues to produce the native glycosylation structure. These 
reactions were not included in the model for three reasons: (i) the scFv proteins are non-
glycosylated, therefore this was assumed to be non-limiting; (ii) the reactions are vastly 
complicated such that models which do describe the reactions have not been linked to 
protein production and vice-versa; and (iii) the glycosylation structures produced in yeast are 
immunogenic, therefore biotherapeutic glycoproteins cannot be made in these strains.  
 
 Unfolded protein response (UPR) 
The current pathway for UPR activation involves the dissociation of Kar2 from Ire1 [64,90] and 
the binding of unfolded protein, which activates the endonuclease domain and splices HAC1 
mRNA [93]. Ligation by Rlg1p allows translation to proceed and the Hac1 protein 
retrotranslocates to the nucleus [94]. There it a large transcriptional program, of around 5% of 
the yeast genome, through an interaction with genes which contain a UPR response element 
(UPRE) [54,62]. In the model, this pathway was reduced to the dissociation of Kar2 and binding 
of UP to Ire1, which produced HAC1S. The up-regulation was targeted only those species 
already included in the model: Kar2, PDI and E3. Although limited, this description is more 
detailed than previous models of the UPR [1,237,238] with the exception of that by Pincus et al. 
[216]. Although the structure of the Pincus model is similar to the one here, they exclusively 
used mass action kinetics whereas the protein-protein interactions here have been 
described by equilibrium kinetics, reducing the number of estimated parameters.  
 
 Endoplasmic reticulum associated degradation (ERAD) 
The incorporation of the ERAD pathway was necessary to prevent the accumulation of 
misfolded protein sequestering Kar2. The pathway was reduced to the action of the E3 ligase, 
as this has been shown to be rate-limiting in vivo [84,85,213].  
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 Aggregation 
While the model incorporated a function to allow for protein misfolding, aggregation was 
neglected. This was a necessary simplification as in vivo data describing this process was 
limited. The crowded milieu of the ER and the strength of the AOX1 promoter, however, 
would suggest that this is an inaccurate assumption that future studies could expand upon. 
 
 Energy requirement  
The majority of processes described here require, directly or indirectly, energy to function. 
As mentioned in Section 1.5.4, metabolic models aim to quantify this with the aim of 
engineering metabolism to increase specific productivity. Here, no energy limit has been 
applied to the processes described in the model to reduce complexity, however future 
studies should prioritise introducing this to start to couple energy production and the 
expenditure in the ER, as protein folding requires extensive amounts of energy [239].  
 
 Oxidative stress 
Protein folding in the ER is thought to generate reactive oxygen species, which could alter 
proteostasis in the ER [239]. The reaction mechanism for this is poorly described, and so this 
effect has been neglected in the model. Having said that, disulphide production by PDI 
requires a terminal electron acceptor, for which oxygen has been implicated (generating 
H2O2)
[74]. With concurrent experimental data, this would be a fruitful angle for extending the 
current model.  
 
 Secretion 
The mathematical model described here concludes with folded protein generated through 
interactions with Kar2 and PDI in the ER, however, the protein production pathway in yeast 
extends from the ER through the Golgi to secretion from the cell membrane. Although this 
was justified in its initial conception by literature which suggested the bottleneck to be in 
the ER, more recent publications have implicated secretion [156]. Future work should consider 
expanding this; other mathematical models have incorporated secretion with a single 
Michaelis-Menten description [155,156]. 
 
 Autophagy and apoptosis 
During prolonged stress, sections of the ER are targeted towards autophagy to help clear 
misfolded protein. Genes implicated in this process have been shown to be activated during 
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scFv expression in P. pastoris [189], having clear implications for yield. Although data 
describing fold changes in expression of these genes is available, the lack of a mechanistic 
understanding of this process limited its incorporation in the model. Moreover, it has 
recently become clear that yeast cells can undergo programmed cell death with markers 
similar to those observed in mammalian cells. This research is still in infancy, however, its 
significant consequences on yield make a priority for future studies [240].  
 
 Host cell proteins 
Finally, the model was reduced to expressions exclusively describing production of the 
recombinant protein and stress caused therein, neglecting the host cell protein pathway. 
Indeed, the levels of Kar2, PDI and E3 were directly related to the concentration of HAC1S 
and omitted transcription and translation steps. The only account for host cell protein was a 
reduction in the total Kar2, PDI and E3 numbers. Disregarding host cell protein was a 
necessary simplification, as to incorporate all host cell proteins would demand a genome-
scale model and little data was available to guide selection of a few representatives. The 
competition between the recombinant and host cell proteins is, however, a productive 
avenue for future research.  
 
3.3.3 Comparisons to previous models and novelty 
 
Currently, only one dynamic, kinetic model exists for the protein production pathway in Pichia 
pastoris which consists of three material balances linking flux out of the ER to secretion and 
degradation, and derives from first principles [156] which this work has expanded on. The number of 
mathematical models describing such processes in yeast is much greater. Most closely related is the 
model of Hildebrandt et al. [157], a mass action model describing the scFv folding pathway in yeast. It 
contained an input of SCFV mRNA, export to the cytosol, translation and folding in the ER with 
interactions for Kar2 and PDI. This research has built on that model with the addition of Michaelis-
Menten and equilibrium kinetics along with the UPR and ERAD pathways. While there are more 
descriptive models of the individual pathways, including transcription [241], translation [242], folding 
[154], degradation [243] and the UPR [216] none are as expansive or specific to yeast. There are models 
linking some aspects for bacteria [155,159], however, these do not include the stress pathways 
restricted to eukaryotes. In mammalian cells, the sequential studies of O'Callaghan et al. 2010 [237], 
McLeod et al. 2011 [244] and Pybus et al. 2014 [245] have been influential in the field. The initial model 
used first principles to describe the synthesis of a mAb including both heavy and light chain 
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transcription, folding, transit through the Golgi and secretion. In the second paper, they built in 
further pathways for folding, from empirical observations. In their latest paper, they have added a 
UPR loop based on the previous model of Trusina et al. [238]. The comprehensive data set compiled in 
conjunction with the modelling makes this research one of the most advanced attempts to engineer 
recombinant protein secretion in cells.  
 
3.3.4 Single chain-antibody fragments are difficult to produce 
 
Simulations reproduced the general consensus that some proteins are harder to express than 
others: based on experimental evidence, scFv fragments were assumed to fold in two stages, the 
latter of which is inefficient. The accumulation of the folding intermediate titrated available Kar2; 
consequently, production from a single copy of the SCFVG activated the UPR (Figure 24 [D]). 
 
While a single copy activated the UPR, integrating multiple copies of the gene increased yield until 
secretion was saturated, a consequence of PDI limitation (Figure 21). Interestingly, a negative effect 
of high yield could not be reproduced unless misfolded protein was allowed to bind PDI, providing 
computational evidence for its role in the ERAD pathway.  
 
Two other major strategies for increasing yield are to overexpress Kar2 and PDI, both separately and 
concomitantly, as has been done for an scFv expressed in P. pastoris [63]. The authors expressed a 
scFv, Kar2 and PDI under the control of separate pAOX1 and found that, while the overexpression of 
Kar2 increased yield, the overexpression of PDI did not – results which have been reproduced by the 
model (Figure 25 [A] & Figure 26 [D]). Having said that, experimental overexpression of both Kar2 
and PDI dissipated the benefit of Kar2 and again yield was not increased. The authors attribute the 
last result to the deleterious effects of using a very strong promoter and that excess protein and 
chaperones induced the UPR. Here, the latter has only shown a positive effect in simulations. It has 
been suggested that the UPR is a double-edged sword: the up-regulation of E3 could increase flux to 
degradation [246]. With respect to the modelling, for this to occur the ERAD pathway would have to 
also degrade unfolded protein, as the increase in E3 caused by the UPR does not increase 
degradation as the pathway is not limited. This would be an interesting development for future 
experimental investigation.  
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3.3.5 Directing experimental analysis 
 
The results from modelling the system, as discussed above, provided targets for experimental 
analysis. Firstly, the correlation of gene copy and yield reflected the importance of the concentration 
of SCFVC (Figure 23); consequently, absolute quantification of SCFV mRNA from strains containing a 
single copy of the heterologous gene was required.  
 
Secondly, simulations suggested the concentration of Kar2 was crucial to determining yield (Figure 
25). Unfortunately, however, the initial conditions employed here have been measured using S. 
cerevisiae under different conditions. Moreover, the up-regulation of UPR targets has been based on 
mRNA data, which may be similarly inappropriate. Consequently, both RT Q-PCR and absolute 
quantification by LC-MS/MS analysis of Kar2 was essential: the former to compare this system with 
literature data and the latter as little post-transcriptional characterisation is available. Indeed, as it is 
the protein and not the mRNA which brings about the effects, this was crucial.  
 
Additionally, although simulations artificially up-regulating PDI had no observable effect on yield 
(Figure 26), the frequency with which experimental studies employ this strategy warranted its 
experimental characterisation concomitant with that for Kar2 – despite a lack of computational 
support. 
 
Finally, the activity of the ERAD pathway has been neglected compared to mRNA studies on the up-
regulation of chaperones; therefore, this was also a target for empirical work. Again, its addition to 
the model did not alter yield predictions (Figure 19) but literature values for its concentration were 
relatively low, along with only a small increase during UPR activation. This could lead to an 
underestimation of its activity – and therefore an underestimate of its capacity to decrease yield – 
consequently the temporal profile of a range of ERAD members was to be ascertained using RT Q-
PCR. 
 
The next chapter describes the generation of an experimental system to provide data that could be 
meaningfully integrated into the model.  
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4. Generating an experimental system 
 
4.1 Introduction 
 
Further development of the protein production model required experimental data. Such a system 
needed to meet two criteria: firstly, it had to embody the full variation in factors that determine 
cellular capacity for productivity; and secondly, the measurement of that variation had to be carried 
out in such a way that the data could be meaningfully integrated into the model.  
 
4.1.1 Heterogeneity in specific productivity in P. pastoris 
 
In addition to the selection of the heterologous protein, a further factor affecting specific 
productivity is the biological variation in cell production capacity. It has been well documented that 
individual cells within a genetically homogenous culture have varying phenotypic behaviours [247]. 
Specifically, clonal variation is the phenomenon whereby a culture, derived from a single cell, shows 
a range of phenotypic behaviour despite being genetically consistent. This phenomenon, with regard 
to production capacity, was first identified in CHO cells [248] and subsequently shown to hold true for 
P. pastoris [249]. There are various biological explanations for the heterogeneity, ranging from the 
stage of the cell cycle, through aging to epigenetic factors which are inherited and continue through 
generations [247]. Effectively all cellular variables, apart from DNA content, are distributed over a 
wide range.  
 
Consequently, transformants from a clonal culture show variations in productivity. Despite some 
variations being short-lived, those that persist over generations give rise to the differences in 
productivity between transformants and that is the focus here. Of course, individuals within cell lines 
derived from those transformants will show similar heterogeneity; however, it is the average 
behaviour which we are concerned with here and all the analysis techniques consider the 
population. The biological variation in the model variables needs to be reflected in the specified 
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parameters; moreover, characterising a low and a high secretor may help identify factors influencing 
specific productivity.  
 
Therefore, once the heterologous genes BC1 and MFE23 had been cloned into P. pastoris GS115, a 
low and a high secreting transformant was identified. As the variation in productivity needs to be 
due to non-genetic factors, and the model specifies only one copy of the SCFV gene, each high and 
low secretor was subject to copy number analysis to confirm that the clones had only one gene copy 
integrated into the correct locus.  
 
4.1.2 Generating an experimental system to produce applicable data 
 
Initially, the most significant assumption in the model required experimental validation. As the 
glycosylation reactions of the Golgi apparatus have been neglected, a non-glycosylated protein was 
required to generate experimental data. As the assumption was central to analysis of the problem, 
the lack of glycosylation needed to be verified experimentally. 
 
Both N-linked and O-linked glycosylation have been identified on recombinant proteins produced in 
P. pastoris [250,251]. Although an in silico analysis of the genes showed no N-linked glycosylation sites 
in either of the scFvs, initial SDS-PAGE analysis of the product raised concerns; therefore, the 
presence of N-linked glycosylation was determined. 
 
The analysis of O-linked glycosylation, however, proved more problematic: although this is known to 
occur on serine and threonine residues, in contrast to N-linked glycosylation, no consensus sequence 
has yet been identified. Predictive bioinformatics tools are trained solely on experimentally verified 
data sets which do not include P. pastoris preventing the use of such tools. More importantly, as 
there is no consensus sequence, few enzymes are available to detect general O-linked glycosylation 
[252]. The common protocol requires removal of O-linked glycans with an alkaline β-elimination 
reaction coupled to high-performance anion-exchange chromatography for carbohydrate detection 
[253]. As this protocol proved unfeasible in the current study, only N-linked glycosylation was 
analysed.  
 
In addition to validating assumptions, the model required a ‘baseline’ for state variables prior to scFv 
expression and details of the ‘response’. This requirement was met on two levels. Firstly, the SCFV 
genes were cloned into P. pastoris under the control of an inducible promoter allowing specific 
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analysis of the effects of protein production. Secondly, a growth and sampling protocol was devised 
to produce the most accurate estimate of the baseline state. 
 
4.2 Results 
 
4.2.1 Construct descriptions  
 
Each scFv is comprised of a heavy chain variable region joined to a light chain variable region by a 
flexible Gly4Ser3 amino acid linker. Both were cloned into the pPICZαA plasmid, a commercial 
construct available from Invitrogen for the expression and secretion of proteins from P. pastoris 
(Figure 28). Expression is controlled by the AOX1 promoter, which is both strongly and specifically 
induced by methanol as the sole carbon source in the media. An N-terminal alpha mating factor 
signal sequence, derived from Saccharomyces cerevisiae, directs extracellular secretion of the 
protein. Following the SCFV gene, C-terminal polyhistidine and Myc tags are encoded to enable 
protein purification and detection, respectively. Finally, the Sh ble gene allows selection of both 
bacterial and yeast transformants on the antibiotic zeocin. 
 
 
 
Figure 28 – pPICZαA expression construct with the SCFV gene 
BC1 and MFE23 genes were inserted into the P. pastoris expression vector pPICZαA according to the 
schematic. Expression was controlled by the AOX1 promoter. The alpha factor signal sequence, from S. 
cerevisiae, directed the protein to the secretion pathway while the Sh ble gene provided resistance to the 
antibiotic zeocin for transformant selection. Finally, the Myc and His tags allowed purification and detection of 
the scFv, respectively. Size: pPICZαA[BC1]: 4.346 kB; pPICZαA[MFE23]: 4.270 kB. 
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4.2.2 Cloning the single-chain antibody fragments into E. coli JM109 
 
BC1 
Primers BC1_F and BC1_R were designed to amplify the BC1 gene from the plasmid pUC119-BC1 
(Mahendra Deonarain, Imperial College London) allowing insertion into the P. pastoris pPICZαA 
expression vector to generate the pPICZαA[BC1] construct. The primers contained the restriction 
sites EcoRI and XbaI for ligation into the pPICZαA vector. TSS competent E. coli JM109 cells were 
transformed with the ligation reaction and selected using zeocin resistance. Colony PCR verified the 
presence of the construct using primers α_F and AOX_F. Sequencing further confirmed correct 
integration of the BC1 gene (Appendix III). 
 
MFE23 
Similarly, primers MFE23_F and MFE23_R were designed to amplify the MFE23 gene from the 
plasmid pcDNA4a-MFE23 (Mahendra Deonarain, Imperial College London) allowing insertion into 
the P. pastoris pPICZαA expression vector to generate the pPICZαA[MFE23] construct. The primers 
contained the restriction sites EcoRI and XbaI for ligation into the pPICZαA vector. TSS competent E. 
coli JM109 cells were transformed with the ligation reaction and selected using zeocin resistance. 
Colony PCR verified the presence of the construct using primers α_F and AOX_F. Sequencing further 
confirmed correct integration of the MFE23 gene (Appendix III). 
 
4.2.3 Transforming P. pastoris GS115 with pPICZαA[BC1/MFE23] 
 
The constructs pPICZαA[BC1] and pPICZαA[MFE23] were linearised with the restriction enzyme MssI, 
which cuts within the AOX1 promoter allowing homologous recombination into the AOX1 locus of 
the yeast genome. A single colony of P. pastoris GS115 was grown to an OD600 of 1.3, prepared for 
electroporation and transformed with the linearised plasmid. The cells were recovered for two hours 
and selected on YPD plates containing 100 μg mL-1 zeocin yielding the strains GS115[BC1] and 
GS115[MFE23]. PCR analysis of colonies confirmed those which had integrated the recombinant 
gene construct. 
 
4.2.4 Dot blot analysis of secretion to select high and low secretors of each scFv 
 
Following the generation of strains, a high and a low secretor of each scFv was identified. Various 
options are available for product quantification, including: densitometry on SDS-PAGE gels or 
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Western blots, enzyme-linked immunosorbent assay (ELISA), protein microarrays and protein dot 
blots. Both ELISAs and protein microarrays require a considerable investment of time and money, 
while densitometry and protein dot blots do not. The results obtained are semi-quantitative, but the 
protocols benefit from speed. Indeed, protein dot blots allow the visualisation of protein 
concentration from up to 96 samples in one assay – giving it an advantage over SDS-PAGE based 
techniques. For the purposes of this study, a dot blot experiment was conducted to analyse scFv 
secretion from clones from a single transformation. This approach allowed the processing of a large 
number of raw samples providing a high-throughput and specific analysis of productivity in a 
relatively short time. 
 
Thirty transformants, confirmed by colony PCR, were grown to an OD600 of 7.0 and induced with 
methanol for 72 hours. The supernatant was filtered, processed through the dot-blot apparatus, 
probed with anti-Myc antibody and developed. 
 
The protocol was initially validated by analysing three technical replicates, in which a subset of the 
samples was processed before all sixty strains were screened (Figure 29).  
 
 
Figure 29 – Dot blot analysis of GS115[BC1] and GS115[MFE23] transformant expression  
[A to C]: Validation of technique: one biological replicate with three technical repeats. L. to R. Negative control 
WT GS115, then GS115[BC1] 1 to 15. [D] Screening transformants: one biological replicate. L. to R. Negative 
control WT GS115, then GS115[BC1] 16 to 30; [E] L. to R. Negative control WT GS115, then GS115[MFE23] 1 to 
15; [F] L. to R. Negative control WT GS115, then GS115[MFE23] 16 to 30. [D to F] Each blot shows one 
biological replicate. Arrows indicate clones chosen for the study; specifically GS115[BC1] 8 (designated 
GS115[BC1]H), GS115[BC1] 13 (designated GS115[BC1]L), GS115[MFE23] 2 (designated GS115[MFE23]L) and 
GS115[MFE23] 6 (designated GS115[MFE23]H).  
 
In the light of the previous discussion of heterogeneity, there were clear variations in productivity 
between clones from the same transformation (internally referenced). The difference between 
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clones suggested a problem with the stability of the heterologous gene. As vectors are integrated 
into the host chromosome, however, they should be stable; despite this to increase the likelihood of 
retention expressions employed the standard antibiotic selection concentration. Confirmation would 
require colony PCR of the final culture. 
 
Selection of a high and a low secreting clone after 72 hours of induction should help identify those 
which exhibit stable phenotypic differences. Those selected for further characterisation were 
GS115[BC1]H, GS115[BC1]L, GS115[MFE23]H and GS115[MFE23]L.  
 
4.2.5 Southern blot analysis to ascertain gene copy number 
 
For such differences in productivity to reflect clonal variation, the genetic composition of the strains 
should be identical. Specifically, while it is a rare occurrence under normal conditions it is possible 
for more than one heterologous gene expression cassette to integrate into the host chromosome. 
Multicopy strains have been shown to have higher specific productivities; if this were the case the 
analysis would not be targeted at the inherent increased capacity of the cell but at an exogenous 
influence. To this end, the strains identified by dot blot selection were analysed for copy number. A 
variety of methods are available for such analysis, based on blotting and various PCR techniques. For 
this study, Southern blot analysis has been used as it is simple and effective; all PCR methods require 
a single copy reference identified by Southern blot in any case. 
 
The genomic DNA of GS115[BC1]H and L, and GS115[MFE23]H and L strains was digested with 
restriction enzymes which cut the yeast host chromosome either side of the scFv sequence; 
specifically NdeI and PshAI for the former and NdeI and KpnI for the latter. The digests were 
resolved on 0.8% TAE agarose gel, the DNA transferred to a nitrocellulose membrane, probed with 
the appropriate DIG-labelled SCFV gene and developed (Figure 30). 
 
The results showed that each of the GS115[BC1] strains contained a single copy of the gene; 
producing bands approximate to the expected mass of 6.5 kB (from the in silico digest). Similarly, 
each of the GS115[MFE23] strains contained a single copy of the gene; producing bands in 
accordance with the 6.6 kB predicted from the in silico digest. For comparison, a digest of a 
transformant harbouring two copies of the expression cassette should produce bands with an 
approximate mass of 10.8 kB. This was not an unusual result; the generation of multicopy strains in 
vivo is difficult and generally requires the screening of thousands of colonies on a much higher 
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concentration of antibiotic to identify just one [118].  
 
In the light of the dot blot selection results there was a clear argument that the high and low 
secreting strains of each scFv are showing clonal variation.  
 
 
 
Figure 30 – Southern blot to analyse SCFV copy number in high and low secreting strains  
Genomic DNA of GS115[BC1]H and L, and GS115[MFE23]H and L strains. [A]: L. to R. Negative control WT 
GS115, GS115[BC1]H and GS115[BC1]L. [B]: L. to R. Negative control WT GS115, GS115[MFE23]L and 
GS115[MFE23]H. Expected approximate mass of a single copy integrant: 6.5 kB; expected approximate mass of 
a two copy integrant: 10.8 kB. Due to the lack of a labelled ladder, bands were sized according to the following 
procedure. Digested DNA was analysed by gel electrophoresis and imaged concomitant with a UV gel ruler. A 
blot was cut to the exact size of the gel, and DNA transferred. Again, the developed blot was imaged with the 
UV ruler to allow an estimation of the DNA length. 
 
4.2.6 Evaluating the secreted scFvs for N-linked glycosylation 
 
Although an in silico prediction of N-glycosylation sites suggested there were none in either of the 
scFv proteins, the lack of glycosylation in the P. pastoris expression system needed experimental 
confirmation to validate the assumption made in the model. Indeed, initial expression analysis of the 
two high secreting clones revealed product bands at a higher molecular weight than that predicted 
and, in particular, MFE23 produced a less defined band which could be associated with inconsistent 
glycosylation (Figure 31). Therefore, experiments were conducted to analyse the carbohydrate 
content of the secreted proteins.  
 
There are a number of methods to directly detect N-linked glycosylation, partly based on the variety 
of glycosylation structures that can be derived. The majority utilise staining or affinity based 
detection; the former including the periodic acid-Schiff reaction and the latter including general 
saccharide binding proteins, enzymes and antibodies [252]. Moreover, glycosylation can be indirectly 
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detected through the use of deglycosylating enzymes which remove the sugars producing a shift in 
migration on SDS-PAGE gels. The bulk of studies employing the latter method use peptide N-
glycosidase F (PNGase F), as it is the most efficient enzyme for this purpose, and that was the 
approach taken here [252]. Removal of sugars should reduce the molecular mass of the protein, which 
can be detected through increased migration on an SDS-PAGE gel.  
 
 
 
Figure 31 – ScFv secretion from GS115[BC1]H and GS115[MFE23]H 
Cultures were induced with methanol at zero hours, and subsequently at 24 and 48 hours, to produce the scFv 
protein. The supernatant was analysed by 12% SDS-PAGE for the presence of the product at 0, 24, 48 and 72 
hours. The predicted size of BC1 and MFE23 are 29 kDa. 
 
The two high secreting strains, GS115[BC1]H and GS115[MFE23]H, were grown overnight in BMGY. 
The cultures were diluted to an OD600 of 1 and returned to incubate for 24 hours, after which scFv 
production was induced by changing the media to BMMY. Following a further 24 hour incubation, 
the supernatant was isolated, filtered, dialysed and the scFv affinity purified. After dialysis, the pure 
scFv was subject to PNGase F digestion and the reaction products analysed by 12% SDS-PAGE (Figure 
32).  
 
Subjecting either of the pure scFv to PNGase F digestion did not, however, appear to reduce their 
masses or produce more clearly defined bands. This suggests that, in accordance with the in silico 
analysis of their sequences, the scFv do not undergo N-linked glycosylation when expressed in P. 
pastoris. Variation in their mass from the predicted value or the presence of multiple bands could be 
due to inefficient cleavage of the alpha factor signal sequence which has been shown to occur on 
scFvs expressed in P. pastoris [254]. The predicted weight of the alpha factor signal sequence is 4 kDa, 
which would bring the whole protein to around 33 kDa – in accordance with that observed in SDS-
PAGE migration. Moreover, Figure 32 shows a faint band below each major band which would be 
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much closer to the predicted weight of the scFv, and could be attributed to the cleaved product. N-
terminal amino acid sequencing of the product would be required to prove this. 
 
 
 
Figure 32 – PNGase F digestion of BC1 and MFE23 
[A] Pre- and post-digestion samples of pure scFv from the two high secreting strains, GS115[BC1]H and 
GS115[MFE23]H, and the positive control fetuin analysed by 12% SDS-PAGE. The predicted weight of BC1 and 
MFE23, following full cleavage of the alpha mating factor signal sequence, is 29 kDa. According to product 
information, the predicted weight of fetuin is 48 kDa. [B] Confirmation of the positive control (Nguyen & 
Strong, 2007).  
 
4.2.7 Developing a growth protocol to meet requirements 
 
In addition to generating an experimental system and verifying important assumptions, an 
appropriate protocol was essential to gather data that could be fed back into the model. Specifically, 
baseline and response values for gene expression of crucial state variables were required.  
 
With current technology, the analysis of gene expression is a trade-off between the number of 
targets, the quality of the data and the cost. While microarrays can provide information on a much 
larger number of genes it is costly, has a smaller dynamic range and lacks the quantitative detail of 
RT Q-PCR [255]. An improved technology, RNA sequencing (RNAseq) can provide more quantitative 
data on the whole transcriptome with a greater dynamic range, and does not suffer from the 
constraint of existing genome knowledge. It is, however, a great deal more expensive and typically 
allows analysis of only a few samples. Both microarrays and RNAseq also require high quality RNA. 
Consequently, RT Q-PCR is the method of choice when relatively detailed quantification of the 
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expression level of a small number of genes across a range of times and conditions is required [256]. 
Therefore this was the strategy applied here. 
 
RT Q-PCR requires an internal reference gene in order to account for any differences in loading 
between samples and efficiencies of amplification. Any changes observed in the target genes are 
compared to what is seen in the reference gene. Ideally, their transcript levels should be invariable 
between samples and treatments, in order to maximise detection of changes in the target [256]. The 
majority of studies use housekeeping genes for this purpose; here β-actin (ACT1) has been analysed 
as this has been commonly used in related studies [156,189]. 
 
Initial experiments focused on characterising ACT1 between samples and treatments according to 
the recommended expression protocol from Invitrogen. Specifically, a single colony was inoculated 
into a baffled flask, grown for 16 to 18 hours to reach the exponential phase and then the cells were 
resuspended cells to an OD600 of 1 in induction medium. Expression continued for up to 96 hours, 
with induction supplemented every 24 hours [257]. The justification for this approach was that 
analysis of the ‘baseline’ in an exponential culture would remove the possibility that stress induced 
by growth limitations would be erroneously incorporated into the analysis.  
 
 
Figure 33 – Culture profiles of P. pastoris GS115 and the scFv strains grown on BMGY 
P. pastoris strains GS115, GS115[BC1]H and L, and GS115[MFE23]H and L were cultured overnight, diluted to 
an OD600 of 1 in fresh BMGY and cell density was tracked over ten subsequent hours. Results were Log10 
transformed and fitted with a linear regression. The R
2
 values for GS115, GS115[BC1]H, GS115[BC1]L, 
GS115[MFE23]H and GS115[MFE23]L were 0.9857, 0.9878, 0.9901, 0.9756 and 0.9819 respectively. 
Experiments were conducted in biological triplicate, the data presented is the average and error bars 
represent standard deviation.  
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The strains GS115, GS115[BC1] H and L, and GS115[MFE23] H and L were inoculated into BMGY, 
grown for 16 hours and subsequently diluted to an OD600 of 1 in fresh BMGY. Growth curve analysis 
was conducted in order to ascertain whether the cultures were in log phase (Figure 33). 
 
Based on these results the experiment was repeated, and RNA samples for the baseline were taken 
at five and a half hours – during exponential phase. The media in the cultures was replaced with 
BMMY and cells incubated for a further 24 hours, at which point further RNA samples were taken for 
the response. Following extraction, the RNA integrity was confirmed and the samples converted to 
cDNA. Finally, RT Q-PCR was used to analyse differences in the transcript levels of ACT1 before and 
after recombinant protein induction. These preliminary results highlighted a problem with the 
experimental setup: the expression of ACT1 decreased following BMMY induction, revealed by a 
significantly increased Ct value (Figure 34). Indeed, the pre-induction samples had Ct values between 
4.6 and 9.1 lower than the post-induction samples. In accordance with the Pfaffl method to calculate 
fold changes, such differences suggest pre-induction samples have up to 324-fold more ACT1 
transcripts.  
 
 
Figure 34 – Change in ACT1 expression before and after scFv induction 
Transcript levels of the ACT1 gene were analysed with RT Q-PCR. Data shows the average of two biological 
replicates, with error bars representing the standard error. Two-sample one tailed t tests were conducted to 
determine whether the C(t) value significantly increased on BMMY; indicate p value < 0.05. 
 
Therefore, the proposed method of analysing the baseline value of target transcripts from cells in 
the exponential phase of growth required amending, as the change in ACT1 would prevent an 
accurate analysis of the response value. As the problem lay in the ACT1 down-regulation between 
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the actively dividing cells in BMGY and the more quiescent cells in BMMY, the next step was to 
deviate from the standard protocol and analyse the change in ACT1 when stationary phase cells 
were transferred from BMGY to BMMY. The requirement for an accurate internal reference was 
prioritised over the possibility of inadvertently incorporating stress caused by growth limitations. 
Furthermore, results from the initial model suggested a time course of the immediate response was 
required. Accordingly, sampling was extended both prior to and after induction.  
 
To test the new protocol, the strain GS115[BC1]H was inoculated into BMGY, grown for 16 hours and 
subsequently diluted to an OD600 of 1 in fresh BMGY. Cultures were incubated for 24 hours, with cell 
density analysed at 22 and 23 hours. After such time the cells were washed with buffer to remove all 
traces of glycerol and the carbon source was replaced with methanol. Cell density was monitored 
over the course of six hours, at two-hour intervals (Figure 35).  
 
The growth profile suggested that the cells had entered a quiescent phase on glycerol; the drop 
observed at zero hours can be attributed to cell loss during the two liquid changes and the difficulty 
in resuspending to precisely the same culture volume. Following the change in carbon source, the 
cell density marginally increased but did not achieve the exponential growth seen in the BMGY 
cultures. If ACT1 levels are related to growth rate, this experimental setup should provide a more 
consistent ACT1 expression level. It was, however, considered prudent to concomitantly analyse a 
second internal reference. A recent study investigating a set of reference genes for S. cerevisiae 
found the transcript level of the SGA1 gene to be independent of carbon source [258]. The gene, 
encoding a vacuolar amylo-1,4 -1,6 glucosidase, is a sporulation-specific glucoamylase involved in 
glycogen degradation [259]. As it is induced under conditions not employed in this study (amino acid 
starvation of diploids, late in sporulation) it was considered to be a good choice for an internal 
control for this study.  
 
RNA was extracted from the samples, subject to quality control measures, converted to cDNA and 
analysed for ACT1 and SGA1 transcript levels (Figure 36). 
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Figure 35 – Culture profile of P. pastoris GS115[BC1]H 
P. pastoris strain GS115[BC1]H was grown overnight in BMGY, diluted in fresh BMGY and incubated for 24 
hours. At that time the cells were harvested, washed in 0.1 M potassium phosphate buffer (pH 6) and 
resuspended in BMMY. Samples were taken at two hours and one hour prior to induction, at induction and 
then subsequently at two, four and six hours. Experiments were conducted in biological triplicate; error bars 
represent the standard error from the average.  
 
 
Figure 36 – Expression of two internal controls, ACT1 and SGA1, before and after scFv induction 
The strain GS115[BC1]H was inoculated into BMGY and grown for 16 hours. Subsequently, it was diluted to an 
OD600 of 1 in BMGY and returned to incubate for 24 hours. RNA samples were taken at 22 and 23 hours. At 24 
hours the culture was washed in 100 mM potassium phosphate buffer, pH 6, and resuspended in BMMY. The 
culture was returned to incubate, with samples taken at 0, 2, 4 and 6 hours. RNA was extracted, subject to 
quality control and converted to cDNA. Transcript levels of the ACT1 and SGA1 genes were analysed by RT Q-
PCR. The data bars show an average of two biological repeats, with error bars representing the standard error. 
ANOVA tests were used to infer significant differences between the Ct values at 0, 2, 4 and 6 hours for ACT1 
and SGA1; significant results are indicated with asterisks (p value < 0.05). 
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In the first instance, the transcript levels of ACT1 at -2, -1 and 0 hours were similar, agreeing with the 
theory that variations in ACT1 expression correlate with growth rate. As it is more stable, this should 
allow a better evaluation of the ‘baseline’ value for target genes. During induction, however, the 
increased cell density measurements was reflected in an increase in the ACT1 transcript level after 
zero hours (as the Ct value decreased). Echoing the start of a plateau observed in cell density 
between four and six hours, the ACT1 transcript levels start to return to the degree seen prior to 
changing the carbon source. An ANOVA test revealed the Ct values post-induction were significantly 
different (F (3, 4) = 5.356, p = 0.069). 
 
Similarly, an ANOVA test revealed the Ct values for SGA1 after induction were significantly different 
(F (3, 4) = 5.079, p = 0.075). Although the previous study validating SGA1 as an internal control 
suggested expression was independent of carbon source, the analysis did not consider the same 
culture subjected to a change in carbon source [258] , therefore this data is not necessarily 
contradictory.  
 
While using SGA1 as an internal control is subject to inaccuracy, it was still selected over ACT1 for 
this study, as the decrease in Ct value at zero hours was 3.16 cycles compared to 5.49 and time 
limitations prevented the analysis of further internal controls.  
 
4.3 Discussion 
 
The model outlined in the previous chapter required an experimental system to gather data for both 
development and validation. This system had to incorporate the variation in factors that determine 
cellular capacity for productivity and have the potential to produce data that could be meaningfully 
integrated into the model. 
 
In light of the first requirement, high and low secretors of each scFv were identified using a dot blot 
experiment, such that the inherent biological variability of any parameters measured could be 
incorporated into the model. The model assumes that strains for comparison contain identical 
numbers of copies of the gene under study, integrated into the host chromosome so that any 
variation in productivity reflects the capacity of the cell line and not copy number. Therefore the 
previously selected high and low secreting strains were subject to Southern blot analysis – and 
shown to have single copies of the SCFV gene integrated.  
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The model assumed that no glycosylation reactions occur and, while an in silico prediction of N-
glycosylation sites suggested this would be the case, initial expression analysis raised concerns. A 
PNGaseF digestion of purified scFv failed to demonstrate glycosylation suggesting that the proteins 
were suitable templates for the model. This did, however, neglect O-linked glycosylation; further 
studies could consider expression of the scFvs in the presence of an O-glycosylation inhibitor for 
comparison [260]. 
 
Finally, a growth and sampling protocol was devised that would allow observations which could be 
integrated into the model. In particular, data was required for both ‘baseline’ and ‘induction’ phases. 
This proved particularly tricky in respect of the RT Q-PCR measurements, as an internal control was 
needed which displayed minimal variation over the culture time course and carbon source change. 
Initial experiments showed that both the conventional protocol and internal reference, ACT1, for 
growth and RT Q-PCR respectively were not suitable for this particular study. Instead, a new growth 
protocol with a different internal reference – one which has not been used before in this organism – 
was developed. Statistical analysis showed that the new internal standard was not significantly 
better than ACT1, however, time constraints prevented analysis of further internal controls. As SGA1 
showed smaller changes in Ct value following the carbon change, it was selected for this research.  
 
The accuracy of RT Q-PCR results depends on an appropriate and stable internal reference gene, 
and, despite the almost ubiquitous use of ACT1 as the literature standard, there can be no singular 
gene whose expression is consistent for all experimental conditions [261]. Indeed, following this work 
a study was published which also found marked changes in actin expression and consequently did 
not normalise RT Q-PCR data for recombinant transcript expression  [262]. Therefore, studies should 
normalise RT Q-PCR data to multiple internal controls: in respect of this, more studies should analyse 
new internal controls such as SGA1 to provide a greater number of reference genes to select from. 
The approach presented here would be improved by emulating the strategy taken by Li et al. where 
the expression stability of 16 reference genes under different experimental treatments was analysed 
[263]. They used statistical algorithm packages, including geNorm [264], BestKeeper [265] and NormFinder 
[266] to stringently select appropriate references before characterising mRNA expression levels.  
 
These initial results suggested that the high and low secreting strains of each scFv could be further 
characterised with the intention of developing the model. 
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5. Development of an LC-MS/MS method to 
quantify Kar2 and PDI 
5.1 Introduction 
 
The UPR is a stress pathway, the immediate response of which is the transcription of target genes 
mediated by Hac1. Consequently, the majority of studies focus on this, using RT-QPCR [100,189,220], DNA 
microarrays [28,72,96,97,267] and more recently RNA sequencing [268] to provide an indication as to the 
activity of the pathway. As the protein is the effecter in the system, however, it would be interesting 
to confirm the mRNA dynamics of Kar2 and PDI are reflected post-transcriptionally. Additionally, the 
modelling results confirmed the importance of the concentration of Kar2 in predicting yield; 
therefore, this research aimed at quantifying the protein before and after induction.  
 
Various methods of quantification were available, including: immunogenic based detection (for 
instance Western blots with densitometry and enzyme-linked immunosorbent assay (ELISA)), 
fluorescent tagging and mass spectrometry. Here, the latter approach was taken as the facilities for 
liquid chromatography mass spectrometry (LC-MS) were available and the technique benefits from 
quantitative accuracy and sample processing speed. Although antibodies directed against Kar2 and 
PDI are commercially available for Saccharomyces cerevisiae, the predicted homology between the 
two was not sufficient to guarantee the approach would work [269], and LC-MS technique has greater 
quantitative accuracy. 
 
5.1.1 Liquid chromatography-mass spectrometry 
 
The first step of LC-MS is to digest the protein sample into peptides; a variety of enzymes are used 
for this process, however trypsin is the most popular [270]. Following cleavage, the protein sample is 
separated with HPLC. Each peak identified in the chromatogram is concomitantly analysed by mass 
spectrometry. In targeted proteomics, multiple reaction monitoring (MRM) is often used based on 
its sensitivity, specificity, throughput and capacity for multiplexing [271,272]. This requires prior 
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information about the proteins: in particular, signature peptides, unique to the target protein, are 
identified as surrogates for the protein of interest. This information is used to derive the MRM 
method, as follows. In MS/MS, a triple quadrupole mass spectrometer is required as there are two 
mass spectrometry filtering stages (Figure 37). Initially, the peptides are ionised and subjected to the 
first step: the signature peptides are extracted based on the mass-to-charge ratio. These peptides 
are processed to the second phase of mass spectrometry: the peptides are fragmented into 
daughter ions and the intensity of these measured to produce an extraction ion chromatogram. The 
pair of a precursor peptide and the daughter ion is termed a ‘transition’. 
 
 
 
 
Figure 37 – Overview of absolute quantification with MRM and LC-MS/MS 
In the first instance, the sample is spiked with a labelled standard at a known concentration and tryptically 
digested to produce peptides. These are separated by HPLC, and the peaks analysed by MS/MS. The peptides 
are ionised, and the specific mass-to-charge ratio of signature peptides selected by the first quadrupole. In the 
second, the signature peptides are fragmented in transition, or daughter, ions. These are measured in the final 
quadrupole to produce an extracted ion chromatogram.  
 
The use of MRM allows the detection of multiple transitions for each signature peptides precursor 
simultaneously. The a priori knowledge of the target protein allows the MRM method to be devised 
specifically to select the target peptide in the first mass spectrometry step based on the mass-to-
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charge ratio. Indeed, the sensitivity of the technique depends on the optimisation of the signal, 
based primarily on the collision energy (CE) and collision exit potential (CXP) employed during 
fragmentation, as the over- or under-fragmentation reduces the signal received by the detector and 
subsequently effects quantitation. While equations exist to predict the energy required, these are 
experimentally optimised in the development of an MRM method [271].  
 
For accurate quantification, mass spectrometry requires the use of internal standards: peptides that 
are spiked into the reaction at a known concentration. These ideally incorporate stable, heavy 
isotopes (such as 13C, 15N, 18O) in amino acids and therefore have an increased mass-to-charge ratio 
allowing differentiation from their native counterparts [272]. The peak area produced by these 
standards is compared to that of the native peptide, and the ratio used to calculate the 
concentration of the native protein. 
 
5.2 Results 
 
5.2.1 Transforming pET28a[KAR2] and pET28a[PDI] into E. coli BL21 (DE3) ΔArgA ΔLysA 
 
As final quantification relied on the peptide, and not the protein, internal standards could be either 
the whole protein or the peptide fragment. The former is generally considered to be a more 
accurate method [273], as any inefficiency in the tryptic digest would affect the protein standard to 
the same extent as the native protein, and consequently account for it.  
 
Such protein standards were generated using stable isotope labelling by amino acids in cell culture 
(SILAC). In essence, SILAC required the incorporation of isotopically labelled arginine and lysine into 
the proteins during recombinant expression in E. coli. These proteins were then purified and the 
concentration determined. Therefore, pET28a[Kar2] and pET28a[PDI] (Karen Polizzi, Imperial College 
London) were transformed into TSS competent E. coli BL21 DE3 ΔArgA ΔLysA (Ron Hay, University of 
Dundee) and selected using kanamycin resistance. Colony PCR confirmed the presence of 
recombinant plasmids. 
 
5.2.2 Optimising expression from auxotrophic strains 
 
In order to achieve the highest yield of protein, a range of induction conditions were studied to 
identify the best combination of IPTG concentration and culture temperature. Consequently the two 
- DEVELOPMENT OF AN LC-MS/MS METHOD TO QUANTIFY KAR2 AND PDI - 
 
- 140 - 
auxotrophic strains were expressed in minimal media under nine conditions; specifically, with 0.125 
mM, 0.5 mM and 1 mM IPTG at 25, 30 and 37°C (Figure 38). 
 
 
Figure 38 – Optimisation of expression conditions for [A] Kar2 and [B] PDI  
E. coli BL21 DE3 ΔArgA ΔLysA strains containing pET28a[KAR2] and pET28a[PDI] were induced under nine 
conditions and the presence of the recombinant protein in the soluble fraction analysed by 12% SDS-PAGE. All 
gels show a pre-induction sample (Pre) and then the three IPTG concentrations for each temperature 
condition. Asterisks indicate optimal conditions selected. Kar2: 78 kDa, PDI: 58 kDa  
 
A consistently low level of Kar2 was observed under all conditions, suggesting that the protein was 
difficult to express in the soluble fraction of E. coli. Contrastingly, much higher yields of PDI were 
gained when induced at 37°C – invariant of IPTG concentration. A repeat expression was conducted 
employing the optimal conditions (0.5 mM IPTG and 30°C for Kar2, and 0.125 mM IPTG and 37°C for 
PDI) and the soluble and insoluble fractions concomitantly analysed (Figure 39). Results showed 
comparable levels of recombinant protein in the soluble and insoluble fractions. The expense of a 
labelled expression justified the recovery of recombinant protein from the insoluble fraction, as the 
structure and function of the proteins were dispensable for mass spectrometry analysis.  
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Figure 39 – Kar2 and PDI expression in the soluble and insoluble fractions 
E. coli BL21 DE3 ΔArgA ΔLysA strains containing pET28a[KAR2] and pET28a[PDI] were induced under optimal 
conditions and the presence of the recombinant protein in both the soluble and insoluble fractions analysed by 
12% SDS-PAGE. Each gel shows the pre-induction sample (Pre), the soluble fraction (Sol) and two sequential 
digests with urea (U1 and U2). Kar2: 78 kDa, PDI: 58 kDa 
 
5.2.3 Small scale purification 
 
As the internal standard required pure protein, Kar2 and PDI were isolated from the cell lysate 
following expression. Initially, small scale purification was conducted with Talon® metal affinity resin 
and 5 mL polypropylene columns (Figure 40). 
 
 
Figure 40 – Kar2 and PDI purification 
The recombinant Kar2 [A] and PDI [B] from E. coli BL21 DE3 ΔArgA ΔLysA strains were affinity purified 
employing the N-terminal his tag. Each gel shows [1]: cell lysate diluted in equilibrium/wash buffer; [2]: flow 
through following binding; [3 to 6]: column washes; [7 & 8]: two sequential eluates. Kar2: 78 kDa, PDI: 58 kDa 
 
The pure protein was subject to tryptic digestion and the signature peptides were identified with LC-
MS/MS. Following success of the optimised protocol, the expression was repeated with the 
isotopically labelled amino acids and a small aliquot of target protein was purified. Mass 
spectrometry analysis of the peptides alone showed full incorporation of the labelled amino acids, a 
benefit of using an auxotrophic production strain. The standards were also analysed when spiked 
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into a P. pastoris cell lysate, where peptide responses were quite altered compared to the pure 
protein digest. Some of the peptides which had previously produced strong responses from pure 
protein were muted when examined in the yeast cell lysate. Results allowed both empirical selection 
of three signature peptides for Kar2 and two for PDI from the candidates identified in silico, and the 
optimisation of the CE and CXP of the MRM method (Table 8).  
 
5.2.4 Expression with labels and large scale purification 
 
The initial studies allowed production of material for the development of the MRM method, 
however, a larger scale purification method was required to provide enough material for 
experimental analysis. Fast protein liquid chromatography (FPLC) was used to scale up yields of pure 
protein from the soluble and insoluble fractions of cell lysate; chromatograms (data not shown) 
directed analysis of elution fractions (Figure 41). 
 
 
Figure 41 – Analysis of FPLC purification of [A] Kar2 and [B] PDI 
Recombinant protein from E. coli BL21 DE3 ΔArgA, ΔLysA with pET28a[KAR2] and pET28a[PDI] was purified 
with FPLC and analysed by 12% SDS-PAGE. Each purification shows the flow through following binding (PB), 
two washes with increasing imidazole (W1 and W2) and 15 sequential eluates (E3 to E17) with increasing 
concentrations of imidazole. Kar2 and PDI were purified from the insoluble and soluble fractions, respectively. 
Kar2: 78 kDa, PDI: 58 kDa. 
 
SDS-PAGE analysis of the FPLC samples revealed a complication with larger scale purification: the 
target proteins have a long elution profile and co-elute with many contaminating proteins. Indeed, 
Kar2 can be detected in elution fractions E5 to E17, and PDI can be detected in all elution fractions 
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analysed. The success of the small scale purification implied that the purity problems may have 
arisen as a result of the higher concentration and pressure of the FPLC protocol. Considering the role 
of both proteins is to bind a broad spectrum of other proteins, the next step was to discover 
whether the target and contaminating proteins were co-eluting as complexes. Therefore, eluates 
were analysed in non-denaturing conditions to preserve the interactions between any proteins in 
complex (Figure 42). 
 
 
Figure 42 – Non-denaturing analysis of [A] Kar2 and [B] PDI elution fractions 
Elution fractions from the FPLC protocol were analysed with 10% Native-PAGE. For each target protein, 
sequential eluates E3 to E17 were analysed. Kar2: 78 kDa, PDI: 58 kDa. 
 
The majority of the target protein, particularly for Kar2, was eluting as part of a very large complex. 
As the column was not binding impurities non-specifically, pooling the eluates and repeating the 
purification with more stringent imidazole washes could lead to simultaneous loss of the target 
protein. On the basis that the complexes dissociated during SDS-PAGE analysis, there was the 
potential for extracting the target protein by simulating these conditions.  
 
Initial attempts used a combination of chemical denaturants, including DTT, β-mercaptoethanol and 
SDS (and latterly, urea and sodium deoxycholate) together with size exclusion for the removal of 
contaminants. All concentrations of chemicals, however, which were compatible with subsequent 
size exclusion, tryptic digest and mass spectrometry, were either not strong enough to dissociate the 
complexes (Figure 43 [A]) or caused protein degradation (Figure 43 [B]).  
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Figure 43 – Chemical denaturants and heat do not dissociate, but can degrade, complexes 
Attempts were made to dissociate the complexes with: [A] 100 mM DTT and β-mercaptoethanol, incubated at 
room temperature for one hour; and [B] 0.1% SDS, incubated at 100°C for five minutes. The former had little 
to no effect, the latter degraded the protein.  
 
As the conditions employed during SDS-PAGE were strong enough to dissociate the complexes, it 
seemed logical to separate the complexes with SDS-PAGE and subsequently extract the protein from 
the correct band. Whole protein extraction methods can be separated into two categories: chemical 
and electro-elution. The former was initially attempted: SDS-PAGE analysis of the eluates was 
performed, and three different extraction solutions applied: 1:3:2 (v/v/v) formic acid, deionised 
water and 2-propanol [178], 1% SDS [179] and 0.1 M NaOH [180]. SDS-PAGE analysis of the extracted 
solution showed no visible target protein (data not shown). 
 
Finally, target protein was extracted from the gel slices using electroelution. Just as the analysis of 
chemical elution was initiated, SDS-PAGE analysis of the eluates was performed. Gel slices, 
containing the target protein, were placed in running buffer and the electric charge applied. The 
solution was then analysed for the presence of the target protein with SDS-PAGE (Figure 44).  
 
While successful to an extent, as all impurities were removed, the efficiency of the protocol is too 
low and varied to make it a valid method to produce mass spectrometry standards. Consequently, 
labelled peptides were commercially synthesised. Based on the preliminary analysis of standards in 
yeast lysate, three peptides were ordered for Kar2 and two for PDI. It is common for around five 
peptides per protein be taken through to validation stages [183], however, the cost of synthesising 
custom peptides prohibited this. Moreover, data from the preliminary analysis gave empirical weight 
to the peptide selection. At least one peptide per protein is suitable for developing a quantitative 
assay [183], which this should allow for.  
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Figure 44 – Analysis of PDI electroelution from polyacrylamide gels 
Elution fractions E8 and E9 were pooled, subject to electroelution and the results analysed by 12% SDS-PAGE. 
The gel shows the sample prior to extraction (Pre) and then five technical replicates (lanes labelled 1 to 5). 
Extracted PDI was visible in elutions 1:2 and 4:5, with varied amounts. PDI: 58 kDa. 
 
5.2.5 Absolute quantification with isotopically labelled synthetic peptides 
 
The synthetic peptides had a C-terminal tag, cleavable by tryptic digest, which released the native 
peptide. This helped incorporate the effect of tryptic digest efficiency; however, as it was not an 
intact protein control for tryptic efficiency, it was prudent to ascertain whether digest time had an 
effect on quantitation. Therefore, the concentration of native protein following three different 
digest times was determined. Three GS115 cell samples were lysed and pooled to provide the same 
background for analysis. For each, 30 μg of cellular protein was prepared for LC-MS/MS analysis, as 
per Section 2.9, with the exception of digest time: this was conducted for 6, 16 and 24 hours 
respectively. The average was then calculated, and the variation within, a consequence of different 
digestion efficiencies (Figure 45). 
 
Results showed more variation in PDI quantification than Kar2. Analysis of each transition over time 
revealed that, for PDI, the 16 hour incubation was greatly reduced compared to either 6 or 24 hours; 
a consequence of no native transitions for FIAGEAEPIVK and SEPIPEIQEEK being detected. As the 
internal standards had been identified, this result could not be attributed to an error in the 
chromatography. As it affected both standards, it could have been caused by problems with PDI in 
the sample preparation, and was therefore considered spurious. To both keep with the majority of 
literature studies, and for convenience, the tryptic digest time was therefore conducted for 16 
hours.  
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Figure 45 – The effect of digest time on quantitation of daughter ions 
Three GS115 cell samples were lysed, pooled to ensure the same background, split into 30 μg aliquots and 
processed for LC-MS/MS analysis. Each was subjected to a different digest time (6, 16 or 24 hours) in a single 
technical replicate. The concentration of the native protein indicated by each daughter ion (a, b, c and d) was 
then determined and averaged; error bars show standard error across the three digest times.  
 
The analysis also showed that YAAEDAALR greatly underestimated the concentration of Kar2, 
compared to VEILANDQGNR and IAYPITSK. This implied the response of the internal standard was 
satisfactory, but that the native peptide was not being detected. Similarly, there was a two-fold 
difference in quantification by the two PDI peptides. These results are not unusual for the 
development and validation of an MRM method; as mentioned previously, it is common for 
researchers to carry around five peptides per protein through to this stage to ensure at least one will 
be used to quantify [183]. The differences in response can be attributed to low tryptic digest 
efficiency, propensity for binding and recovery from the C18 resin, low solubility, poor 
chromatography and – particularly in the case of YAAEDAALR – PTMs on the native peptide, altering 
its behaviour and eluding detection. This could occur in two ways: either modification of arginine or 
lysine prevented tryptic digestion, or the modification changed the ionisation potential and 
fragmentation [274]. No PTMs of P. pastoris Kar2 have been reported, therefore, any reports of PTMs 
on the S. cerevisiae homolog were sought. An alignment of the two proteins showed that the P. 
pastoris peptide YAAEDAALR overlaps with the S. cerevisiae peptide FASEDASIK (Section 12.4). 
Although the two serine residues have been reported to undergo phosphorylation (BioGRID 
v.3.2.104 [275]), the respective alanine residues in the P. pastoris Kar2 cannot. Alternatively, it could 
be attributable to the C-terminal arginine residue, which can be methylated, dimethylated or 
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citrullinated (the conversion of arginine to citrulline) [274]. Such modifications can inhibit trypsin 
cleavage thereby preventing detection of the signature peptide. 
 
 
Figure 46 – Dose response analysis of internal standards 
Five GS115 cell samples were lysed, pooled, split into 30 μg aliquots and processed for LC-MS/MS analysis. 
Each was spiked with a different concentration of internal standard: 0.5 nM, 5 nM, 12.5 nM, 25 nM and 50 nM. 
The area of the internal standard peak was determined and plotted against concentration (data from a single 
technical replicate). Linear regression was conducted to verify the correlation; R
2
 values are presented next to 
each peptide transition. 
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A second consideration was the dose response behaviour of the peptides. Five GS115 cell samples 
were lysed, pooled and aliquoted into 30 μg samples. The samples were prepared for LC-MS/MS 
analysis with different concentrations of internal standard ranging from 0.5 to 50 nM (Figure 46). A 
strong linear correlation was observed over all concentrations tested, with R2 values between 0.9821 
and 0.9982, with the exception of SEPIPEIQEEK-d. As this transition showed a particularly low 
response, it was removed from the quantitative method.  
 
In addition to confirming the linearity of response, an appropriate concentration of internal standard 
was required which allowed reasonable quantification without wasting the custom synthesised 
peptides. Analysis of the stationary phase of GS115 suggested 12.5 nM to be reasonable (Figure 47). 
 
  
Figure 47 – Selecting an appropriate concentration of internal standard 
GS115 lysate, from -2 hours, was tryptically digested with 12.5 nM internal standard, purified and analysed by 
LC-MS/MS (data from a single technical replicate). For simplicity, only the first transition of each peptide has 
been shown. 
 
A further consideration of the method development was sample loss during purification. Therefore, 
loss during the binding step was analysed by taking the flow-through, processing it through a second 
purification column and analysing the results. The loss associated with recovery from the column 
resin was also analysed, by eluting the same column again (Figure 48). Although all peptides were 
eluting from the column with the standard procedure, there was a small loss of Kar2 peptides during 
sample binding. The could be attributed to maximum binding capacity of the columns, stated by the 
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manufacturers to be 30 μg, which is the concentration of cell protein employed in the digest. The 
most affected peptide was YAAEDAALR, however, as this had been previously shown to 
underestimate Kar2 concentration (Figure 45) and was excluded from the analysis, the effect was 
disregarded.  
 
 
Figure 48 – Analysis of peptide loss during C18 purification 
The loss of sample during the binding and elution step was analysed. A tryptic digest of GS115 was bound to 
the column, and the flow-through retained and the peptides eluted in the standard procedure (1
st
 extraction). 
The flow-through was processed with a new C18 column, and eluted in the standard procedure (2
nd
 
extraction). The first column was also subject to a second elution (2
nd
 elution). The profiles presented are 
derived from the internal standard (data from a single technical replicate). For simplicity, only the first 
transition for each peptide has been shown.  
 
Finally, quantifying and qualifying transition ions were selected. In the first instance, this required 
selection of the peptides and their respective transitions with the highest and most consistent 
response over different concentrations. Therefore, four samples with the lowest native peak area 
counts and four with the highest were identified and the response of each peptide and their 
transition analysed (Table 9).  
 
Besides YAAEDAALR, the two remaining signature peptides for Kar2 behaved similarly. As there was 
no clear consensus suggesting one peptide over another, it was deemed more accurate to average 
their results rather that select one. Contrastingly, FIAGEAEPIVK consistently gave lower values for 
the concentration of PDI, so SEPIPEIQEEK was used for quantification.  
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Table 9 – Heat map of Kar2 and PDI concentration detected by each of the transitions 
Four low (L1 to L4) and four high (H1 to H4) time points, producing the lowest and the highest native area peak 
counts respectively, were selected. A heat map for each strain was produced, showing transitions which 
detected the highest concentration (Kar2: green, PDI: blue) and those that detected the least (red).  
Protein Peptide Transition 
Concentration (nM) 
L1 L2 L3 L4 H1 H2 H3 H4 
Kar2 
IAY* 
a 8.0 13.5 13.0 9.7 12.8 13.4 9.3 13.1 
b 13.0 13.0 15.3 11.2 10.8 13.1 10.1 11.8 
c 22.0 15.6 22.5 9.0 10.6 15.4 8.1 10.9 
YAA* 
a 2.7 3.7 4.7 3.7 3.5 5.7 2.8 3.9 
b 2.5 3.9 6.0 3.3 3.0 5.4 2.7 3.8 
c 4.8 5.9 5.0 6.1 5.0 6.3 3.1 6.4 
VEI* 
a 10.9 11.4 23.4 9.0 13.2 14.7 9.2 11.6 
b 7.2 15.9 20.7 8.6 12.9 16.7 9.8 11.6 
d 7.7 8.4 24.9 7.7 11.4 13.2 8.1 11.5 
PDI 
FIA* 
a 9.3 15.7 11.2 8.0 98.9 67.5 40.3 69.9 
b 8.7 19.3 13.3 9.1 109.0 77.7 42.9 79.9 
d 10.4 18.7 11.7 10.4 107.9 82.4 43.4 84.4 
SEP* 
a 24.9 25.8 16.4 15.5 173.4 130.7 65.1 141.3 
b 20.4 21.7 18.3 15.8 170.9 131.5 66.2 140.8 
 
 
In addition to the amplitude, the signal-to-noise ratio of each transition was an important factor. 
This would be most critical when the native area peak counts were low; therefore, the time point at 
which this occurred was identified. Signal-to-noise ratios were calculated by integrating the 
background response and comparing it to the transition peak (Table 10).  
 
Results again displayed no consensus for Kar2: the native transitions with a high signal-to-noise ratio 
had a low ratio for the internal peptide, and vice-versa. Contrastingly, the ratios for PDI peptides 
strongly suggested the selection of the two ‘a’ transitions.  
 
Overall, the analysis indicated that quantification of Kar2 would be based on the response of six 
transitions from two signature peptides (VEILANDQGNR and IAYPITSK). On the other hand, removal 
of FIAGEAEPIVK due to amplitude only left PDI with a single peptide and one transition. The 
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consistent response and high signal-to-noise ratio of the ‘a’ transition from FIAGEAEPIVK (37.2% of 
SEPIPEIQEEK, S.D. 10.5%, n = 8), however, allowed it to act as a qualifying ion for PDI, improving the 
accuracy of the method. 
 
Table 10 – Heat map of signal-to-noise ratio of each of the transitions 
The signal-to-noise ratio for each of the peptides from the time point producing the lowest native area peak 
counts was calculated. A heat map was generated highlighting the best (green) and worst (white) transitions. 
Protein Peptide Transition 
Signal: Noise 
Native Internal Standard 
Kar2 
IAY 
a 7.5 17.5 
b 16.7 8.5 
c 6.6 3.5 
VEIL 
a 4.6 10 
b 5.5 22.4 
d 2.1 16.3 
PDI 
FIA 
a 12.3 24.5 
b 4.7 8.3 
d 6.9 7.7 
SEP 
a 12.6 11.4 
b 3.3 7.6 
 
5.3 Discussion 
 
To summarise, modelling simulations in Chapter 3 suggested that concentration of Kar2 was 
important when determining yield. The only value for its concentration in the literature is, however, 
from Saccharomyces cerevisiae – making this important aspect of the model potentially inaccurate. 
Additionally, studies in P. pastoris have traditionally analysed the activation of the UPR response by 
measuring transcript response, however, the effector in the system is the protein. Therefore, this 
research aimed to characterise the protein dynamics in addition to those observed with RT Q-PCR. 
To do this, an LC-MS/MS method was devised to quantify the absolute number of Kar2 molecules 
within the P. pastoris strains secreting scFvs that had been selected in Chapter 4. Although 
simulations artificially up-regulating PDI had no observable effect on yield, the frequency with which 
studies employ this strategy warranted its concurrent experimental characterisation. 
 
LC-MS/MS was selected as the antibodies specific to P. pastoris Kar2 and PDI were not available but 
mass spectrometry facilities were; moreover, the technique benefits from quantitative accuracy and 
sample processing speed. To optimise accuracy of the method, the generation of whole protein 
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standards was initially attempted. Although small scale studies were successful, and allowed the 
empirical selection of signature peptides and the optimisation of protocol parameters (such as the 
collision energy and collision cell exit potential), the scale up proved problematic. In particular, the 
target proteins eluted as large complexes during FPLC purification, the dissociation of which was 
possible with SDS-PAGE and electroelution but too inefficient for this application.  
 
The difficulty of purifying the human Kar2 homologue, BiP, was recently shown in a study analysing 
how it binds to various substrates, including Ire1 [276]. The authors employed two additional wash 
steps, one at a low pH and a one at a high pH, to dislodge bound proteins during his-tag purification. 
Future studies could attempt the isolation of Kar2 with such conditions.  
 
On the other hand, the full length protein did not express well in the E. coli BL21 strain, despite 
analysing a range of conditions. As the full length protein is the most optimal standard, a different 
expression host could be used: indeed, the generation of a strain of P. pastoris auxotrophic for 
arginine and lysine synthesis [277] would make this possible in the native host. Alternatively, the 
expression of Kar2 and PDI fragments could increase the yield and decrease the binding of host cell 
proteins during purification.  
 
In place of whole protein standards, the method was developed using isotopically labelled peptides. 
The linear range of response was determined, along with the effect of digest time and peptide loss 
during purification. Finally, the most accurate and consistent quantifying and qualifying ions were 
identified for quantification purposes. In addition to the experimental system generated in Chapter 
4, this method allowed the targeted empirical analysis as suggested by the modelling results of 
Chapter 3. 
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6. Targeted experimental characterisation 
of strains 
 
6.1 Introduction 
 
Chapters 4 and 5 provided the experimental system and tools for analysing aspects of the biology 
that had been incorporated into the model but were subject to uncertainty.  
 
In the first instance, doubts surrounded the SCFV transcript level. The steady state value, while in 
line with the estimate that pAOX1 produces 5% of the total mRNA, contradicted that which had been 
assumed by previous models [157]. As discussed, transcript levels are frequently cited as a 
determinant of yield – indeed, this is the justification for the use of strong promoters and multicopy 
strains – and have important ramifications on the productivity predicted by the model (Figure 23). 
Consequently, experiments were required to confirm this value. Moreover, while the level of 
transcription was important, so was the profile. Although the model assumed induction was 
constant, the experimental growth protocol does not maintain the concentration of methanol, 
therefore this could be incorrect. If induction did diminish, it was important to incorporate this into 
the model as it would feature prominently in the recovery from ER stress. Therefore, RT Q-PCR 
analysis of SCFV transcript levels was conducted. 
 
A second requirement was the baseline and UPR up-regulated values of Kar2 and PDI, as these 
proteins were crucial to setting the capacity of the system. Unfortunately, the concentrations of 
these proteins are only known for Saccharomyces cerevisiae and literature values vary over orders of 
magnitude [200,222,224,278]. Therefore, experiments were required to confirm these values for P. 
pastoris. There were two levels at which this analysis could have been conducted, targeting either 
mRNA transcripts or protein. Almost all studies investigating the activation of the UPR in P. pastoris 
do so by observing changes in the transcript level, either with Northern blot or RT Q-PCR analysis. 
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The effector, however, is the protein; as there is no clear correlation between transcript and protein 
levels [279] one cannot be reliably extrapolated from the other. Therefore this study complemented 
the traditional RT Q-PCR approach with an analysis of their respective proteins. This should allow an 
interesting insight into any post-transcriptional regulation of Kar2 and PDI. 
 
Finally, the ERAD response was crucial to the stress status of the system: if misfolded protein was 
not removed at a sufficient rate, it sequestered Kar2 and PDI. The scarcity of quantitative literature 
data relating to the process, and its role in determining productivity, justified its experimental 
characterisation.  
 
The analysis described above was undertaken for the high and low secreting strains of each scFv, 
which had been identified in Chapter 4. The dot blot analysis qualitatively showed clear differences 
in yield which could not be attributed to the number of heterologous gene copies integrated into the 
chromosome. Differences in yield may therefore be a result of variations in the key factors identified 
above. Analysing these factors and comparing them between the high and the low strains may 
confirm those factors which correlate with yield, and also provide a biological range for these 
variables. 
 
6.2 Results 
 
6.2.1 Culture profile of P. pastoris wild-type and scFv strains 
 
The wild-type, high and low secreting scFv strains were grown according to the protocol developed 
in Section 4.2.7 and samples for cell density, RNA and MS taken (Figure 49).  
 
The strains were inoculated into BMGY, grown for 16 hours and subsequently diluted to an OD600 of 
1 in fresh BMGY. Cultures were incubated for 24 hours, with samples taken at 22 and 23 hours. After 
such time the cells were washed with buffer to remove all traces of glycerol and the carbon source 
was replaced with methanol. Further samples were taken over the course of six hours, at two hour 
intervals. The growth profile mimicked that observed for GS115[BC1]H during protocol development 
(Figure 35). The cells enter a quiescent phase on glycerol, with a similar artificial drop at zero hours, 
before a small increase in growth associated with the new carbon source. 
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Figure 49 – Culture profiles of P. pastoris GS115 and the scFv strains  
P. pastoris strains GS115, GS115[BC1]H and L, and GS115[MFE23]H and L were grown overnight in BMGY, 
diluted in fresh BMGY and incubated for 24 hours. At that time the cells were harvested, washed in 0.1 M 
potassium phosphate buffer (pH 6) and resuspended in BMMY. Samples were taken at two hours and one hour 
prior to induction, at induction and then subsequently at two, four and six hours. Experiments were conducted 
in biological triplicate; error bars represent the standard error from the average.  
  
 
 
Figure 50 – BC1 and MFE23 standards for absolute quantification of SCFV transcripts 
The two vectors pPICZαA[BC1] and pPICZαA[MFE23] were digested with BamHI and HindIII to release a 1.558 
Kb and 1.487 kB fragment respectively. The digests were analysed by 1% agarose gel, visualised and the 
correct band excised. DNA was isolated from the band, and analysed by a further 1% agarose gel to check 
purity. 
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6.2.2 Absolute quantification of SCFV transcripts before and after induction 
 
The transcriptional response of the low and high yield strains of each scFv underwent absolute 
quantification with RT Q-PCR, using standard curves derived from the expression vectors 
pPICZαA[BC1] and pPICZαA[MFE23]. The two expression vectors were digested with BamHI and 
HindIII to generate fragments of DNA containing the genes (Figure 50). 
 
The concentration of the DNA was measured and subsequently converted into copy number per 
microlitre, using the formula outlined in Section 2.3.11. From this a set of standards was generated, 
ranging from 2 copies μL-1 to 210 copies μL-1, and used to quantify the SCFV transcript level in BC1 
and MFE23 strains (Figure 51). To ensure accuracy, the reproducibility of the standard curves was 
assayed. Three independent serial dilutions of each SCFV were generated and measured in duplicate 
reactions. The average of the three curves was calculated and plotted and a linear regression carried 
out; R2 values were 0.9991 and 0.9989 for BC1 and MFE23 respectively confirming the linear 
relationship assumed for quantification (Appendix IV). The average standard deviation in Ct values, 
across different concentrations and three repeats, varied by 0.344 and 0.691 for BC1 and MFE23 
respectively. Therefore, the standard curves were shown to be highly reproducible.  
 
SCFV transcript analysis revealed leaky expression from the AOX1 promoter; that is, it exhibited a 
low level of activity on glycerol under the assayed conditions. Although SCFV transcription at zero 
hours could be attributed to a delay between cell resuspension in the methanol media and sampling, 
this was unlikely as the samples were aliquoted and quenched within a few minutes. Moreover, such 
reasoning could not account for the transcription observed at -2 and -1 hours. Again, the relatively 
small values observed prior to methanol induction could be attributed to a loss of accuracy at high Ct 
values, however, this was not the case here. The Ct values obtained for pre-induction were well 
within the range of the standard curve. 
 
The second point of note is that induction of transcription was far from the idealised switch used in 
the model: following the change of substrate at zero hours, transcription peaked and subsequently 
tailed off. By six hours, transcription levels were close to that observed pre-induction. While the 
commercial protocol suggested supplementation at 24 hour intervals, indicating that induction is not 
constant, the speed at which it tailed off was surprising. Methanol, as a carbon substrate, could be 
expected to decrease both as the cells metabolised and by evaporation. A similar study also 
observed a peak in AOX1 transcription shortly after induction [220], with comparable timing.  
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Figure 51 – SCFV transcription profile, before and after induction 
The P. pastoris strains expressing [A] BC1 and [B] MFE23 were analysed by RT Q-PCR. The cDNA was amplified 
concurrent with a standard curve ranging from 10 to 10
10
 copies per reaction, allowing calculation of copy 
number per cell. The data presented are the average of three biological repeats; the error bars represent 
standard error. Two-sample one tailed t tests were conducted to determine statistical significance between 
strain means, asterisks indicate p value < 0.05. 
 
The third point to note is the transcript level achieved; generally, those observed were much lower 
than those derived from simulations using literature rates for transcription or from the values used 
in previous models. For example, the maximal level achieved by any of the strains at the peak of 
induction was 422 (± 24.9 SE) transcripts per cell compared to 1,000 used in the Hildebrandt model 
[157]. Mostly importantly, however, there was a clear difference between the high and the low yield 
scFv strains. Prior to induction, high yield strains appeared to produce more transcripts than low 
yield strains. A two-sample one tailed t test was conducted at each time point to assess whether one 
mean was significantly higher than the other; however the only difference observed was at -2 hours 
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for BC1 (See Appendix V: Statistical results for full details). Post induction, transcript production in 
both of the high producing strains was much less than that of the low producing strains. The t tests 
revealed that four hours post-induction, the low yield strains have significantly higher numbers of 
transcripts than the high yield strains. Finally, the temporal profile of the strains also differed, as the 
peak of transcription occurred two hours later in the BC1 strains compared to the MFE23 strains. 
 
6.2.3 UPR characterisation before and after induction 
 
In addition to SCFV analysis, the KAR2, PDI and HAC1 transcript response to induction was 
quantified. The standard method in the literature is to calculate the fold change in expression of 
targets relative to a non-expressing strain (the wild-type, GS115), once variations in the 
housekeeping gene have been taken into account [189]. This strategy assumes the only difference in 
transcripts will be caused by production of the scFvs, therefore taking into account any stress 
triggered by changing the carbon source. Alternatively, considering the evidence for clonal variation, 
it may be more accurate to use pre-induction samples of the same strain as a control, even though 
any stress induced by changing carbon source will be undetermined. To quantify how much error 
clonal variation may introduce, the difference in UPR transcripts between GS115 and the scFv strains 
at zero hours was analysed (Figure 52).  
 
 
Figure 52 – Relative quantification of UPR transcripts in scFv strains at zero hours 
The P. pastoris strains expressing the scFvs were analysed by RT Q-PCR. The relative fold changes in KAR2, PDI 
and HAC1 were first normalised to the internal reference gene SGA1, and subsequently expressed relative to 
GS115, following the Pfaffl method of calculation. The data bars are the average of three biological repeats; 
the error bars represent standard error. Two sample t tests were used to show differences between the wild-
type GS115 and the scFv secreting strains; significant results are indicated with asterisks (p value < 0.05). 
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Clearly, GS115 was an unsuitable control for the experimental conditions employed in this study. The 
scFv strains, with the exception of GS115[BC1]L, show at least double the number of KAR2 and PDI 
transcripts at 0 hours prior to induction. In particular, GS115[MFE23]L has 16.7 (± 2.84 SE) and 4.75 
(± 0.401 SE) times more KAR2 and PDI transcripts than GS115, respectively. Two sample t tests 
revealed significant differences in KAR2 expression between GS115 and the two low secreting 
strains, in PDI expression between GS115 and GS115[BC1]H/GS115[MFE23]L, and HAC1 between 
GS115 and GS115[BC1]L/GS115[MFE23]L. 
 
Therefore, changes in UPR transcript level were expressed relative to a pre-induction sample, 
specifically -2 hours (Figure 53). Initially, the response of the wild-type was considered. Prior to 
induction, the UPR transcripts fluctuate around a value of one – reflecting the quiescent, stationary 
phase. ANOVA and post-hoc Tukey’s tests found KAR2 and PDI, but not HAC1, to be significantly up-
regulated by between six and nine times following the change in carbon substrate. 
 
 
Figure 53 – Relative quantification of UPR transcripts in GS115 
The presence of the UPR stress response in the wild-type strain, GS115, was analysed by RT Q-PCR. The 
relative fold change in targets (KAR2, PDI and HAC1) was first subject to normalisation using the internal 
reference gene SGA1, and subsequently compared to the -2 hour point, following the Pfaffl method of 
calculation. The data bars are the average of three biological repeats; the error bars represent standard error. 
ANOVA and post-hoc Tukey’s comparison tests were conducted to see if transcript levels were significantly 
different following the change in carbon substrate; positive results are indicated with asterisks.  
 
Subsequently, RT Q-PCR data for the scFv strains was also expressed relative to the -2 hour sample 
(Figure 54).  
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Figure 54 – Relative quantification of UPR transcripts in scFv strains 
The presence of the UPR stress response in the high and low secreting scFv strains was analysed by RT Q-PCR. 
The relative fold change in targets (A: KAR2, B: PDI and C: HAC1) was first subject to normalisation using SGA1 
and subsequently compared to the -2 hour point, following the Pfaffl method of calculation. Data are the 
average of three biological repeats; the error bars represent standard error. Two sample, one tailed t tests 
were used to show differences between the high and the low secreting strains; significant results are indicated 
with asterisks (p value < 0.05).  
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Regarding general trends across the strains, the quiescent phase was again reflected in all target 
transcripts at -1 and 0 hours. There was a spike in KAR2 and PDI transcripts occurring 2 to 4 hours 
after induction, with the exception of GS115[MFE23]L. By 6 hours, however, this up-regulation had 
ceased and transcript values were lower than that observed at -2 hours, prior to induction. This 
pattern cannot be extended to HAC1, however, as transcripts only deviated marginally from a value 
of one. If any trend was suggested, it was that HAC1 is down-regulated following induction, most 
clearly in GS115[MFE23]H.  
 
Additionally, none of the scFv strains up-regulated KAR2 and PDI to the extent observed in GS115 – a 
maximum of a five-fold increase of KAR2 was observed in GS115[MFE23]H compared to nine-fold in 
GS115. Interestingly, while GS115 up-regulated both KAR2 and PDI to a similar extent, the scFv 
strains show a greater response in KAR2. This was in agreement with literature studies which 
showed P. pastoris up-regulates KAR2 to a greater extent than PDI during recombinant protein 
production [189,220]. 
 
A comparison within strains suggested differences in KAR2 up-regulation may correlate with yield. At 
both 2 and 4 hours, the high yield strains had relatively greater numbers of KAR2 transcripts than the 
low yield strains – a difference that only manifested following the induction of scFv production. A 
two sample one tailed t test was conducted to test if the high yield strains had significantly higher 
fold changes in KAR2: this was the case four hours post-induction for the BC1 strains and two hours 
post-induction for the MFE23 strains. This trend held true when comparing PDI transcripts in 
GS115[MFE23]H and L; a two sample one tailed t test showed the high yield strain had significantly 
higher fold changes than the low yield strain at two and six hours post-induction. It cannot, however, 
be extended to GS115[BC1]H and L for which the low yield strain showed significantly higher 
transcript changes at four and six hours. 
 
Finally, there was a contrasting response in HAC1 between the high and the low yield strains. 
GS115[BC1]L had a higher HAC1 response compared to GS115[BC1]H, whereas the MFE23 strains 
had the opposite. 
 
6.2.4 Quantification of Kar2 and PDI before and after induction 
 
Although the UPR in P. pastoris is conventionally assessed by analysing the dynamics of key targets – 
such as KAR2, PDI and HAC1 – the reduction in ER stress is brought about by the protein (Kar2 and 
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PDI). To provide a genuine correlation with the mRNA data from the previous section, samples for 
LC-MS/MS quantification of Kar2 and PDI were taken concomitantly. Each of the strains was 
characterised using the method developed in Chapter 5 and the formulae outlined in Section 2.10. 
All concentrations found were within the linear range of the internal standards (Figure 46). 
 
Considering the variation in transcripts observed at zero hours (Figure 52), the initial analysis 
focused on the difference in Kar2 and PDI protein level prior to induction (Figure 55).  
 
 
Figure 55 – Kar2 and PDI concentration in the scFv strains at zero hours 
Samples for LC-MS/MS analysis were taken concomitant with RNA samples (Section 2.7). Cells were lysed, the 
protein concentration standardised to 30 μg per sample and spiked with the internal standards. Samples were 
reduced, alkylated and digested before purification with a C18 column. Peaks for each of transitions, together 
with the respective internal standard, were integrated and those used for quantification averaged. Data show 
the average of the peptides across three biological replicates; error bars show the standard error. Two sample 
t tests were used to show differences between the wild-type GS115 and the scFv secreting strains; significant 
results are indicated with asterisks (p value < 0.05). 
 
Surprisingly, two sample t tests showed all strains had significantly lower levels of the target proteins 
than the wild-type, with the exception of GS115[BC1]L. This is the inverse of the mRNA data, where 
all strains showed increased KAR2 and PDI transcript numbers compared to GS115, except 
GS115[BC1]L (Figure 52). While the latter maintained a significantly higher level of Kar2, there is no 
difference in the level of PDI compared to GS115. Indeed, the relationship between GS115 and 
GS115[BC1]L appears to be quite close with respect to the two levels: at induction, the scFv strain 
had 1.9 times the amount of KAR2 mRNA and 1.4 times the amount of protein; and there was no 
perceivable difference between the PDI mRNA and protein levels in both. 
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Counter intuitively, the high secreting strains showed lower concentrations of Kar2 and PDI 
compared to the wild-type strain. Moreover, compared to their low secreting pair, the anticipated 
positive correlation of yield with these two proteins does not hold true (Figure 56). Indeed, the low 
secreting strain of BC1 had almost three times the concentration of Kar2. 
 
 
 
Figure 56 – Comparisons of Kar2 and PDI concentration between the scFv strains 
[A] Kar2 profile of GS115[BC1]L and H; [B] PDI profile for same strains. [C] Kar2 profile of GS115[BC1]L and H; 
[D] PDI profile for same strains. Experimental details as per Figure 55. Two sample t tests were used to show 
differences between the high and the low secreting BC1/MFE23 strains; significant results are indicated with 
asterisks (p value < 0.05). GS115[BC1]L showed statistically higher Kar2 and PDI across all time points, in 
comparison to GS115[BC1]H. Only Kar2, at -1 and 4 hours, showed a statistical difference between the high 
and low secreting MFE23 strains. ANOVA and post-hoc Tukey’s comparison tests were conducted to see if 
protein levels changed over the time course; the symbol † indicated a positive results (p value < 0.05). Only 
Kar2, in GS115[MFE23]H, showed a significant change over time, with the concentration at 2, 4 and 6 hours 
statistically different from 0 hours. 
 
Overall, the strains showed an unexpected constancy in the protein levels during recombinant 
protein production. ANOVA tests showed no significant difference in the concentrations of either 
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Kar2 or PDI in the strains over the course of the experiment, with the exception of GS115[MFE23]H 
which peaked at 4 hours post-induction. The dynamics observed in mRNA levels (Figure 54) were not 
reflected post-transcriptionally. 
 
In addition to the lack of dynamics, a correlation had been observed at the transcriptional level 
between the high yield strains and an increase in KAR2 mRNA. Contrastingly, two sample t tests 
showed GS115[BC1]L to have significantly more Kar2 and PDI protein; a fold increase of between 
two and three. The high and low yield MFE23 strains had more similar levels of Kar2 and PDI, with 
the only significant difference observed in Kar2 and -1 and 4 hours. Interestingly, this did reflect the 
mRNA levels as the high yield strain had an increased level of the protein.  
 
6.2.5 ERAD characterisation before and after induction 
 
Finally, the cDNA samples were analysed for a change in ERAD transcript levels following scFv 
induction. The ERAD response has not yet been clearly defined and involves a great number of 
different proteins. Indeed, the components of the ER membrane complex which orchestrate this are, 
to an extent, substrate specific and function in different pathways. For instance, 12 E2s and 60 to 
100 E3s have been identified in Saccharomyces cerevisiae [82]. There does, however, appear to be 
some conservation of key participants and it is these that RT Q-PCR primers were designed to target. 
Specifically, sequences for E1, UBC7, HRD1, DOA10 and CDC48 were found in ORCAE [280] (an online 
genome annotation source based on two P. pastoris genome sequences [281,282]). Targeting these five 
genes was by no means exhaustive, but they should provide an indication of ERAD activity.  
 
Analysis of GS115 revealed that, prior to induction, ERAD transcripts fluctuated around a value of 
one – again reflecting the quiescent, stationary phase (Figure 57). Following a change in carbon 
substrate, however, there was a response in the level of ERAD transcripts: AVOVA and post-hoc 
Tukey’s tests showed E1, UBC7, HRD1 and CDC48 were significantly increased at 2 hours post-
inductions, whereas DOA10 was not. However, such an increase was not maintained, with the 
exception of CDC48 – the most downstream effector of ERAD targeted by RT Q-PCR.  
 
- TARGETED EXPERIMENTAL CHARACTERISATION OF STRAINS - 
 
- 165 - 
 
Figure 57 – Relative quantification of ERAD transcripts in GS115 
The presence of the ERAD response in the wild-type strain, GS115, was analysed by RT Q-PCR. The relative fold 
change in targets (E1, UBC7, HRD1, DOA10 and CDC48) analysed by normalisation to SGA1 and compared to 
the -2 hour point, following the Pfaffl method of calculation. The data bars are the average of three biological 
replicates; the error bars represent standard error; asterisks indicate significant differences (p value < 0.05). 
ANOVA and post-hoc Tukey’s comparison tests revealed that: E1, UBC7 and HRD1 transcripts at 2 hours are 
significantly higher, and CDC48 transcripts are significantly higher at 2, 4 and 6 hours, compared to the -2 hour 
time point.  
 
 
Figure 58 – Relative quantification of ERAD transcripts in scFv strains at zero hours  
The P. pastoris strains expressing the scFvs were analysed by RT Q-PCR. The relative fold changes in E1, UBC7, 
HRD1, DOA10 and CDC48 were first normalised to the internal reference gene SGA1, and subsequently 
expressed relative to GS115, following the Pfaffl method of calculation. The data bars are the average of two 
biological repeats; the error bars represent standard error. Two sample t tests were used to show differences 
between the wild-type GS115 and the scFv secreting strains; significant results are indicated with asterisks (p 
value < 0.05). 
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Figure 59 – Relative quantification of ERAD transcripts in high and low secreting scFv strains 
The presence of the ERAD stress response in the scFv strains was analysed by RT Q-PCR. The relative fold 
change in targets (E1, UBC7, HRD1, DOA10 and CDC48) was subject to normalisation using SGA1 and compared 
to the -2 hour point, following the Pfaffl method of calculation. The data bars are the average of three 
biological repeats; the error bars represent standard error. ANOVA and post-hoc Tukey’s comparison tests 
were conducted; significant results were indicated by † (p value < 0.05). Two sample t tests were used to show 
differences between the scFv secreting strains; significant results are indicated with asterisks (p value < 0.05). 
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The expression of ERAD targets in the scFv strains was also considered (Figure 58). Consistent with 
the UPR analysis, the scFv strains showed high expression of the ERAD transcripts prior to scFv 
induction, with the exception of GS115[BC1]L. GS115[MFE23]L again showed higher levels of these 
transcripts than all other strains.  
 
An analysis of the expression of ERAD targets over the time course, relative to the -2 hour point, was 
subsequently conducted (Figure 59). In general, values for ERAD transcripts appeared to decrease 
during the quiescent phase (-2 to 0 hours), with the exception of UBC7. Using ANOVA tests, with 
post-hoc Tukey comparisons, the transcripts were analysed to identify any statistically different 
changes with time. Each target showed changes, although none were consistent across the strains. 
Of particular note is that, with the exception of GS115[BC1]L, the strains all showed down-regulation 
of some ERAD-associated transcripts by six hours. Moreover, GS115[BC1]L was the only strain to 
show a significant up-regulation of ERAD-associated targets (E1, HRD1 and DOA10) at 4 hours, 
compared to pre-induction levels.  
 
This suggested that the low yield strains had greater ERAD activity than the high yield strains. 
Consequently, two sample t tests were conducted to see if there were any significant differences 
between the high and the low yield strains. Indeed, for all significant differences observed between 
the low and the high yield BC1 strains, the low yield strain had more ERAD-associated transcripts 
than the high yield strain. This pattern did not transfer to the MFE23 strains, however, as higher 
levels were observed in GS115[MFE23]H. In particular, GS115[MFE23]L showed no significant change 
in targets over time, and the average decreased following induction (as observed in the UPR 
transcripts, Figure 54).  
 
6.3 Discussion 
 
6.3.1 Transcription from the AOX1 promoter was not an idealised switch 
 
Induction of protein production in the computational model was initiated when the parameter kTscript 
had a positive value. This value was constant, resulting in a transcriptional switch. Results from RT Q-
PCR analysis of the scFv strains, however, revealed transcription from the AOX1 promoter to be both 
leaky, as all strains showed SCFV transcripts prior to methanol induction, and inconstant.  
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The exact mechanism of AOX1 transcription initiation is not known; the sole identified transcription 
factor is the methanol expression regulator 1 protein (Mxr1). This protein is constitutively expressed 
regardless of carbon source suggesting a role for post-translational regulation. Specifically, this 
regulation may be mediated by localisation: Mxr1 is found exclusively in the cytoplasm when glucose 
is the carbon source. Fluorescent imaging has, however, detected Mxr1 in the nucleus when cells are 
grown on glycerol [193]. This corroborates the observation that a ΔMXR1-/- strain, while showing a 
reduced growth rate on all substrates, shows even greater slower growth on glycerol such that 
doubling time is almost twice that of the wild-type [193].  
 
Considering this, the nuclear localisation of Mxr1 during growth on glycerol may account for the 
leaky transcription of SCFV from pAOX1. It has been shown that carbon-starved cells can display 
around 2% activity from pAOX1 [283], akin to the leaky expression shown here. The study used glucose 
as a substrate; following 20 hours of growth, media was replaced with YNB containing no utilisable 
carbon source and followed for a further 20 hours. It would seem plausible that glucose starvation 
leads to a deregulation of Mxr1 localisation in the nucleus, allowing migration to the nucleus. These 
conditions, therefore, mimic growth on glycerol.  
 
This does, however, leave the explanation of the huge increase in activity from the AOX1 promoter 
on methanol problematic: it cannot simply be an increase in the concentration of Mxr1 as this 
protein has been shown to be constitutively expressed. This therefore suggests a role for a 
secondary activation factor, one which may have been recently identified. 14-3-3 proteins are highly 
conserved regulatory proteins which act through binding, usually to the phosphorylated form, 
altering the substrate conformation and activity [284]. The conserved binding domain of 14-3-3 
proteins has been identified in residues 212 to 225 of Mxr1, and abolishing this site prevents 
methanol regulation of pAOX1 activity [285]. Consequently, this evidence proposes a model of pAOX1 
transcription with two levels of regulation: cytoplasmic localisation represses activity (glucose) and 
14-3-3 dissociation induces activity (methanol). Growth on glycerol, or glucose starvation, where 
Mxr1 is contained within the nucleus but is bound to 14-3-3, leads to leaky transcription. 
 
In light of the leaky and diminishing activity of the pAOX1 prior to and following induction, future 
studies may want to investigate recently characterised, repressible promoters [286,287]. Although 
benefitting from stronger regulation, the research would be less pertinent as pAOX1 is the most 
frequently used inducible promoter [94]. Again, while the decreasing activity is far from the idealised 
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switch utilised in the model, the waning of transcription could help in understanding the return to 
homeostasis following a burst in scFv production. 
 
6.3.2 HAC1 up-regulation indicates stress, but KAR2 and PDI alone does not 
 
Preliminary experiments showed GS115 to be a poor control for the experiment as it did not have 
the same basal activity or the same response to methanol induction. In terms of the basal activity, 
prior to induction, the scFv strains had higher expression levels of KAR2, PDI and HAC1 compared to 
GS115. Although this could have been due to the low level of leaky transcription from pAOX1, there 
was no correlation between the especially high levels of UPR transcripts observed in GS115[MFE23]L 
and its lower, leaky SCFV transcript level. Instead, it seemed more likely that selection of strains from 
a heterogeneous population based on yield phenotype accounted for these differences.  
 
In addition to the basal activity, the wild-type strain differed in its response to methanol induction. 
Indeed, analysis revealed an eight-fold increase in KAR2 and PDI following the change in substrate, 
without any concomitant increase in HAC1. Following the transfer to a new carbon substrate, the 
yeast proteome drastically changes: enzymes involved in the assimilation and dissimilation of 
methanol start to dominate [233]. The increase in these protein processing transcripts reflected this 
reconstruction of the metabolic pathway.  
 
The scFv strains, on the other hand, displayed lower increases in KAR2 and PDI with a parallel 
increase in HAC1 transcripts. Considering the response of GS115, these results suggested that 
fluctuations in KAR2 and PDI do not alone indicate ER stress, but that HAC1 might. This is biologically 
realistic: the target genes KAR2 and PDI function both during UPR and non-UPR conditions and 
consequently integrate signals from both to calibrate expression levels. Therefore an increase in 
transcripts does not necessarily reflect UPR. Hac1, on the other hand, is a specific mediator of the 
response and for this reason a change in HAC1 transcript levels is a better indicator of stress. 
 
With respect to the magnitude of the response, this counterintuitive result can be understood in 
light of the expression levels observed at zero hours. If there is a maximum transcriptional capacity, 
the scFv strains will not be able to up-regulate these targets to the same extent as GS115 as they will 
reach this upper limit earlier. In support of this, the strain with the highest up-regulation of UPR 
targets at zero hours and the strongest induction of SCFV transcription – GS115[MFE23]L – has by far 
the lowest change in targets following induction. 
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6.3.3 Kar2 and PDI protein levels  
 
The interpretation of the differences in KAR2 and PDI levels between GS115 and the scFv strains, 
prior to induction, was problematic. From transcript data alone, it could be suggested that either: (i) 
clones displaying a higher level of transcripts associated with protein processing prior to induction 
had a greater basal capacity; or (ii) the same clones had high KAR2 and PDI transcripts because they 
were activating the UPR response. To be able to tease these apart, protein data was required, as if 
the strains had lower protein levels then the second hypothesis would be much more likely.  
 
The LC-MS/MS results revealed two interesting features. Firstly, GS115 and the low yield strain 
GS115[BC1]L had much higher levels of Kar2 and PDI than the scFv strains: this surprising result 
prompted three GS115 samples to be re-analysed for confirmation (92% of original Kar2/PDI 
measurement, ± 5.48% S.E). GS115[BC1]L appeared to behave most similarly to the parental strain: 
prior to induction, it showed 1.4 times the level of KAR2 in GS115 and 1.9 times the protein. It had 
almost identical levels of PDI transcripts and protein. Intriguingly, it also showed even less HAC1 
than the wild-type strain, strengthening the correlation between HAC1 transcripts and stress, and 
attributable to the additional Kar2 in the system. The other scFv strains, however, had much lower 
concentrations of Kar2 and PDI, presumably inducing ER stress, accounting for the increased KAR2, 
PDI and HAC1 transcripts prior to induction. Together, these results implicate the second hypothesis 
– that clones with high KAR2 and PDI at zero hours were activating the UPR response. 
 
This cannot, however, be a complete explanation as logically an increased level of KAR2 and PDI 
transcripts should result in an increase in protein levels. Any fluctuations in transcript level during 
methanol induction had little effect on the concentration of the proteins, with particular reference 
to Kar2. While the difficulty in correlating mRNA and protein levels has long been acknowledged in 
yeast [279], such minor fluctuations in concentration were surprising.  
 
One explanation could be that the analysis only considered soluble protein – any PDI, or in particular 
Kar2, contained within insoluble aggregates may have been pelleted with the cell debris following 
lysis. Recently, however, an iTRAQ study has been published investigating the proteomic changes 
between P. pastoris strains expressing one copy, four copies of Bacillus halodurans xylanase A (xynA) 
and four copies of xynA together with HAC1S, all under control of the AOX1 promoter 
[288]. RT Q-PCR 
revealed the latter strain to up-regulate KAR2 twenty-fold after 96 hours of methanol growth in 
shake flasks, however, it was not presented as a differentially regulated protein (by the authors’ 
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definition, a greater than 1.2-fold change in concentration and a p value less than 0.05). Similarly, a 
study analysing the intracellular proteome with 2-D gel electrophoresis and Maldi-ToF did not 
mention any changes in Kar2 concentration, although they observed an increase in PDI [233].  
 
Therefore, setting aside insolubility, the result could be attributed to either of two, broad factors: a 
translation bottleneck or an uncharacterised regulation pathway. Here, the behaviour of the wild-
type is crucial: while the level of Kar2 barely changes (an increase of 1.07-fold between -2 and 6 
hours) the level of PDI increases by 1.46-fold. Considering the large and consistent increase in KAR2 
and PDI transcripts over the measured period of induction, this is a strong case for post-
transcriptional regulation of Kar2. The most prominent changes observed in Kar2 was during scFv 
production in GS115[BC1]L and GS115[MFE23]H. The consistent difference between the scFv strains 
and the wild-type is the activation of stress, prompting the interpretation that during the ER stress 
the post-transcriptional regulation of Kar2 is alleviated. The change in protein level could then be 
prescribed to the very large increase in HAC1 observed in GS115[BC1]L and the high level of KAR2 in 
GS115[MFE23]H. 
 
This conclusion is not without basis: a study investigating the effect of expressing mouse BiP in 
human HeLa cells concluded that transcriptional and translational control of BiP are autonomous, 
and that the increase in transcripts does not necessarily result in greater amounts of protein [289]. 
Indeed, the authors suggest a model of the BiP production whereby during the UPR translational 
restraint is alleviated and classic transcript up-regulation results in an increase in protein. Despite 
the evolutionary divergence between the experimental hosts, this study has clear similarities with 
the results found here. Such a model of Kar2 regulation is crucial to traditional strategies for 
increasing yield, as many studies employ up-regulation.  
 
6.3.4 A role for transcriptional down-regulation in stress amelioration? 
 
The UPR has, particularly in P. pastoris, been generally described by a difference in transcript levels 
of the response targets using RT-QPCR [100,189,220], DNA microarrays [28,72,96,97,267] and more recently 
RNA sequencing [268]. This study followed such an approach using RT Q-PCR to show that, with the 
exception of GS115[MFE23]L, the strains showed an increase in KAR2, PDI and HAC1 transcripts 
following induction. According to the previous literature, this would suggest the scFv strains activate 
the UPR during heterologous protein production. 
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For the UPR to function as a homeostatic feedback loop, the increase in KAR2 and PDI transcripts has 
to be reflected in protein levels, such that the unfolded and misfolded protein in the ER can be 
removed. Therefore, the incongruence between the RNA and MS data was surprising. Although 
some Kar2 and PDI increases were observed, the muted response raises the question of how these 
strains reduce the stress induced by recombinant protein production, if indeed they do. 
Interestingly, almost all of the measured UPR and ERAD associated transcripts in the scFv strains 
have lower values at six hours post-induction than pre-induction, suggesting transcriptional down-
regulation may be a significant feature of the response. In comparison the wild-type maintains UPR 
and ERAD transcript up-regulation over the time course measured. It is tempting to speculate that 
when the up-regulation of UPR and ERAD targets does not return the ER to homeostasis, a general 
transcriptional down-regulation is employed to rescue the strains. 
 
6.3.5 Correlations with yield: more than one route to productivity 
 
The comparison of responses between high and low strains did not yield many consistent 
correlations between experimental targets and recombinant protein yield. For instance, SCFV 
transcript levels negatively correlated with yield; and both the high yield strains showed statistically 
greater increases in KAR2 transcripts following induction. Contrastingly, only GS115[MFE23]H 
showed a statistical increase in Kar2 protein following induction, confusing the interpretation. 
Similarly, an increase in PDI transcripts was observed in GS115[MFE23]H but not GS115[BC1]H; and 
the high yield strains showed a down-regulation of ERAD transcripts but then so did GS115[MFE23]L. 
Moreover, GS115[BC1]L had the highest concentration of Kar2 and PDI protein of any of the strains. 
Clearly, the experimental analysis here has revealed a picture that is incomplete for any reliable 
prediction of yield from these targets.  
 
Such counter intuitive results may, however, be rationalised if productivity is considered a balance of 
SCFV transcription, UPR and ERAD up-regulation (Table 11). The results from SCFV, UPR and ERAD 
transcript analysis, together with the LC-MS/MS protein data, were combined into a heat map where 
higher numbers have greater colour intensity. Here, the focus was on the response to induction, so 
values were an added response of two and four hours. 
 
From the heat map analysis came the hypothesis that the low yield of GS115[MFE23]L may be due to 
a transcriptional bottleneck. Prior to methanol induction, the strain showed much greater levels of 
UPR and ERAD transcripts. Moreover, upon induction the strain had the highest SCFV transcript 
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numbers. The combination of the two previous results, however, appeared to cause a transcriptional 
bottleneck as the strain showed minimal up-regulation of any targets following induction. Although, 
in theory, it should produce the greatest yield based on SCFV transcripts alone, the low Kar2 and PDI 
prevented the strain from capitalising on this. Having said that, the strain did show similar Kar2 and 
PDI levels to GS115[BC1]H and GS115[MFE23]H, suggesting that the much greater up-regulation of 
UPR and ERAD targets prior to induction was caused by an unmeasured factor. 
 
Table 11 – Heat map of RNA and MS targets with yield 
The combined average fold change, or concentration, of each target at two and four hours was expressed as a 
function of colour intensity. SCFV transcripts were scored from white to blue for low to high expression levels. 
KAR2 and PDI transcripts, together with the protein (Kar2 and PDI), were considered to correlate with high 
expression; therefore they were scored from white to green for low to high expression levels. The ERAD 
transcripts, namely E1, UBC7, HRD1, DOA10 and CDC48, are considered to correlate with low expression and 
have been scored from white to red for low to high expression levels. HAC1, the regulator of both responses, 
has been scored from white to orange for low to high expression levels. 
Strain 
Target 
SCFV KAR2 Kar2 PDI PDI HAC1 E1 UBC7 HRD1 DOA10 CDC48 
GS115 0 16.9 38.3 15.2 77.2 1.3 10.4 9.1 7.1 3.6 7.7 
GS115[BC1]H 208 6.6 21.8 1.9 40.1 0.8 1.8 1.0 1.2 1.0 1.2 
GS115[BC1]L 321 4.6 62.8 3.7 74.9 2.7 3.5 1.7 2.9 3.1 2.5 
GS115[MFE23]H 405 7.6 29.3 2.8 48.6 1.0 3.1 1.7 1.7 1.3 1.8 
GS115[MFE23]L 683 0.8 24.9 0.8 44.6 0.4 0.8 0.5 0.7 0.8 0.4 
 
 
The high yield MFE23 strain had a much lower level of SCFV transcripts, at just under 60%. It also, in 
contrast to the low yield strain, had a lower level of KAR2 and PDI transcripts pre-induction. 
Consequently, it did not appear to suffer from the same transcriptional bottleneck: induction of scFv 
production generated a large increase in KAR2 (and, to a lesser extent, PDI transcripts). This increase 
was replicated in the protein data, albeit at a lower magnitude. The UPR transcriptional response 
was not mimicked in the ERAD pathway; therefore, it seems as though the difference in yield 
between the two strains could be attributed to the high yield strain having not reached a 
transcriptional maximum and consequent Kar2 and PDI increase following scFv production. Indeed, 
it has been shown experimentally that the protein resulting from Kar2 induction during the UPR is 
dedicated to relieving ER stress [212], suggesting the high yield strain is better able to manage to 
unfolded protein increase in the ER following scFv production. 
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The trend in SCFV transcript numbers and yield is again reflected in the BC1 strains; the rest of the 
correlations do not remain true: perhaps there is more than one route to high yield. At zero hours, 
the high yield strain expressed more KAR2, PDI and HAC1 than the low yield strain, implying that the 
ER had a higher level of stress. Indeed, the protein data verified this: GS115[BC1]L contained almost 
three times the concentration of Kar2 and double the amount of PDI. Although during scFv induction 
the high yield strain increased KAR2 transcript levels to a greater extent than the low yield strain, the 
opposite was true for PDI. More crucially, this did not translate to large increase in Kar2 and PDI 
protein in GS115[BC1]H, whereas there was a noticeable increase in the two proteins in 
GS115[BC1]L. Therefore, it seems that the high yield strain has a translation bottleneck that the low 
yield strain is not subject to. Moreover, GS115[BC1]L has a high SCFV transcript number and far 
greater Kar2 and PDI concentration, implying it should have a high yield. However, during scFv 
production the low yield strain up-regulated ERAD transcripts to a greater extent than any of the 
scFv strains, implying it had a higher activity. The high yield strain, on the other hand, down-
regulated all ERAD targets measured. In summary, although GS115[BC1]L has both the capacity for 
the highest flux of unfolded protein and the increased chaperone and foldase concentration to 
manage it, a great deal of the protein is degraded through the ERAD pathway.  
 
6.3.6 High yield strains correlate with low native Kar2 and PDI concentration 
 
The most interesting result was that the majority of the scFv strains have, both before and after 
induction, less Kar2 and PDI than the parental strain. Biological systems have evolved a fine balance 
for protein production, and the integration of a recombinant gene for high level production 
consumes host resources. The results presented here suggest that strain selection identifies clones 
with minimal resources directed towards host cell proteins. Such a strategy leads to ER stress prior 
to protein production, but so long as the strains can still respond to scFv production this is not 
detrimental.  
 
There is a lack of research directed towards the interplay – and competition – between host and 
recombinant proteins for resources in the ER [246]. Although the traditional strategies for increasing 
protein production try to incorporate additional capacity into host strains, this can often lead to 
undesired, negative effects on yield. Particularly, up-regulation of chaperones and foldases can 
cause as much stress [63] as the recombinant protein itself, by sequestering resources which are 
already saturated.  
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6.3.7 Ramifications for the model 
 
The results from modelling the system, discussed in Chapter 3, provided targets for experimental 
analysis. Firstly, the correlation of gene copy and yield reflected the importance of the concentration 
of SCFVC (Figure 23); consequently, absolute quantification of SCFV mRNA in the system was required 
(Figure 51). The model predicted that increasing the gene copy number would generate proportional 
increases in SCFV mRNA, which in turn would increase the yield – up to a threshold. When more 
than 12 copies of the heterologous gene were simulated, the yield decreased. Experimental results, 
however, showed that even though just one copy of the SCFV gene was present large variations in 
transcript numbers could occur – a finding not accounted for by the current model structure. 
Despite this, pairing the transcript numbers with the qualitative dot blot result did confirm the 
hypothesis that higher transcript numbers have a detrimental effect on yield. Finally, the model 
produced a steady state value of 610 transcripts per cell. RT Q-PCR data revealed a range of 
maximum values, all below the model value but within the same order of magnitude: 113 to 422. 
 
Secondly, simulations strongly suggested the concentration of Kar2 was important in determining 
yield (Figure 25). Here, both RT Q-PCR and absolute quantification by LC-MS/MS analysis of Kar2 was 
performed, along with simultaneous analysis of PDI. On a transcript level, an increase in KAR2 
transcripts following induction correlated with yield, but not before. Moreover, the protein levels 
did not show any clear correlation; suggesting that the picture is more complicated than the model 
could represent. With regard to the estimated parameters, the vmax and km parameters were 
estimated assuming a 2.75-fold increase for KAR2 [220], a two-fold increase for PDI [220] and a 1.5-fold 
increase in E3 [28]. Here, up-regulation of KAR2 ranged from two- to five-fold, PDI from 1.2- to 2.5-
fold and E3 from 1.1- to 3.7-fold between the strains. Therefore, the model underestimates the 
maximum responses for KAR2 and E3 transcript changes.  
 
Clearly, the experimental analysis returned a much more complex system than the canonical 
interpretation of the UPR would have suggested. The two principal inaccuracies revolve around the 
limited regulation and lack of a host cell protein pathway in the model.  
 
As outlined in Section 6.3.5, the strains up-regulated different secretion-associated transcriptions 
independently, allowing multiple routes to yield. The model, however, reduced regulation to a single 
factor: HAC1S. As it stands, activation of the UPR in the model up-regulates the folding and 
degradation pathways to a similar extent. The basis for this interpretation stemmed from the initial 
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identification of a 22 bp element (UPRE) in the S. cerevisiae KAR2 promoter to which Hac1 could bind 
[54,62]. A transcriptomics study, however, revealed that the UPR up-regulates around 5% of the 
genome [96] which a bioinformatics analysis of promoters revealed the original UPRE could not 
account for [290]. The authors identified two more sequences implicating the transcription factor 
Gcn4, however, this still only accounts for 50% of target UPR genes. An experimental analysis 
reproduced these results, and additionally, showed that the promoter region of HAC1 contained a 
further sequence with a motif for Crz1 without which no transcriptional up-regulation would occur 
[291]. Finally, an experimental analysis of the UPRE in S. cerevisiae showed that only removal from the 
native chromosomal locus could ablate UPR induction of KAR2, not simply the mutation of the UPRE 
sequence [212]. These results indicate that the regulation of stress responses is coordinated by more 
factors than Hac1 alone, and this may account for the observed disparity in folding and degradation 
capacities detected in the strains. 
 
Finally, the results suggested a competition between the host cell protein pathway and scFv 
production: strains with a lower concentration of Kar2 and PDI prior to induction correlated with 
high yield. Clonal variation appeared to act to minimise host requirements, diverting more resources 
to recombinant production. Without this competition, the model presented in Chapter 3 will never 
reproduce experimental results as the yield increases simulated with Kar2 and PDI overexpression 
demonstrated. 
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7. Overexpressing Kar2 and PDI in the high 
secreting strains 
 
7.1 Introduction 
 
The model showed the over-expression of Kar2 only increased yield by 10.5% but decreased cellular 
stress by 96.8% (Figure 25); while the over-expression of PDI had little effect (Figure 26). Although 
no increase in yield was observed for the concomitant up-regulation, cellular stress was almost 
completely eliminated – a reduction of 99.6% (Figure 27). Experimental results did show a 
correlation between low Kar2/PDI and high HAC1 expression prior to induction, agreeing with model 
results, but this occurred in the high yield strains. This counter-intuitive result highlighted an 
inaccuracy in the model which required development; but to do so would require a better 
understanding of the relationship: would artificially increasing the Kar2 and PDI concentration 
remove the cellular stress in GS115[BC1]H and GS115[MFE23]H? Moreover, increases in KAR2 and 
PDI transcripts did not necessarily translate to higher protein levels, possibly due to an 
uncharacterised regulation pathway. This raised the question of whether artificial up-regulation 
would translate to higher protein levels, for either Kar2 or PDI.  
 
The ideal strategy required constitutive overexpression of Kar2 and PDI, increasing the baseline 
capacity of the strains. Evidence from GS115[MFE23]L suggested that there was a maximum 
transcriptional capacity that the employment of pAOX1 could saturate; in additions, a previous study 
which overexpressed Kar2 and PDI in conjunction with production of an scFv found a deleterious 
effect with pAOX1 [63]. As the molecular toolbox of P. pastoris is still relatively underdeveloped, there 
are not many well characterised promoters to select from [94]. Therefore, the popular glyceraldehyde 
3-phosphate dehydrogenase promoter (pGAP) was selected for this purpose. 
 
Glyceraldehyde 3-phosphate dehydrogenase is a key enzyme in glycolysis, consequently its promoter 
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is both strong and constitutive [51]. Its expression does, however, change with carbon source: the 
original isolation of the promoter recorded 100%, 73%, 45% and 36% activity of β-lactamase on 
glucose, glycerol, oleic acid and methanol respectively [292]. This should, however, be beneficial: the 
lower activity on methanol should moderate the strength of pGAP such that Kar2 and PDI production 
does not outcompete that of the scFv.  
 
To up-regulate both proteins simultaneously, they were integrated as a bicistronic product, 
separated by an IRES (internal ribosome entry site) sequence. The first discovered, and best 
characterised, method of translation is cap-dependent [293]. In other words, the mRNA contains a 5’ 
cap structure which binds the cap-binding complex and recruits the 40S ribosomal subunit as a 43S 
pre-initiation complex [294]. Subsequently, it was shown that viruses could mediate cap-independent 
translation through IRES sequences [295], by forming 3D structures with which to interact with the 
translation complex [293]. These were also later observed in cellular mRNAs; although, the efficiency 
of translation is much lower than that of viruses [293]. 
 
The IRES sequence was employed for three reasons: firstly, although KAR2 and PDI could have been 
integrated under separate GAP promoters at different loci, there is evidence that the 
recombinogenic propensity of P. pastoris could act upon such sites of homology – making such a 
strategy genetically unstable [296]. Secondly, only one study has employed an IRES sequence in P. 
pastoris, however, no quantification of its efficiency was conducted [297]. Here, this could be analysed 
by comparing transcript and LC-MS/MS data providing a useful analysis of this new tool. Finally, an 
exogenous IRES sequence may bypass post-transcriptional regulation pathways; for this reason, 
KAR2 was integrated as the second cistron. 
 
7.2 Results 
 
7.2.1 Construct description  
 
The PDI and KAR2 genes, linked by the IRES sequence, were cloned into the pIB2 plasmid [170] to 
generate the pIB2[PDI.Stop-IRES-KAR2] (pIB2[PIK]) expression construct (Figure 60). Transcription of 
the bicistronic mRNA is initiated by the GAP promoter and terminated by the AOX1 termination 
sequence. PDI is translated through the cap-dependent mechanism, while KAR2 is translated in a 
cap-independent mechanism dependent on the IRES sequence. To encourage ribosome detachment 
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after the first gene, three extra stop codons were inserted after the PDI sequence. Finally, the bla 
and HIS4 genes allow selection of both bacterial and yeast transformants respectively. 
 
 
 
Figure 60 – pIB2[PIK] expression construct 
Each of the chaperones was integrated into the pIB2 expression vector under the GAP promoter, allowing 
constitutive production. Transcription utilised the AOX1 terminator sequence. Bacterial replication of the 
plasmid was determined with an origin of replication derived from pMB1, while selection was mediated by 
incorporation of the ampicillin resistance gene, bla. Integration into the yeast chromosome was directed by 
HIS4 regions of homology; this also reconstituted the HIS4 gene allowing selection in the auxotroph GS115. For 
expression of both chaperones simultaneously, a region of S. cerevisiae genomic DNA reported to function as 
an IRES was integrated into the vector - following the PDI gene and preceding the KAR2 gene. To prevent any 
transcription read-through from PDI into the IRES, three extra stop codons were cloned in. 
 
7.2.2 Cloning KAR2 and PDI into pIB2 
 
Initially, the primers PDI_F and PDI.Stop_R were designed to amplify the PDI gene from the plasmid 
pET28a[PDI] (Karen Polizzi, Imperial College London) with three extra stop codons at the terminus. 
The primers contained the restriction sites EcoRI and HindIII for ligation into the P. pastoris pIB2 
expression vector to generate the pIB2[PDI.Stop] construct. TSS competent E. coli JM109 cells were 
transformed with the ligation reaction and selected using ampicillin resistance. Colony PCR verified 
the presence of the construct using primers PDI_SeqF and PDI_SeqR. 
 
The primers IRES_F and IRES_R were then designed to amplify the IRES region from S. cerevisiae 
genomic DNA (Karen Polizzi, Imperial College London) allowing insertion into pIB2[PDI.Stop], after 
the PDI gene, to generate the pIB2[PDI.Stop-IRES] construct. The primers contained the restriction 
sites AgeI and HindIII for ligation into the vector. TSS competent E. coli JM109 cells were 
pIB2[PIK]
9.487 kB
- OVEREXPRESSING KAR2 AND PDI IN THE HIGH SECRETING STRAINS - 
- 180 - 
transformed with the ligation reaction and selected using ampicillin resistance. Colony PCR verified 
the presence of the construct using primers PDI_F and IRES_R. 
 
To complete the vector, the primers KAR2_F2 and KAR2_R2 were designed to amplify the KAR2 gene 
from the plasmid pET28a[KAR2] allowing insertion into pIB2[PDI.Stop-IRES] to generate the pIB2[PIK] 
construct. Both primers contained the restriction site AgeI for ligation into the vector. TSS 
competent E. coli JM109 cells were transformed with the ligation reaction and selected using 
ampicillin resistance. Colony PCR verified the presence of the construct using primers PDI_F and 
KAR2_R2. 
 
To sequence the entire vector, reactions using the primers: (1) PDI_SeqF and IRES_R, (2) IRES_F and 
KAR2_SeqR1, and (3) KAR2_SeqF2 and KAR2_SeqR2 were analysed and a consensus of the readouts 
generated (Appendix III). 
 
7.2.3 Transforming high secreting strains with pIB2-PDI-IRES-KAR2 
 
The construct pIB2[PIK] was linearised with the restriction enzyme NheI, which cuts within HIS4 
allowing homologous recombination into the HIS4 locus of the yeast genome. Cultures of the high 
secreting scFv strains, GS115[BC1]H and GS115[MFE23]H, were grown to an OD600 of 1.3, prepared 
for electroporation and transformed with the linearised plasmid. The cells were recovered for five 
hours and selected on RD plates. Resistant colonies were replica plated onto RD plates containing 
100 μg mL-1 zeocin to isolate clones with both SCFV and PIK constructs. Colony PCR analysis with 
primers PDI_SeqF and KAR2_SeqR2 confirmed those which had integrated the recombinant gene 
construct, denoted GS115[BC1-PIK]H and GS115[MFE23-PIK]H. 
 
7.2.4 Characterisation of overexpression strains  
 
Both GS115[BC1-PIK]H and GS115[MFE23-PIK]H were grown overnight in BMGY, diluted in fresh 
BMGY and incubated for 24 hours. At that time the cells were harvested, washed in 0.1 M potassium 
phosphate buffer (pH 6) and resuspended in BMMY. Cell density was measured two hours prior to 
and for six hours following induction, and compared to the high secreting parental strains (Figure 
61). 
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Figure 61 – Culture profile of the high secreting parental strains and PIK transformants 
P. pastoris strains GS115[BC1]H, GS115[BC1-PIK]H, GS115[MFE23]H and GS115[MFE23-PIK]H were grown 
overnight in BMGY, diluted in fresh BMGY and incubated for 24 hours. At that time the cells were harvested, 
washed in 0.1 M potassium phosphate buffer (pH 6) and resuspended in BMMY. Samples were taken at two 
hours and one hour prior to induction, at induction and then subsequently at two, four and six hours. 
Experiments were conducted in biological triplicate; error bars represent the standard error from the average. 
 
 
 
Figure 62 – Standards for absolute quantification of KAR2 and PDI 
The vector pIB2[PIK] was digested with (i) AgeI for KAR2, and (ii) PshAI and HindIII for PDI, to release a 2.050 kB 
fragment and a 1.717 kB fragment respectively. The digests were analysed by 1% agarose gel, visualised and 
the correct band excised. DNA was isolated from the band, and analysed by a further 1% agarose gel to check 
purity. 
 
0
5
10
15
20
25
30
35
40
-2 -1 0 1 2 3 4 5 6
O
D
6
0
0
(a
rb
it
ra
ry
 u
n
it
s)
Induction time (hours)
10
6
3
2
1.5
1
0.25
kB
KAR2 PDI
- OVEREXPRESSING KAR2 AND PDI IN THE HIGH SECRETING STRAINS - 
- 182 - 
7.2.5 Absolute quantification of KAR2 and PDI in pIB2[PIK] transformants 
 
Initial experiments sought to quantify the transcription of the construct. As KAR2 and PDI are both 
expressed natively, with temporal fluctuations (Figure 54), the use of relative quantification would 
be subject to similar problems as those encountered when comparing scFv strains to the wild-type. 
Therefore, absolute quantification of KAR2 and PDI in the parental (GS115[BC1]H and 
GS115[MFE23]H) and pIB2[PIK] transformants was analysed using RT Q-PCR. Standard curves were 
derived by digesting pIB2-PIK with (i) AgeI for KAR2; and (ii) PshAI and HindIII for PDI (Figure 62). 
 
The DNA concentration of the KAR2 and PDI standards was quantified and the number of copies 
calculated, as shown outlined Section 2.3.11. The DNA was subsequently serially diluted to produce 
a standard curve for each, from 1010 copies to 10 copies per RT Q-PCR reaction. To ensure accuracy 
of quantification, the reproducibility of the standard curves was assayed. Three independent serial 
dilutions of the KAR2 and PDI standards were generated and measured in duplicate reactions. The 
average of the three curves was calculated, plotted and a linear regression carried out; R2 values 
were 0.9995 and 0.9973 respectively (Appendix IV). The average standard deviation in Ct values, 
across different concentrations and three repeats, varied by 0.519 and 0.348 for KAR2 and PDI 
respectively. Therefore, the standard curves were shown to be highly reproducible. The Ct value of 
each sample analysed was well within the linear range of the standard curve. 
 
The standards were used for absolute quantification of the transcripts in GS115[BC1-PIK]H and 
GS115[MFE23-PIK]H before and after scFv induction (Figure 63). Transcript numbers for KAR2 are an 
order of magnitude lower than PDI and display stronger ‘peak’ behaviour. The only significant 
increase in KAR2 transcripts in the daughter strains was observed in GS115[BC1-PIK]H at two hours 
post-induction, as shown by a two sample t test. Contrastingly, PDI was significantly up-regulated at 
every time point in both daughter strains, with the exception of GS115[MFE23-PIK]H at two hours 
post-induction. The peak behaviour observed in the parental strain led to the hypothesis that this 
insignificant data point is the result of the UPR in the parental strain increasing PDI transcripts.  
 
The pIB2[PIK] construct produced a bicistronic mRNA leading to the impression that the exogenously 
produced KAR2 and PDI should be in a one-to-one ratio. Initially, the KAR2 peak response was 
interpreted as a consequence of additional promoter activity from the new carbon source; however, 
the difference in PDI transcripts at 0 and 2 hours does not reflect the same pattern. This led to the 
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hypothesis that either the construct or the bicistronic mRNA was not stable, and perhaps the later 
portion was not being maintained.  
 
 
 
Figure 63 – Absolute quantification of [A] KAR2 and [B] PDI in parental and pIB2[PIK] strains 
The high secreting P. pastoris strains GS115[BC1]H and GS115[MFE23]H, together with the PIK daughter strains 
by RT Q-PCR, were analysed. The cDNA was amplified concurrent with either a standard curve of [A]: KAR2 or 
[B]: PDI ranging from 10 to 10
10
 copies per reaction, allowing calculation of copy number per cell. The data 
presented are the average of three biological repeats; the error bars represent standard error. Two-sample 
one tailed t tests were conducted to determine if the PIK strains contained significantly higher target transcript 
numbers, asterisks indicate positive results (p value < 0.05). 
 
The integration site, his4, reconstituted histidine synthesis in an auxotrophic strain. To maintain 
comparisons with previous experiments, and because such a strategy has been published before [101], 
expression was conducted in complex media (BMGY/BMMY) – removing the selection pressure. 
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Preliminary studies were conducted to ascertain whether chromosomal stability could account for 
the low PIK transcript levels. GS115[BC1-PIK]H and GS115[MFE23-PIK]H were cultured according to 
the standard protocol (Section 2.7). At 24 hours, samples were taken and the culture transferred to a 
methanol substrate for a further 24 hours. At such time, a second set of samples were taken. The 
cells from each were serially diluted and recovered on agar plates containing rich media. Fifteen 
colonies of each strain were subject to colony PCR, using primers PDI_SeqF and KAR2_SeqR2 to 
detect the presence of the construct. At such time, the cells in the first sample had been exposed to 
rich media for 92 hours while cells in the second sample had been exposed to rich media for 116 
hours.  
 
Significantly, none of the GS115[BC1-PIK]H colonies were positive for the construct at either 92 or 
116 hours. GS115[MFE23-PIK]H, on the other hand, showed 11 positive results at 92 hours and three 
at 116. The standard expression protocol, however, requires only 50 hours therefore the experiment 
was repeated with a reduced time. A serial dilution of cells from an overnight culture was conducted 
and single colonies isolated, reducing the exposure time to 64 hours. This increased the retention of 
the construct, with two positive GS115[BC1-PIK]H colonies and 11 positive GS115[MFE23-PIK]H 
colonies.  
 
7.2.6 LC-MS/MS quantification of Kar2 and PDI in pIB2[PIK] transformants 
 
Despite a negligible increase in KAR2 expression, LC-MS/MS quantification of protein levels was 
carried out. RT Q-PCR results in Section 6.2.3 had shown post-induction increases in PDI transcripts 
which were not reflected in protein data (Section 6.2.4). Analysing the protein levels would help 
understand whether this disconnection was a consequence of a translational bottleneck or an 
unknown host cell regulation pathway.  
 
Samples, taken concomitantly with those for transcript analysis, were analysed by LC-MS/MS 
employing the same protocol as devised in Section 5.2.5 (Figure 64).  
 
The data gathered in Chapter 6 indicated that there may be an internal regulation pathway that 
restrained any post-induction fluctuation in transcripts being reflected in protein data. The strains 
containing up-regulation constructs appeared to reflect a contradictory story: generally speaking, 
any increase in mRNA level between the parental strains and PIK transformants was reflected at the 
protein level. Specifically, two sample t tests showed GS115[BC1-PIK]H and GSS15[MFE23-PIK]H to 
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have significantly higher KAR2 at 2 hours and 0 hours, respectively. The same statistical tests showed 
the protein levels to also be significantly higher at these time points. The PDI up-regulation, shown in 
both PIK strains at the transcript level, was also clear at the protein level. Indeed, the increased 
mRNA level in the PIK transformants resulted in a seven-fold increase in PDI, successfully up-
regulating the native concentration. 
 
   
Figure 64 – Kar2 and PDI profile in the parental and pIB2[PIK] transformants 
Samples for LC-MS/MS analysis were taken concomitant with RNA samples (Section 2.7). Cells were lysed, the 
protein concentration standardised to 30 μg per sample and spiked with the internal standards. Samples were 
reduced, alkylated and digested before purification with a C18 column. Peaks for each of transitions, together 
with the respective internal standard, were integrated and those used for quantification averaged. Data show 
the average of the peptides across biological triplicates; error bars show the standard error. Two sample t tests 
were used to test the hypothesis that PIK strains had a higher concentration of Kar2/PDI; significant results are 
indicated with asterisks (p value < 0.05). ANOVA and post-hoc Tukey’s comparison tests were conducted to see 
if protein levels changed over the time course; the symbol † indicated a positive results (p value < 0.05). Kar2, 
in GS115[BC1-PIK]H, showed a significant change over time, with the concentration at 2 hours statistically 
different from all other time points. The same strain had statistically less PDI at 4 and 6 hours compared to 2 
hours. In GS115[MFE23-PIK]H, Kar2 was statistically increased at 2, 4 and 6 hours in comparison to -2 and -1 
hours; while PDI showed no significant change over time. 
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7.2.7 Relative quantification of HAC1 expression in pIB2[PIK] transformants 
 
The unclear relationship between yield and Kar2/PDI concentration revealed in Chapter 5 prompted 
the artificial up-regulation of these proteins. The model predicted an up-regulation would decrease 
stress by reducing the available unfolded protein in the system, preventing formation of Ire1A. 
Indeed, experimental results revealed that the high yield strains had lower Kar2 and PDI 
concentration (Figure 55) prior to induction and consequently higher HAC1 levels (Figure 52), the 
indicator of ER stress. Conversely, GS115[BC1]L had the highest Kar2 and PDI protein concentration 
prior to induction and the lowest HAC1 concentration. On this basis, up-regulation of Kar2 and PDI 
should decrease HAC1 levels.  
 
Having said that, the induction of scFv production in GS115[BC1]L generated more stress in this 
strain leading to the highest HAC1 response post-induction (Table 11). Perhaps the high Kar2 and PDI 
native concentration added to the burden of heterologous production generating the highest stress 
level. If this was the case, the seven-fold increase in PDI concentration in the PIK strains should 
exaggerate this effect. To clarify the effect of up-regulation, the transcript level of HAC1 in pIB2[PIK] 
transformants was analysed in comparison to the parental strain (Figure 65).   
 
With only a general up-regulation of PDI in pIB2[PIK] transformants, it is interesting that no great 
reduction in stress was observed prior to induction. Two sample t tests showed no significant 
difference in HAC1 expression, with one exception. Both GS115[BC1-PIK]H and GS115[MFE23-PIK]H 
showed a significant increase in HAC1 expression in the PIK transformants at six hours. As predicted 
from the analysis of GS115[BC1]L, the induction of scFv production in addition to the Kar2 and PDI 
up-regulation caused the transformants to be more stressed than the parental strain.  
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Figure 65 – Relative quantification of HAC1 transcripts in scFv strains with PIK construct 
The high secreting P. pastoris strains, GS115[BC1]H (A) and GS115[MFE23]H (B) were transformed with pIB2-
PIK and analysed by RT Q-PCR. The relative fold change in HAC1 was first subjected to normalisation using the 
internal reference gene SGA1, and subsequently compared to parental strain, following the Pfaffl method of 
calculation. The data bars are the average of three biological repeats; the error bars represent standard error. 
Two sample t tests were used to test the hypothesis that PIK strains had a higher concentration of Kar2/PDI; 
significant results are indicated with asterisks (p value < 0.05). 
 
7.3 Discussion 
 
7.3.1 pIB2[PIK] transformants are not stable 
 
The quantification of KAR2 and PDI transcripts in the pIB2[PIK] transformants revealed the former to 
be an order of magnitude lower than the latter: a surprising result considering those derived from 
the bicistronic mRNA should be in a one-to-one ratio. This result suggested that either the stability of 
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the chromosomal construct or the composite mRNA was low and that the second portion was 
disintegrating. Preliminary experiments were conducted to assess the former: indeed, the presence 
of the whole construct dramatically decreased during cultivation. 
 
Although the constructs had been integrated into the his4 locus, removing histidine auxotrophy, the 
experiments were conducted in rich media in order to maintain consistent experimental conditions. 
This removed the selection pressure maintaining chromosomal integration of the construct, 
permitting recombination to occur. Considering the strong regulation of Kar2 observed in Chapter 6, 
the overexpression may have caused a selective disadvantage to the strains. A study investigating 
the stability of P. pastoris strains expressing multiple copies of porcine insulin precursor also 
observed instability during methanol induction [298]. This preliminary data does, however, only show 
the loss of the full construct from the yeast chromosome, and cannot rule out additional bicistronic 
mRNA instability.  
 
7.3.2 Exogenous constructs not subject to the same internal regulation  
 
Prior to induction, the high yield scFv strains showed increased levels of KAR2 and PDI transcripts, 
but LC-MS/MS data revealed there to be significantly less Kar2 and PDI protein intracellularly. This 
led to two contrasting hypotheses: either (i) the strains were experiencing a translation bottleneck; 
or (ii) there was an uncharacterised regulatory pathway accounting for this – particularly with 
reference to Kar2. Either have implications for one of the most commonly employed strategies for 
increasing cell specific productivity: the overexpression of chaperones and foldases.  
 
The artificial up-regulation of PDI using the pIB2[PIK] constructs showed that the former was not the 
case. The five- to ten-fold increase in PDI was reflected in a six- to seven-fold increase in PDI protein, 
prior to induction, therefore a general translation bottleneck was not applicable. Clearly, the 
parental high yield scFv strains are subject to regulation that the exogenous construct is not. 
 
Unfortunately the low KAR2 copy number across the cultivation period prevented a similarly 
convincing result. The two-fold increase of KAR2 in the BC1 strains at two hours was reflected in a 
similar increase in protein. Although this is a proof of principle for the S. cerevisiae IRES sequence 
and Kar2, the data cannot elaborate on the suggestion that Kar2 is subject to a native regulation 
pathway. 
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7.3.3 Chaperone up-regulation is a double-edged sword 
 
Considering HAC1 fluctuations as an indicator of stress, the integration of pIB2[PIK] constructs into 
the high yield strains did not greatly alter this. This could be attributed to two compounding factors: 
firstly, the increase in Kar2 – the most direct link to ER stress – was not great; and secondly, the up-
regulation of PDI was to such an extent that the production of this protein alone was likely to cause 
some stress. Certainly, following induction the PDI transcripts appeared to suffer from translation 
attenuation or a bottleneck. Between zero and four hours their numbers almost doubled, however, 
protein levels on the whole decreased.  
 
Therefore, up-regulation is a double-edged sword: the huge increase in PDI negated any beneficial 
effect on unfolded protein flux. The promoters available to this study could not provide a more 
suitable dynamic range, and highlighted a gap in the research field: if more targeted engineering 
strategies are to be implemented, the molecular toolbox requires expansion.  
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8. Discussion  
 
The aim of this study was to develop an engineering strategy for increasing the specific productivity 
of scFvs from P. pastoris, using a combination of modelling and experimental analysis. 
 
8.1 Summary of results 
 
In respect of the research aim, the first result was the generation of a dynamic model of scFv 
production in P. pastoris. The mathematical formulation and parameters were derived from the 
literature, with kinetic simplifications where appropriate. The final model structure was capable of 
reproducing two experimental phenomena: secretion saturation and the negative influence of copy 
number on yield.  
 
Nonetheless the model accuracy was limited by the data used to generate it. The majority of 
information came from studies using S. cerevisiae and related protein substrates. Therefore, aspects 
that were either correlated with yield (SCFV mRNA, Kar2), or lacking literature characterisation 
(ERAD), required empirical analysis to improve accuracy. To this end, an experimental system was 
generated which could: (i) capture the biological variation in factors which determine cellular 
capacity for scFv productivity; and (ii) provide compatible data such that it could be meaningfully 
integrated into the model.  
 
Consequently, the genes for BC1 and MFE23 were cloned into the P. pastoris strain GS115 and a high 
and a low secretor of each identified. These were confirmed to contain a single copy of the 
heterologous gene, as model results had highlighted the effect of copy number on yield. 
Additionally, there was no N-glycosylation pathway in the model; therefore the absence of N-
glycosylation on scFv molecules was experimentally confirmed. A growth and sampling protocol was 
also developed to aid the integration of data into the model; likewise, a new internal standard for RT 
Q-PCR was validated as the literature standard, ACT1, was found to be unsuitable. Finally, an LC-
MS/MS method was developed for the absolute quantification of Kar2 and PDI in P. pastoris.  
- DISCUSSION - 
 
- 191 - 
The experimental system and protocols developed in Chapters 4 and 5 were then implemented in 
the characterisation of the low and high yield strains expressing BC1 or MFE23. Immediately, the 
analysis of SCFV transcripts showed a negative correlation between the mRNA and yield. Subsequent 
analysis of UPR and ERAD transcripts revealed a number of routes to productivity, and emphasised 
the role of clonal variation: two results which may rationalise the unpredictable results of traditional 
genetic engineering strategies. Finally, while the majority of scFv strains activated the UPR as 
measured by transcription, these responses did not translate to the protein level. In fact, it 
suggested that there could be either a bottleneck in translation or that the proteins were subject to 
an unknown internal regulation pathway. Indeed, the high yield strains showed lower levels of Kar2 
and PDI than the wild-type or GS115[BC1]L. As the up-regulation of Kar2 and PDI is so frequently 
employed to improve yield, the last result was especially surprising. Therefore, the pIB2[PIK] 
construct was assembled and integrated into the two high secreting strains. Both of the strains 
contained low baseline levels of Kar2 and PDI, allowing this approach to show whether it was indeed 
a translation bottleneck preventing an increase in Kar2 and PDI.  
 
Unfortunately, RT Q-PCR showed very low levels of KAR2 transcripts. This could be due to either the 
instability of the pIB2[PIK] construct when expressed in rich media, or the stability of the bicistronic 
mRNA. The increases in KAR2 and PDI transcript numbers which were observed, however, resulted 
in higher protein levels suggesting that the exogenous construct was not subject to the same 
regulation as the native proteins. Finally, the correlation found between the level of the 
chaperones/foldases and HAC1 in Chapter 6 prompted the investigation of HAC1 levels in the 
pIB2[PIK] transformants. Although PDI was substantially up-regulated across the pre-induction 
period, the magnitude in combination with scFv production caused the up-regulation strains to be 
more stressed under protein production conditions. 
 
8.2 Main conclusions 
 
8.2.1 Modelling the protein production pathway of P. pastoris for industrial production 
 
Unclear correlations between mRNA, protein and recombinant expression levels 
 
In some ways, the experimental findings qualitatively reproduced model correlations with yield. The 
negative effect of increasing gene copy number on yield was experimentally validated by the low 
yield strains both showing higher SCFV mRNA than the high yield strains. The model also suggested a 
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beneficial effect of Kar2 on yield, and an increase in KAR2 transcripts was observed in the high yield 
strains during scFv induction. 
 
The experimental results did, however, reveal a far more complicated picture than the model could 
represent. For instance, all experimental targets varied greatly between the transformants during 
pre-induction conditions, when the effect of scFv induction could not account for differences. 
Indeed, the high yield transformants had the lowest Kar2 and PDI concentration prior to induction, 
and any up-regulation of KAR2 and PDI transcripts during the UPR was not reflected at the protein 
level. Moreover, the low yield BC1 strain showed high PDI up-regulation during induction, but the 
low yield MFE23 strain did not. Both the high yield strains showed ERAD down-regulation during 
induction, but then so did GS115[MFE23]L, preventing any clear rule for ERAD regulation in 
productivity. 
 
To account for these differences, this research would like to suggest that there is more than one 
route to productivity, with implications for traditional strategies to increase yield. In particular, 
strains varied in their capacity for up-regulating the folding (KAR2, PDI) and degradation (E1, UBC7, 
HRD1, DOA10 and CDC48) pathways such that yield was a balance of factors. For instance, high yield 
could arise from a transformant with a low folding capacity if the degradation capacity and SCFV 
transcription rate was similarly low. If this hypothesis is correct, it could help explain the 
unpredictable success rate of traditional strategies to increase yield. Increasing the copy number of a 
transformant with a low folding capacity would only increase misfolding, degradation and stress in 
the system. Therefore, in light of the phenomenon of clonal variation, all transformants cannot be 
considered identical and the host cell background needs to be characterised for strategies to have a 
predictable outcome.  
 
Finally, the greatest drawback of this research is the absence of data for the specific productivity of 
scFvs from each strain, with which to more accurately produce correlations. Although this was a 
target of the study, time limitations prevented its inclusion in this thesis. 
 
In comparison with other studies published, this is the first dynamic modelling and experimental 
analysis of the protein production pathway in P. pastoris. A few metabolic modelling studies have 
been published [148,299]; however, this work represents a different approach to understanding the 
burden of recombinant protein production with particular emphasis on the ER and its associated 
stress pathways. In terms of dynamic models of protein production, this work has expanded on the 
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seminal work by Hildebrandt et al. [157] with the addition of Michaelis-Menten and equilibrium 
kinetics along with the UPR and ERAD pathways. While there are more descriptive models of the 
individual pathways, including transcription [241], translation [242], folding [154], degradation [243] and the 
UPR [216] none are as expansive or specific to yeast. Perhaps here lies the limitation of the approach 
to this research: the models targeting parts of the pathway allow more room for description, and 
represent experimental data better. Here, a parsimonious approach was taken to link these parts 
together to represent some features of the pathway, but in this reduction its capacity to recapitulate 
experimental data was lost. 
 
The experimental analysis attempted to correlate some factors with recombinant protein yield, and 
followed some of the traditional methods – such as using RT Q-PCR to characterise the expression of 
UPR and ERAD targets [189]. Here, however, the protein levels of Kar2 and PDI were also analysed, 
adding an additional layer of detail and pointing towards a future of proteomic studies in this field. 
Moreover, while many studies have generated multicopy strains to increase heterologous transcript 
numbers, this research observed a great deal of variation in the SCFV mRNA of single copy integrants. 
The results, however, did not generate clear correlations for all of the targets and was ultimately 
limited by the insufficient number of clones selected for characterisation. A great deal of time was 
dedicated to the development of the LC-MS/MS method, however, it benefits from high sample 
throughput once validated. Therefore, future studies could take advantage of this method to make 
the analysis of protein (in addition to mRNA expression) more routine. 
 
Experimental implications for model assumptions 
 
With respect to the experimental analysis, the current model assumed a general host cell 
background from which to predict yield. The analysis produced some factors, most importantly SCFV 
transcript level, which correlated with yield. Simulating the model with the experimental SCFV 
transcript levels, however, would not reproduce the observed yield; high transcript levels would 
generate high scFv yield and vice-versa.   
 
The shortcomings in the model are a consequence of the assumptions made. Firstly, the mass action 
kinetics employed in the transcription and translation expressions were deemed appropriate as the 
ER capacity was assumed to primarily limit production. The results from GS115[MFE23]L, however, 
revealed a bottleneck such that the induction of scFv production saturated transcriptional capacity 
preventing any UPR or ERAD response. Transcription, along with most of the processes included in 
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the model, required energy to function yet this was not included. Therefore, in addition to saturating 
the components of transcription, these processes may have been limited by a lack of energy in 
GS115[MFE23]L. 
 
Secondly, as noted in the previous section, the experimental results suggested that there might be 
more than one route to yield. This implies independent regulation of factors, including KAR2, PDI 
and ERAD transcripts. The current model only has one global regulator, HAC1S; therefore the 
regulation needs expanding. It has to capture the ability of GS115 to up-regulate Kar2 and PDI 
without concomitant HAC1, and the up-regulation of ERAD activity separate from the folding 
pathway.  
 
Moreover, a better understanding of the native Kar2 regulation pathway is required. During the 
course of this research, pIB2 constructs containing either KAR2 or PDI alone were generated; the 
former may well prove useful in understanding the regulation and what features determine it. The 
simple up-regulation through an exogenous construct may be a heavy handed approach to the 
problem: understanding the regulation may provide the option for exogenous control. Indeed, the 
ability to fine tune the native production is a far better prospect than duplicating the proteins – 
particularly as P. pastoris shows some signs of instability. 
 
Finally, the lower Kar2 and PDI protein levels prior to induction in the high yield strains could be 
attributed to selection of “minimal strains”; that is, clonal variation and the selection of productivity 
following growth in minimal media may have identified more economical transformants (a reduced 
host protein pathway would leave greater resources heterologous protein production). The model, 
in its current form, incorporates no influence of host cell proteins other than to reduce the available 
chaperones, foldases and E3 ubiquitin ligases to 40% of the total. Consequently, simulating the 
model with a lower initial Kar2 and PDI concentration will never produce a higher yield.  
 
8.3 Recommendations for future work 
 
From the previous analysis, it is clear that the experimental results invalided many of the model 
assumptions. In the current form, it cannot be reliably applied to engineering productivity of scFvs in 
P. pastoris. Therefore, future work should initially focus on expanding the model and resolving 
experimental implications for model assumptions.  
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8.3.1 Expansion of the model with the aim of engineering productivity 
 
The output of the computational model was folded scFv in the ER of the cell, while the experimental 
dot blot selection of strains considered the secreted scFv. At the very least, this assumed no loss or 
temporal delay during secretion. Clearly this is implausible; initially, this research aimed to quantify 
the intracellular and extracellular scFv over the experimental time course using the C-terminal 
polyhistidine tag and the BLItz™ protein quantitation system. The results would allow the calculation 
the secretion rate, as a single step, for incorporation into the model.  
 
Secondly, the mass action kinetics of transcription and translation need amending, to allow 
competition between the heterologous gene and the host cell protein pathway and stress responses. 
Moreover, this would have ramifications for the negative consequences of up-regulating Kar2 and 
PDI to increase yield, as this would also provide a drain of resources that may aid heterologous 
protein production. To do this, the pathways which currently lack limits (such as transcription and 
translation) will need upper bounds, otherwise competition will not occur. One way to do this would 
be to make the rate of transcription and translation a composite of the basal rate multiplied by the 
number of polymerases or ribosomes, with an expression to constrain the latter. With no available 
polymerases or ribosomes, no transcription or translation would occur. Such a model might simulate 
the competition between the host and heterologous genetic elements for resources, and 
incorporate the trade off traditional strategies to increase yield face.  
 
Thirdly, the HAC1 autocracy requires revision: the model should be able to capture KAR2, PDI and 
ERAD regulation without concomitant increases in HAC1 (as shown by the wild-type, GS115). It also 
requires the protein level regulation, to reproduce the increases in mRNA that are not reflected at 
the protein level. To do this, the parsimonious approach to the host cell proteins (whereby 
expressions only described the protein levels) first needs expanding to allow for both transcription 
and translation. Secondly, the regulation of each level has to be incorporated – this is more difficult 
as literature evidence is lacking. An initial step could include a proteomics approach, which have 
been lacking in P. pastoris. The generation of constructs to knock out arginine and lysine synthesis in 
P. pastoris will aid [277] this by allowing a SILAC approach to understanding the proteome changes in 
heterologous protein production. Once a list of differentially translated proteins, both between 
glycerol and methanol phases and between the strains, has been identified individual targets could 
be selected for further characterisation. Additionally, the work would provide a suite of markers for 
the high-throughput analysis of capacity and stress, perhaps particularly relevant in the screening of 
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industrial production strains.  
 
The canonical explanation of systems biology is an iterative process: the researcher starts with an 
understanding of the process derived from the literature and develops a computational model. This 
model is used to formulate hypotheses which are then investigated experimentally. Finally, the 
results can be used to either validate a complete model, or highlight areas of development. Here, 
the initial model developed was the simplest that was thought to encapsulate the necessary 
behaviours qualitatively. The experimental investigation has, however, highlighted areas which 
require a more detailed kinetic representation. The recommended inclusions above may go some 
way towards generating a model that more accurately represents the data found during the course 
of this research. 
 
8.3.2 The P. pastoris molecular toolbox and a synthetic approach to host optimisation  
 
While the focus of the research presented here was to understand the route to yield, the end goal 
was to develop a strategy for increasing scFv specific productivity from P. pastoris. The results from 
strains overexpressing PDI emphasised the need for molecular tools which can more precisely 
regulate any exogenous elements.  
 
This should aid research in two directions. Initially, the tools will help researchers investigating the 
biology and biochemistry underlying protein production. Currently, the most utilised tools are DTT 
and tunicamycin, chemical inducers of the UPR and ER stress. Both, however, have pleiotropic 
effects which cause widespread activation of multiple pathways preventing any subtle investigation 
of specific pathways. The pIB2[PIK] constructs, similarly, had such a great up-regulation of PDI that it 
in itself caused as much stress as the scFv production.  
 
Synthetic biology has the goal of developing new tools, and redesigning current ones, in a precise 
and quantifiable way. These standard parts can be incorporated into systems with, in theory, 
predictable outcomes [300]. This starts with the development and characterisation of integral parts 
such as promoters. A few studies have started to expand beyond the habitual pAOX1 and pGAP, 
either through transcriptomics studies to find differentially regulated genes under the required 
conditions [287], adding and deleting putative transcription factor binding sites (pAOX1) [301], or 
random mutagenesis (pGAP) [302]. Moreover, bidirectional promoters would aid the implementation 
of optimisation strategies, as doubtless they will require more than one amendment to the host 
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pathway. Here, the implementation of the IRES sequence is a first step towards a combinatorial 
approach; however, a more detailed characterisation of its properties is required. 
 
Finally, beyond applying a synthetic approach to expression strategies, it could be applied to the very 
mediators employed. Specifically, a recent study found that a mutation in the S. cerevisiae Kar2 
sequence allowed it to mediate ERAD degradation but could not participate in protein translocation 
into the ER [303]. Clearly, development of mutants with specific and quantifiable roles will help the 
predictability of overexpression strategies. For instance, the use of a mutant Kar2 that could not 
participate in ERAD may help divert flux through the folding pathway.  
 
8.4 Summary 
 
To optimise P. pastoris strains for heterologous protein production a clearer 
understanding of the competition between host proteins, heterologous proteins and the 
regulation applying to factors which determine productivity is required. To do this the 
experimental tools with which we investigate the system need developing. Initially, a 
better understanding of the proteomic changes is required as the changes in transcript 
levels have been heavily relied upon but do not necessarily correlate. Further ahead, a 
synthetic approach to the tools with which the system is investigated and strategies are 
implemented is needed.  
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10. Appendix I: Single cell model of scFv 
production 
10.1 Equations 
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10.2 Parameters 
 
Table 12 – Parameters values employed in model simulations 
Parameter Value 
Transcription, translation, folding and misfolding 
        molecule 
          .    molecules s
   
      .  molecules s
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   molecules s   
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ERAD degradation 
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Kar2, PDI and E3 production and degradation 
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           .   molecules 
            .    s
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                      molecules 
UPR and HAC1U splicing 
           .        molecules s   
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10.3 Initial conditions 
 
Table 13 – Initial conditions for each state variable of the model 
State variable Value 
Matrices 
      molecules 
      molecules 
           molecules 
              molecules 
             molecules 
          molecules 
Others 
        molecules 
        molecules 
        molecules 
      molecules 
         molecules 
        molecules 
          molecules 
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11. Appendix II: In silico prediction of N-
linked glycosylation sites 
 
BC1 [A] and MFE23 [B] amino acid sequences were analysed with the NetNGlyc 1.0 Server [304], along 
with human corticosteroid-binding globulin (CBG) as a positive control [C]; neither scFv contains any 
predicted N-linked glycosylation sites. 
 
 
[A]
[B]
[C]
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12. Appendix III: DNA sequences 
 
Alignments of were produced using Multalin Version 5.4.1 [305]. 
 
12.1 BC1 sequence of pPICZαA[BC1] 
 
BC1 (BC1_gene) against sequencing results from pPICZαA[BC1] (BC1_seq): 
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12.2 MFE23 sequence of pPICZαA[MFE23] 
 
MFE23 (MFE23_gene) against sequencing results from pPICZαA[MFE23] (MFE23_seq): 
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12.3 PIK sequence of pIB2[PIK] 
 
(Continued on next page…) 
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12.4 P. pastoris and S. cerevisiae Kar2 alignment 
 
P. pastoris Kar2 (GenBank: AAX77226.1) against S. cerevisiae Kar2 (GenBank: CAA89325.1); in the 
consensus line, upper case indicates conserved amino acids, lower case indicates non-conserved 
amino acids, '!' is I or V, '$' is L or M, '%' is F or Y and '#' is either one of NDQEBZ. Box indicates 
signature peptide. 
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13. Appendix IV: RT Q-PCR standard curve 
reproducibility 
 
For each absolute quantification assay, the reproducibility of the standard curve was tested. Three 
curves, ranging from 10 copies to 1010 copies per reaction, were independently generated and 
assayed in separate mastermixes. Duplicate reactions were averaged and the Ct value plotted 
against a log transformation of the copy number per well. The data was fitted with a linear 
regression; error bars represent the standard deviation.  
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14. Appendix V: Statistical results 
 
t Test Results 
Subject 
Degrees of 
freedom 
t stat p value 
ACT1 GS115[BC1]H BMGY and BMMY (Figure 34)  2 6.91 0.0102 
ACT1 GS115[BC1]L BMGY and BMMY (Figure 34) 2 4.03 0.0283 
ACT1 GS115[MFE23]H BMGY and BMMY (Figure 34) 2 22.1 0.00102 
ACT1 GS115[MFE23]L BMGY and BMMY (Figure 34) 2 6.63 0.0110 
SCFV 4 HR GS115[BC1]H and GS115[BC1]L (Figure 51 [A]) 4 2.45 0.0352 
SCFV 4 HR GS115[MFE23]H and GS115[MFE23]L (Figure 51 [B]) 4 3.10 0.0181 
KAR2 GS115 and GS115[BC1]L (Figure 52) 5 2.12 0.0439 
KAR2 GS115 and GS115[MFE23]L (Figure 52) 4 5.52 0.00263 
PDI GS115 and GS115[BC1]H (Figure 52) 4 2.30 0.0414 
PDI GS115 and GS115[MFE23]L (Figure 52) 4 9.35 0.000364 
HAC1 GS115 and GS115[BC1]L (Figure 52) 5 13.4 2.08 x 10
-5
 
HAC1 GS115 and GS115[MFE23]L (Figure 52)  2.32 0.0404 
KAR2 4 HR GS115[BC1]H and GS115[BC1]L (Figure 54 [A]) 5 3.61 0.00763 
KAR2 2 HR GS115[MFE23]H and GS115[MFE23]L (Figure 54 [A]) 4 9.48 0.000346 
PDI 4 HR GS115[BC1]H and GS115[BC1]L (Figure 54 [B]) 4 2.34 0.0330 
PDI 6 HR GS115[BC1]H and GS115[BC1]L (Figure 54 [B]) 4 3.29 0.0109 
PDI 2 HR GS115[MFE23]H and GS115[MFE23]L (Figure 54 [B]) 4 4.96 0.00385 
PDI 4 HR GS115[MFE23]H and GS115[MFE23]L (Figure 54 [B]) 4 2.89 0.0222 
PDI 6 HR GS115[MFE23]H and GS115[MFE23]L (Figure 54 [B]) 4 3.11 0.0179 
Kar2 GS115 and GS115[BC1]L (Figure 55) 10 2.37 0.0195 
Kar2 GS115 and GS115[BC1]H (Figure 55) 10 9.27 1.59 x 10
-6
 
Kar2 GS115 and GS115[MFE23]L (Figure 55) 10 5.48 0.000135 
Kar2 GS115 and GS115[MFE23]H (Figure 55) 10 8.75 2.66 x 10
-6
 
PDI GS115 and GS115[BC1]H (Figure 55) 4 3.77 0.00979 
PDI GS115 and GS115[MFE23]H (Figure 55) 4 2.50 0.0333 
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PDI GS115 and GS115[MFE23]L (Figure 55) 4 2.43 0.0361 
E1 GS115 and GS115[BC1]L (Figure 58) 5 2.56 2.02 
E1 GS115 and GS115[MFE23]H (Figure 58) 3 6.88 2.35 
E1 GS115 and GS115[MFE23]L (Figure 58) 3 122 2.35 
UBC7 GS115 and GS115[BC1]L (Figure 58) 5 2.20 2.02 
UBC7 GS115 and GS115[MFE23]H (Figure 58) 3 7.23 2.35 
HRD1 GS115 and GS115[BC1]L (Figure 58) 5 9.74 2.02 
HRD1 GS115 and GS115[MFE23]H (Figure 58) 3 97.9 2.35 
HRD1 GS115 and GS115[MFE23]L (Figure 58) 3 7.04 2.35 
DOA10 GS115 and GS115[MFE23]H (Figure 58) 3 5.59 2.35 
DOA10 GS115 and GS115[MFE23]L (Figure 58) 3 16.2 2.35 
CDC48 GS115 and GS115[BC1]H (Figure 58) 3 368 2.35 
CDC48 GS115 and GS115[BC1]L (Figure 58) 5 3.67 2.02 
CDC48 GS115 and GS115[MFE23]H (Figure 58) 3 4.65 2.35 
CDC48 GS115 and GS115[MFE23]L (Figure 58) 3 3.18 2.35 
E1 6 HR GS115[BC1]H and GS115[BC1]L (Figure 59 5 3.63 2.57 
E1 2 HR GS115[MFE23]H and GS115[MFE23]L (Figure 59) 4 6.16 2.78 
E1 4 HR GS115[MFE23]H and GS115[MFE23]L (Figure 59) 4 4.03 2.78 
E1 6 HR GS115[MFE23]H and GS115[MFE23]L (Figure 59) 4 2.89 2.78 
UBC7 6 HR GS115[BC1]H and GS115[BC1]L (Figure 59) 5 3.48 2.57 
UBC7 2 HR GS115[MFE23]H and GS115[MFE23]L (Figure 59) 4 3.87 2.78 
HRD1 2 HR GS115[BC1]H and GS115[BC1]L (Figure 59) 5 3.47 2.57 
HRD1 4 HR GS115[BC1]H and GS115[BC1]L (Figure 59) 5 2.79 2.57 
HRD1 6 HR GS115[BC1]H and GS115[BC1]L (Figure 59) 5 11.6 2.57 
DOA10 2 HR GS115[BC1]H and GS115[BC1]L (Figure 59) 5 4.36 2.57 
DOA10 4 HR GS115[BC1]H and GS115[BC1]L (Figure 59) 5 3.73 2.57 
DOA10 6 HR GS115[BC1]H and GS115[BC1]L (Figure 59) 5 5.17 2.57 
DOA10 2 HR GS115[MFE23]H and GS115[MFE23]L (Figure 59) 4 4.37 2.78 
DOA10 4 HR GS115[MFE23]H and GS115[MFE23]L (Figure 59) 4 2.99 2.78 
CDC48 6 HR GS115[BC1]H and GS115[BC1]L (Figure 59) 5 2.84 2.57 
CDC48 2 HR GS115[MFE23]H and GS115[MFE23]L (Figure 59) 4 5.15 2.78 
CDC48 4 HR GS115[MFE23]H and GS115[MFE23]L (Figure 59) 4 4.83 2.78 
CDC48 6 HR GS115[MFE23]H and GS115[MFE23]L (Figure 59) 4 4.56 2.78 
KAR2 0 HR GS115[MFE23]H and GS115[MFE23-PIK]H (Figure 63 [A]) 4 2.44 0.0354 
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KAR2 2 HR GS115[BC1]H and GS115[BC1-PIK]H (Figure 63 [A]) 4 4.07 0.00760 
PDI -2 HR GS115[BC1]H and GS115[BC1-PIK]H (Figure 63 [B]) 4 3.31 0.0148 
PDI -1 HR GS115[BC1]H and GS115[BC1-PIK]H (Figure 63 [B]) 4 3.72 0.0102 
PDI 0 HR GS115[BC1]H and GS115[BC1-PIK]H (Figure 63 [B]) 4 9.39 0.000359 
PDI 2 HR GS115[BC1]H and GS115[BC1-PIK]H (Figure 63 [B]) 4 7.29 0.00939 
PDI 4 HR GS115[BC1]H and GS115[BC1-PIK]H (Figure 63 [B]) 4 5.18 0.00331 
PDI 6 HR GS115[BC1]H and GS115[BC1-PIK]H (Figure 63 [B]) 4 6.52 0.00143 
PDI -2 HR GS115[MFE23]H and GS115[MFE23-PIK]H (Figure 63 [B]) 4 2.79 0.0245 
PDI -1 HR GS115[MFE23]H and GS115[MFE23-PIK]H (Figure 63 [B]) 4 3.37 0.0140 
PDI 0 HR GS115[MFE23]H and GS115[MFE23-PIK]H (Figure 63 [B]) 4 19.6 2 X 10
-5
 
PDI 4 HR GS115[MFE23]H and GS115[MFE23-PIK]H (Figure 63 [B]) 4 4.27 0.00647 
PDI 6 HR GS115[MFE23]H and GS115[MFE23-PIK]H (Figure 63 [B]) 4 3.94 0.00851 
Kar2 2 HR GS115[BC1]H and GS115[BC1-PIK]H (Figure 64 [A]) 10 4.15 1.81 
PDI -2 HR GS115[BC1]H and GS115[BC1-PIK]H (Figure 64 [B]) 4 16.2 2.13 
PDI -1 HR GS115[BC1]H and GS115[BC1-PIK]H (Figure 64 [B]) 4 9.68 2.13 
PDI 0 HR GS115[BC1]H and GS115[BC1-PIK]H (Figure 64 [B]) 4 11.3 2.13 
PDI 2 HR GS115[BC1]H and GS115[BC1-PIK]H (Figure 64 [B]) 4 10.0 2.13 
PDI 4 HR GS115[BC1]H and GS115[BC1-PIK]H (Figure 64 [B]) 4 7.1 2.13 
PDI 6 HR GS115[BC1]H and GS115[BC1-PIK]H (Figure 64 [B]) 4 7.25 2.13 
Kar2 0 HR GS115[MFE23]H and GS115[MFE23-PIK]H (Figure 64 [C]) 10 4.85 1.81 
Kar2 6 HR GS115[MFE23]H and GS115[MFE23-PIK]H (Figure 64 [C]) 10 1.98 1.81 
PDI -2 HR GS115[MFE23]H and GS115[MFE23-PIK]H (Figure 64 [D]) 4 14.1 2.13 
PDI -1 HR GS115[MFE23]H and GS115[MFE23-PIK]H (Figure 64 [D]) 4 21.2 2.13 
PDI 0 HR GS115[MFE23]H and GS115[MFE23-PIK]H (Figure 64 [D]) 4 16.1 2.13 
PDI 2 HR GS115[MFE23]H and GS115[MFE23-PIK]H (Figure 64 [D]) 4 17.8 2.13 
PDI 4 HR GS115[MFE23]H and GS115[MFE23-PIK]H (Figure 64 [D]) 4 10.7 2.13 
PDI 6 HR GS115[MFE23]H and GS115[MFE23-PIK]H (Figure 64 [D]) 4 18.8 2.13 
HAC1 6 HR GS115[BC1]H and GS115[BC1-PIK]H (Figure 65 [A]) 4 2.40 2.13 
HAC1 6 HR GS115[MFE23]H and GS115[MFE23-PIK]H (Figure 65 [A]) 4 11.9 2.13 
ANOVA Results 
Subject 
Degrees of 
freedom 
F value p value 
ACT1 GS115[BC1]H (Figure 36) 3, 4 5.36 0.069 
SGA1 GS115[BC1]H (Figure 36) 3, 4 4.24 0.019 
KAR2 GS115 (Figure 53) 5, 12 25.4 5.44 x 10
-6
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PDI GS115 (Figure 53) 5, 12 14.0 0.000117 
Kar2 GS115[MFE23]H (Figure 56) 5, 30 8.65 0.000037 
E1 GS115 (Figure 57) 5, 12 6.18 0.00465 
UBC7 GS115 (Figure 57) 5, 12 5.32 0.00835 
HRD1 GS115 (Figure 57) 5, 12 5.70 0.00640 
CDC48 GS115 (Figure 57) 5, 12 15.4 0.000074 
E1 GS115[BC1]L (Figure 58 [A]) 5, 18 6.37 0.00143 
E1 GS115[BC1]H (Figure 58 [A]) 5, 12 17.1 0.000043 
UBC7 GS115[BC1]H (Figure 58 [B]) 5, 12 13.4 0.000145 
UBC7 GS115[BC1]L (Figure 58 [B]) 5, 18 7.38 0.000639 
UBC7 GS115[MFE23]H (Figure 58 [B]) 5, 12 4.52 0.015 
HRD1 GS115[BC1]L (Figure 58 [C]) 5, 18 6.43 0.00137 
HRD1 GS115[BC1]H (Figure 58 [C]) 5, 12 7.22 0.00247 
DOA10 GS115[BC1]L (Figure 58 [D]) 5, 18 6.91 0.000924 
DOA10 GS115[BC1]H (Figure 58 [D]) 5, 12 10.1 0.000571 
DOA10 GS115[MFE23]H (Figure 58 [D]) 5, 12 5.27 0.00861 
CDC48 GS115[MFE23]L (Figure 58 [E]) 5, 12 8.69 0.00111 
CDC48 GS115[BC1]H (Figure 58 [E]) 5, 12 4.24 0.019 
CDC48 GS115[MFE23]H (Figure 58 [E]) 5, 12 9.38 0.000786 
 
